Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Alzheimer's Disease

  Free Subscription


Articles published in J Alzheimers Dis

Retrieve available abstracts of 1112 articles:
HTML format



Single Articles


    November 2022
  1. GARCIA MJ, Leadley R, Lang S, Ross J, et al
    Real-World Use of Symptomatic Treatments in Early Alzheimer's Disease.
    J Alzheimers Dis. 2022 Nov 18. doi: 10.3233/JAD-220471.
    PubMed     Abstract available


  2. SWERDLOW NR, Joshi YB, Sprock J, Talledo J, et al
    Preliminary Evidence that Memantine Enhances Prepulse Effects on Startle Magnitude and Latency in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2022 Nov 17. doi: 10.3233/JAD-220769.
    PubMed     Abstract available


  3. WHITEHOUSE PJ, George DR
    Dignity for All: How the Challenges of Alzheimer's Disease Need Rethinking and Revaluing.
    J Alzheimers Dis. 2022 Nov 15. doi: 10.3233/JAD-221066.
    PubMed    


  4. KIM J, Jang H, Park YH, Youn J, et al
    Motor Symptoms in Early- versus Late-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2022 Nov 15. doi: 10.3233/JAD-220745.
    PubMed     Abstract available


  5. LUKKARINEN H, Vanninen A, Tesseur I, Pemberton D, et al
    Concordance of Alzheimer's Disease-Related Biomarkers Between Intraventricular and Lumbar Cerebrospinal Fluid in Idiopathic Normal Pressure Hydrocephalus.
    J Alzheimers Dis. 2022 Nov 15. doi: 10.3233/JAD-220652.
    PubMed     Abstract available


  6. LIU S, Dashper SG, Zhao R
    Association Between Oral Bacteria and Alzheimer's Disease: A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2022 Nov 14. doi: 10.3233/JAD-220627.
    PubMed     Abstract available


  7. CHEN L, Xue J, Zhao Q, Liang X, et al
    A Pilot Study of Near-Infrared Light Treatment for Alzheimer's Disease.
    J Alzheimers Dis. 2022 Nov 11. pii: JAD220866. doi: 10.3233/JAD-220866.
    PubMed     Abstract available


  8. LIU Z, Zhang H, Liu S, Hou Y, et al
    The Dual Role of Astrocyte-Derived Exosomes and Their Contents in the Process of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Nov 11. pii: JAD220698. doi: 10.3233/JAD-220698.
    PubMed     Abstract available


  9. DOVER M, Moseley T, Biskaduros A, Paulchakrabarti M, et al
    Polyunsaturated Fatty Acids Mend Macrophage Transcriptome, Glycome, and Phenotype in the Patients with Neurodegenerative Diseases, Including Alzheimer's Disease.
    J Alzheimers Dis. 2022 Nov 8. pii: JAD220764. doi: 10.3233/JAD-220764.
    PubMed     Abstract available


  10. JOHNSON AL, Seep E, Norton DL, Mundt MP, et al
    Wisconsin Healthcare Utilization Cost Among American Indians/Alaska Natives with and without Alzheimer's Disease and Related Dementias.
    J Alzheimers Dis. 2022 Nov 8. pii: JAD220393. doi: 10.3233/JAD-220393.
    PubMed     Abstract available


  11. GAUBERT F, Borg C, Chainay H
    Decision-Making in Alzheimer's Disease: The Role of Working Memory and Executive Functions in the Iowa Gambling Task and in Tasks Inspired by Everyday Situations.
    J Alzheimers Dis. 2022 Nov 3. pii: JAD220581. doi: 10.3233/JAD-220581.
    PubMed     Abstract available


  12. CHEN X, Jiang S, Wang R, Bao X, et al
    Neural Stem Cells in the Treatment of Alzheimer's Disease: Current Status, Challenges, and Future Prospects.
    J Alzheimers Dis. 2022 Nov 2. pii: JAD220721. doi: 10.3233/JAD-220721.
    PubMed     Abstract available



  13. Erratum to: A Machine Learning-Based Holistic Approach to Predict the Clinical Course of Patients within the Alzheimer's Disease Spectrum.
    J Alzheimers Dis. 2022 Nov 1. pii: JAD229016. doi: 10.3233/JAD-229016.
    PubMed    


  14. KRISHNA G, Santhoshkumar R, Sivakumar PT, Alladi S, et al
    Pathological (Dis)Similarities in Neuronal Exosome-Derived Synaptic and Organellar Marker Levels Between Alzheimer's Disease and Frontotemporal Dementia.
    J Alzheimers Dis. 2022 Nov 1. pii: JAD220829. doi: 10.3233/JAD-220829.
    PubMed     Abstract available


  15. HUANG L, Lu Z, Zhang H, Wen H, et al
    A Novel Strategy for Alzheimer's Disease Based on the Regulatory Effect of Amyloid-beta on Gut Flora.
    J Alzheimers Dis. 2022 Nov 1. pii: JAD220651. doi: 10.3233/JAD-220651.
    PubMed     Abstract available


    October 2022
  16. KLEIMAN MJ, Chang LC, Galvin JE
    The Brain Health Platform: Combining Resilience, Vulnerability, and Performance to Assess Brain Health and Risk of Alzheimer's Disease and Related Disorders.
    J Alzheimers Dis. 2022 Oct 31. pii: JAD220927. doi: 10.3233/JAD-220927.
    PubMed     Abstract available


  17. GIRALDO DL, Smith RE, Struyfs H, Niemantsverdriet E, et al
    Investigating Tissue-Specific Abnormalities in Alzheimer's Disease with Multi-Shell Diffusion MRI.
    J Alzheimers Dis. 2022 Oct 31. pii: JAD220551. doi: 10.3233/JAD-220551.
    PubMed     Abstract available


  18. LATON J, Van Schependom J, Goossens J, Wiels W, et al
    Improved Alzheimer's Disease versus Frontotemporal Lobar Degeneration Differential Diagnosis Combining EEG and Neurochemical Biomarkers: A Pilot Study.
    J Alzheimers Dis. 2022 Oct 29. pii: JAD220693. doi: 10.3233/JAD-220693.
    PubMed     Abstract available


  19. MUSAEUS CS, Waldemar G, Andersen BB, Hogh P, et al
    Long-Term EEG Monitoring in Patients with Alzheimer's Disease Using Ear-EEG: A Feasibility Study.
    J Alzheimers Dis. 2022 Oct 29. pii: JAD220491. doi: 10.3233/JAD-220491.
    PubMed     Abstract available


  20. SCHAFFERT J, Bue CL, Hynan LS, Hart J, et al
    Erratum to: Predictors of Life Expectancy in Autopsy-Confirmed Alzheimer's Disease.
    J Alzheimers Dis. 2022 Oct 26. pii: JAD229015. doi: 10.3233/JAD-229015.
    PubMed    


  21. GOLZARI-SORKHEH M, Weaver DF, Reed MA
    COVID-19 as a Risk Factor for Alzheimer's Disease.
    J Alzheimers Dis. 2022 Oct 26. pii: JAD220800. doi: 10.3233/JAD-220800.
    PubMed     Abstract available


  22. GAO F, Zhang PF, Gao J, Song J, et al
    The CCL2 rs4586 SNP Is Associated with Slower Amyloid-beta Deposition and Faster Tau Accumulation of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Oct 26. pii: JAD220716. doi: 10.3233/JAD-220716.
    PubMed     Abstract available


  23. MA Y, Li W, Fan C, Wang Y, et al
    Comprehensive Analysis of Long Non-Coding RNAs N4-Acetylcytidine in Alzheimer's Disease Mice Model Using High-Throughput Sequencing.
    J Alzheimers Dis. 2022 Oct 26. pii: JAD220564. doi: 10.3233/JAD-220564.
    PubMed     Abstract available


  24. DISSANAYAKE AS, Tan YB, Bowie CR, Butters MA, et al
    Sex Modifies the Associations of APOEvarepsilon4 with Neuropsychiatric Symptom Burden in Both At-Risk and Clinical Cohorts of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Oct 25. pii: JAD220586. doi: 10.3233/JAD-220586.
    PubMed     Abstract available


  25. CHAUDHARY S, Zhornitsky S, Chao HH, van Dyck CH, et al
    Hypothalamic Functional Connectivity and Apathy in People with Alzheimer's Disease and Cognitively Normal Healthy Controls.
    J Alzheimers Dis. 2022 Oct 22. pii: JAD220708. doi: 10.3233/JAD-220708.
    PubMed     Abstract available


  26. GAITAN JM, Asthana S, Carlsson CM, Engelman CD, et al
    Circulating Klotho Is Higher in Cerebrospinal Fluid than Serum and Elevated Among KLOTHO Heterozygotes in a Cohort with Risk for Alzheimer's Disease.
    J Alzheimers Dis. 2022 Oct 22. pii: JAD220571. doi: 10.3233/JAD-220571.
    PubMed     Abstract available


  27. JACOBS N, Theunissen B
    It's Groundhog Day! What Can the History of Science Say About the Crisis in Alzheimer's Disease Research?
    J Alzheimers Dis. 2022 Oct 21. pii: JAD220569. doi: 10.3233/JAD-220569.
    PubMed     Abstract available


  28. PONTRELLO CG, McWhirt JM, Glabe CG, Brewer GJ, et al
    Age-Related Oxidative Redox and Metabolic Changes Precede Intraneuronal Amyloid-beta Accumulation and Plaque Deposition in a Transgenic Alzheimer's Disease Mouse Model.
    J Alzheimers Dis. 2022 Oct 19. pii: JAD220824. doi: 10.3233/JAD-220824.
    PubMed     Abstract available


  29. WANG YR, Wang MT, Zeng XQ, Liu YH, et al
    Associations of Naturally Occurring Antibodies to Presenilin-1 with Brain Amyloid-beta Load and Cognitive Impairment in Alzheimer's Disease.
    J Alzheimers Dis. 2022 Oct 19. pii: JAD220775. doi: 10.3233/JAD-220775.
    PubMed     Abstract available


  30. EHLEN JC, Forman CM, Ostrowski D, Ostrowski TD, et al
    Autonomic Dysfunction Impairs Baroreflex Function in an Alzheimer's Disease Animal Model.
    J Alzheimers Dis. 2022 Oct 19. pii: JAD220496. doi: 10.3233/JAD-220496.
    PubMed     Abstract available


  31. HILUND-CARLSEN PF, Revheim ME, Alavi A, Satyamurthy N, et al
    Amyloid PET: A Questionable Single Primary Surrogate Efficacy Measure on Alzheimer Immunotherapy Trials.
    J Alzheimers Dis. 2022 Oct 17. pii: JAD220841. doi: 10.3233/JAD-220841.
    PubMed     Abstract available


  32. SEGURA-URIBE JJ, Garcia-de la Torre P, Castillo-Mendieta T, Bribiesca-Cruz I, et al
    Tibolone Improves Memory and Decreases the Content of Amyloid-beta Peptides and Tau Protein in the Hippocampus of a Mice Model of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Oct 17. pii: JAD220434. doi: 10.3233/JAD-220434.
    PubMed     Abstract available


  33. ROVETA F, Cermelli A, Boschi S, Ferrandes F, et al
    Synaptic Proteins as Fluid Biomarkers in Alzheimer's Disease: A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2022 Oct 15. pii: JAD220515. doi: 10.3233/JAD-220515.
    PubMed     Abstract available


  34. XIA X, Qin Q, Peng Y, Wang M, et al
    Retinal Examinations Provides Early Warning of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Oct 14. pii: JAD220596. doi: 10.3233/JAD-220596.
    PubMed     Abstract available


  35. RITCHIE M, Witbracht M, Nuno MM, Hoang D, et al
    Effect of Aducanumab Approval on Willingness to Participate in Preclinical Alzheimer's Disease Trials.
    J Alzheimers Dis. 2022 Oct 12. pii: JAD220801. doi: 10.3233/JAD-220801.
    PubMed     Abstract available


  36. LI TR, Lyu DY, Liu FQ
    Cerebrospinal Fluid sTREM2 in Alzheimer's Disease Is Associated with Both Amyloid and Tau Pathologies but not with Cognitive Status.
    J Alzheimers Dis. 2022 Oct 6. pii: JAD220598. doi: 10.3233/JAD-220598.
    PubMed     Abstract available


  37. WELLER AE, Ferraro TN, Doyle GA, Reiner BC, et al
    Single Nucleus Transcriptome Data from Alzheimer's Disease Mouse Models Yield New Insight into Pathophysiology.
    J Alzheimers Dis. 2022 Oct 1. pii: JAD220391. doi: 10.3233/JAD-220391.
    PubMed     Abstract available


  38. HUANG Y, Driedonks TAP, Cheng L, Rajapaksha H, et al
    Brain Tissue-Derived Extracellular Vesicles in Alzheimer's Disease Display Altered Key Protein Levels Including Cell Type-Specific Markers.
    J Alzheimers Dis. 2022 Oct 1. pii: JAD220322. doi: 10.3233/JAD-220322.
    PubMed     Abstract available


  39. FUKUDA H, Maeda M, Murata F, Murata Y, et al
    Anti-Dementia Drug Persistence Following Donepezil Initiation Among Alzheimer's Disease Patients in Japan: LIFE Study.
    J Alzheimers Dis. 2022 Oct 1. pii: JAD220200. doi: 10.3233/JAD-220200.
    PubMed     Abstract available


    September 2022
  40. LIN J, Yang S, Wang C, Yu E, et al
    Prediction of Alzheimer's Disease Using Patterns of Methylation Levels in Key Immunologic-Related Genes.
    J Alzheimers Dis. 2022 Sep 30. pii: JAD220701. doi: 10.3233/JAD-220701.
    PubMed     Abstract available


  41. VALVERDE A, Mitrofanis J
    Photobiomodulation for Hypertension and Alzheimer's Disease.
    J Alzheimers Dis. 2022 Sep 30. pii: JAD220632. doi: 10.3233/JAD-220632.
    PubMed     Abstract available


  42. GUO Q, Cai Q, Huang F, Wei Z, et al
    The Therapeutic Effects of Seven Lycophyte Compounds on Cell Models of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Sep 29. pii: JAD220704. doi: 10.3233/JAD-220704.
    PubMed     Abstract available


  43. WU X, Peng C, Nelson PT, Cheng Q, et al
    Machine Learning Approach Predicts Probability of Time to Stage-Specific Conversion of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Sep 27. pii: JAD220590. doi: 10.3233/JAD-220590.
    PubMed     Abstract available


  44. SHEN WB, Elahi M, Wang B, Zhan M, et al
    Oxidative Stress Kinase Activation and Impaired Insulin Receptor Signaling Precede Overt Alzheimer's Disease Neuropathology.
    J Alzheimers Dis. 2022 Sep 26. pii: JAD215687. doi: 10.3233/JAD-215687.
    PubMed     Abstract available


  45. VILLAREJO-GALENDE A, Garcia-Arcelay E, Pinol-Ripoll G, Del Olmo-Rodriguez A, et al
    Quality of Life and the Experience of Living with Early-Stage Alzheimer's Disease.
    J Alzheimers Dis. 2022 Sep 23. pii: JAD220696. doi: 10.3233/JAD-220696.
    PubMed     Abstract available


  46. SABBIR MG, Speth RC, Albensi BC
    Loss of Cholinergic Receptor Muscarinic 1 (CHRM1) Protein in the Hippocampus and Temporal Cortex of a Subset of Individuals with Alzheimer's Disease, Parkinson's Disease, or Frontotemporal Dementia: Implications for Patient Survival.
    J Alzheimers Dis. 2022 Sep 22. pii: JAD220766. doi: 10.3233/JAD-220766.
    PubMed     Abstract available


  47. ALVAREZ XA, Winston CN, Barlow JW, Sarsoza FM, et al
    Modulation of Amyloid-beta and Tau in Alzheimer's Disease Plasma Neuronal-Derived Extracellular Vesicles by Cerebrolysin(R) and Donepezil.
    J Alzheimers Dis. 2022 Sep 22. pii: JAD220575. doi: 10.3233/JAD-220575.
    PubMed     Abstract available


  48. YAMADA Y, Kobayashi M, Shinkawa K, Nemoto M, et al
    Characteristics of Drawing Process Differentiate Alzheimer's Disease and Dementia with Lewy Bodies.
    J Alzheimers Dis. 2022 Sep 20. pii: JAD220546. doi: 10.3233/JAD-220546.
    PubMed     Abstract available


  49. XU C, Zhao L, Dong C
    A Review of Application of Abeta42/40 Ratio in Diagnosis and Prognosis of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Sep 19. pii: JAD220673. doi: 10.3233/JAD-220673.
    PubMed     Abstract available


  50. KHEZRI MR, Esmaeili A, Ghasemnejad-Berenji M
    Platelet Activation and Alzheimer's Disease: The Probable Role of PI3K/AKT Pathway.
    J Alzheimers Dis. 2022 Sep 19. pii: JAD220663. doi: 10.3233/JAD-220663.
    PubMed     Abstract available


  51. DOWNEY J, Lam JCK, Li VOK, Gozes I, et al
    Somatic Mutations and Alzheimer's Disease.
    J Alzheimers Dis. 2022 Sep 19. pii: JAD220643. doi: 10.3233/JAD-220643.
    PubMed     Abstract available


  52. ZARBOCK KR, Han JH, Singh AP, Thomas SP, et al
    Trimethylamine N-Oxide Reduces Neurite Density and Plaque Intensity in a Murine Model of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Sep 19. pii: JAD220413. doi: 10.3233/JAD-220413.
    PubMed     Abstract available


  53. DENTONI G, Naia L, Portal B, Leal NS, et al
    Mitochondrial Alterations in Neurons Derived from the Murine AppNL-F Knock-In Model of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Sep 19. pii: JAD220383. doi: 10.3233/JAD-220383.
    PubMed     Abstract available


  54. PALMER JA, Kaufman CS, Vidoni ED, Honea RA, et al
    Sex Differences in Resilience and Resistance to Brain Pathology and Dysfunction Moderated by Cerebrovascular Response to Exercise and Genetic Risk for Alzheimer's Disease.
    J Alzheimers Dis. 2022 Sep 19. pii: JAD220359. doi: 10.3233/JAD-220359.
    PubMed     Abstract available


  55. TRUMBORE CN, Raghunandan A
    An Alzheimer's Disease Mechanism Based on Early Pathology, Anatomy, Vascular-Induced Flow, and Migration of Maximum Flow Stress Energy Location with Increasing Vascular Disease.
    J Alzheimers Dis. 2022 Sep 17. pii: JAD220622. doi: 10.3233/JAD-220622.
    PubMed     Abstract available


  56. MORROW A, Panyard DJ, Deming YK, Jonaitis E, et al
    Cerebrospinal Fluid Sphingomyelins in Alzheimer's Disease, Neurodegeneration, and Neuroinflammation.
    J Alzheimers Dis. 2022 Sep 17. pii: JAD220349. doi: 10.3233/JAD-220349.
    PubMed     Abstract available


  57. STURCHIO A, Dwivedi AK, Malm T, Wood MJA, et al
    High Soluble Amyloid-beta42 Predicts Normal Cognition in Amyloid-Positive Individuals with Alzheimer's Disease-Causing Mutations.
    J Alzheimers Dis. 2022 Sep 16. pii: JAD220808. doi: 10.3233/JAD-220808.
    PubMed     Abstract available


  58. BALDEIRAS I, Silva-Spinola A, Lima M, Leitao MJ, et al
    Alzheimer's Disease Diagnosis Based on the Amyloid, Tau, and Neurodegeneration Scheme (ATN) in a Real-Life Multicenter Cohort of General Neurological Centers.
    J Alzheimers Dis. 2022 Sep 16. pii: JAD220587. doi: 10.3233/JAD-220587.
    PubMed     Abstract available


  59. TARIOT PN, Braeckman R, Oh C
    Comparison of Steady-State Pharmacokinetics of Donepezil Transdermal Delivery System with Oral Donepezil.
    J Alzheimers Dis. 2022 Sep 16. pii: JAD220530. doi: 10.3233/JAD-220530.
    PubMed     Abstract available


  60. OTA M, Sato N, Nakaya M, Shigemoto Y, et al
    Relationships Between the Deposition of Amyloid-beta and Tau Protein and Glymphatic System Activity in Alzheimer's Disease: Diffusion Tensor Image Study.
    J Alzheimers Dis. 2022 Sep 15. pii: JAD220534. doi: 10.3233/JAD-220534.
    PubMed     Abstract available


  61. YEH WC, Hsu CY, Li KY, Chien CF, et al
    Association between Subclinical Epileptiform Discharge and the Severity of Cognitive Decline in Alzheimer's Disease: A Longitudinal Cohort Study.
    J Alzheimers Dis. 2022 Sep 12. pii: JAD220567. doi: 10.3233/JAD-220567.
    PubMed     Abstract available


  62. NOLAN JM, Power R, Howard AN, Bergin P, et al
    Supplementation With Carotenoids, Omega-3 Fatty Acids, and Vitamin E Has a Positive Effect on the Symptoms and Progression of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Sep 9. pii: JAD220556. doi: 10.3233/JAD-220556.
    PubMed     Abstract available


  63. DU XL, Song L, Schulz PE, Xu H, et al
    Associations Between Vascular Diseases and Alzheimer's Disease or Related Dementias in a Large Cohort of Men and Women with Colorectal Cancer.
    J Alzheimers Dis. 2022 Sep 9. pii: JAD220548. doi: 10.3233/JAD-220548.
    PubMed     Abstract available


  64. LATGE-TOVAR S, Bertrand E, Cosentino S, Dourado MCN, et al
    Self- and Other-Evaluation in Alzheimer's Disease.
    J Alzheimers Dis. 2022 Sep 9. pii: JAD220453. doi: 10.3233/JAD-220453.
    PubMed     Abstract available


  65. WANG G, Estrella A, Hakim O, Milazzo P, et al
    Mini-Mental State Examination and Montreal Cognitive Assessment as Tools for Following Cognitive Changes in Alzheimer's Disease Neuroimaging Initiative Participants.
    J Alzheimers Dis. 2022 Sep 9. pii: JAD220397. doi: 10.3233/JAD-220397.
    PubMed     Abstract available


  66. MIGLIORATI M, Manrique C, Rahrah M, Escoffier G, et al
    The Helico Maze Detects Early Impairment of Reference Memory at Three Months of Age in the 5XFAD Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Sep 9. pii: JAD220281. doi: 10.3233/JAD-220281.
    PubMed     Abstract available


  67. AHULLO-FUSTER MA, Ortiz T, Varela-Donoso E, Nacher J, et al
    The Parietal Lobe in Alzheimer's Disease and Blindness.
    J Alzheimers Dis. 2022 Sep 8. pii: JAD220498. doi: 10.3233/JAD-220498.
    PubMed     Abstract available


  68. SAGUES-SESE E, Rioja J, Garzon-Maldonado FJ, Narvaez M, et al
    Insulin-Related Biomarkers in Cerebrospinal Fluid in Mild Cognitive Impairment and Alzheimer's Disease: A Systematic Review.
    J Alzheimers Dis. 2022 Sep 6. pii: JAD220688. doi: 10.3233/JAD-220688.
    PubMed     Abstract available


  69. CEJUDO JC, Samaniego M, Almeria M, Castrillo S, et al
    Ikos Test: New Tool for the Assessment of Semantic Knowledge in Early Alzheimer Disease.
    J Alzheimers Dis. 2022 Sep 6. pii: JAD220516. doi: 10.3233/JAD-220516.
    PubMed     Abstract available


  70. WANG X, Wang Y, Liu H, Zhu X, et al
    Macular Microvascular Density as a Diagnostic Biomarker for Alzheimer's Disease.
    J Alzheimers Dis. 2022 Sep 6. pii: JAD220482. doi: 10.3233/JAD-220482.
    PubMed     Abstract available


  71. CAMARGO MVZA, Pais MV, Bellan AFR, Tahira AC, et al
    Impact of Cognitive Demand on Eye Movement Pattern in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2022 Sep 6. pii: JAD220385. doi: 10.3233/JAD-220385.
    PubMed     Abstract available


  72. SHELTON MG, Kerns KA, Castora FJ, Coleman RA, et al
    Incorporating Mitochondrial Gene Expression Changes Within a Testable Mathematical Model for Alzheimer's Disease: Stress Response Modulation Predicts Potential Therapeutic Targets.
    J Alzheimers Dis. 2022 Sep 6. pii: JAD220163. doi: 10.3233/JAD-220163.
    PubMed     Abstract available


  73. CASTORA FJ, Kerns KA, Pflanzer HK, Hitefield NL, et al
    Expression Changes in Mitochondrial Genes Affecting Mitochondrial Morphology, Transmembrane Potential, Fragmentation, Amyloidosis, and Neuronal Cell Death Found in Brains of Alzheimer's Disease Patients.
    J Alzheimers Dis. 2022 Sep 6. pii: JAD220161. doi: 10.3233/JAD-220161.
    PubMed     Abstract available


  74. BEHESHTI I, Geddert N, Perron J, Gupta V, et al
    Monitoring Alzheimer's Disease Progression in Mild Cognitive Impairment Stage Using Machine Learning-Based FDG-PET Classification Methods.
    J Alzheimers Dis. 2022 Sep 2. pii: JAD220585. doi: 10.3233/JAD-220585.
    PubMed     Abstract available


  75. WRIGHT JR, Deen QFE, Stevenson A, Telford-Cooke L, et al
    Plasma Myeloperoxidase as a Potential Biomarker of Patient Response to Anti-Dementia Treatment in Alzheimer's Disease.
    J Alzheimers Dis. 2022 Sep 1. pii: JAD220642. doi: 10.3233/JAD-220642.
    PubMed     Abstract available


  76. COMON M, Rouch I, Edjolo A, Padovan C, et al
    Impaired Facial Emotion Recognition and Gaze Direction Detection in Mild Alzheimer's Disease: Results from the PACO Study.
    J Alzheimers Dis. 2022 Sep 1. pii: JAD220401. doi: 10.3233/JAD-220401.
    PubMed     Abstract available


  77. SPINELLI G, Bakardjian H, Schwartz D, Potier MC, et al
    Theta Band-Power Shapes Amyloid-Driven Longitudinal EEG Changes in Elderly Subjective Memory Complainers At-Risk for Alzheimer's Disease.
    J Alzheimers Dis. 2022 Sep 1. pii: JAD220204. doi: 10.3233/JAD-220204.
    PubMed     Abstract available


    August 2022
  78. BARDENHEIER BH, Resnik LJ, Jutkowitz E, Gravenstein S, et al
    Patterns of Limitation in Physical Function in Late Midlife Associated with Late-Onset Alzheimer's Disease and Related Dementias: A Cluster Analysis.
    J Alzheimers Dis. 2022 Aug 23. pii: JAD220573. doi: 10.3233/JAD-220573.
    PubMed     Abstract available


  79. LI S, Liu B, Li QH, Zhang Y, et al
    Evaluating the Bidirectional Causal Association Between Daytime Napping and Alzheimer's Disease Using Mendelian Randomization.
    J Alzheimers Dis. 2022 Aug 23. pii: JAD220497. doi: 10.3233/JAD-220497.
    PubMed     Abstract available


  80. WAWRZICZNY E, Picard S, Buquet A, Traversac E, et al
    Hypnosis Intervention for Couples Confronted with Alzheimer's Disease: Promising Results of a First Exploratory Study.
    J Alzheimers Dis. 2022 Aug 23. pii: JAD220430. doi: 10.3233/JAD-220430.
    PubMed     Abstract available


  81. KURASZ AM, De Wit L, Smith GE, Armstrong MJ, et al
    Neuropathological and Clinical Correlates of Lewy Body Disease Survival by Race and Ethnicity in the National Alzheimer's Coordinating Center.
    J Alzheimers Dis. 2022 Aug 22. pii: JAD220297. doi: 10.3233/JAD-220297.
    PubMed     Abstract available


  82. YANG J, Oveisgharan S, Liu X, Wilson RS, et al
    Risk Models Based on Non-Cognitive Measures May Identify Presymptomatic Alzheimer's Disease.
    J Alzheimers Dis. 2022 Aug 17. pii: JAD220446. doi: 10.3233/JAD-220446.
    PubMed     Abstract available


  83. DOREY CK, Gierhart D, Fitch KA, Crandell I, et al
    Low Xanthophylls, Retinol, Lycopene, and Tocopherols in Gray and White Matter of Brains with Alzheimer's Disease.
    J Alzheimers Dis. 2022 Aug 16. pii: JAD220460. doi: 10.3233/JAD-220460.
    PubMed     Abstract available


  84. YOSHIDA K, Seo M, Luo Y, Sahker E, et al
    Personalized Prediction of Alzheimer's Disease and Its Treatment Effects by Donepezil: An Individual Participant Data Meta-Analysis of Eight Randomized Controlled Trials.
    J Alzheimers Dis. 2022 Aug 16. pii: JAD220263. doi: 10.3233/JAD-220263.
    PubMed     Abstract available


  85. ALA T, Bakir D, Goel S, Feller N, et al
    A Mini-Mental State Examination Formula May Help to Distinguish Alzheimer's Disease from Dementia with Lewy Bodies.
    J Alzheimers Dis. 2022 Aug 12. pii: JAD220392. doi: 10.3233/JAD-220392.
    PubMed     Abstract available


  86. OU YN, Zhao B, Fu Y, Sheng ZH, et al
    The Association of Serum Uric Acid Level, Gout, and Alzheimer's Disease: A Bidirectional Mendelian Randomization Study.
    J Alzheimers Dis. 2022 Aug 11. pii: JAD220649. doi: 10.3233/JAD-220649.
    PubMed     Abstract available


  87. FINGERHUT H, Gozdas E, Hosseini SMH
    Quantitative MRI Evidence for Cognitive Reserve in Healthy Elders and Prodromal Alzheimer's Disease.
    J Alzheimers Dis. 2022 Aug 11. pii: JAD220197. doi: 10.3233/JAD-220197.
    PubMed     Abstract available


  88. ROSENDE-ROCA M, Canabate P, Moreno M, Preckler S, et al
    Sex, Neuropsychiatric Profiles, and Caregiver Burden in Alzheimer's Disease Dementia: A Latent Class Analysis.
    J Alzheimers Dis. 2022 Aug 9. pii: JAD215648. doi: 10.3233/JAD-215648.
    PubMed     Abstract available


  89. FREBERG E, Taglialatela G
    Exercise as a Potential Therapeutic Strategy to Target the Clinical Link Between Depression and Alzheimer's Disease: A Narrative Review.
    J Alzheimers Dis. 2022 Aug 9. pii: JAD210632. doi: 10.3233/JAD-210632.
    PubMed     Abstract available


  90. BU K, Patel D, Morris R, Han W, et al
    Dysphagia Risk in Patients Prescribed Rivastigmine: A Systematic Analysis of FDA Adverse Event Reporting System.
    J Alzheimers Dis. 2022 Aug 6. pii: JAD220583. doi: 10.3233/JAD-220583.
    PubMed     Abstract available


  91. SERRA L, Giancaterino G, Giulietti G, Petrosini L, et al
    Cognitive Reserve Modulates Brain Structure and Cortical Architecture in the Alzheimer's Disease.
    J Alzheimers Dis. 2022 Aug 6. pii: JAD220377. doi: 10.3233/JAD-220377.
    PubMed     Abstract available


  92. SOARES JZ, Valeur J, Saltyte Benth J, Knapskog AB, et al
    Associations Between Intrathecal Levels of Vitamin D, Cytokines, and Core Biomarkers of Alzheimer's Disease: A Cross-Sectional Study.
    J Alzheimers Dis. 2022 Aug 1. pii: JAD220407. doi: 10.3233/JAD-220407.
    PubMed     Abstract available


  93. PEREZ SD, Phillips JS, Norise C, Kinney NG, et al
    Neuropsychological and Neuroanatomical Features of Patients with Behavioral/Dysexecutive Variant Alzheimer's disease (AD): A Comparison to Behavioral Variant Frontotemporal Dementia and Amnestic AD Groups.
    J Alzheimers Dis. 2022 Aug 1. pii: JAD215728. doi: 10.3233/JAD-215728.
    PubMed     Abstract available


  94. CANARIO E, Chen D, Han Y, Niu H, et al
    Global Network Analysis of Alzheimer's Disease with Minimum Spanning Trees.
    J Alzheimers Dis. 2022 Aug 1. pii: JAD215573. doi: 10.3233/JAD-215573.
    PubMed     Abstract available


    July 2022
  95. TAHAMI MONFARED AA, Stern Y, Doogan S, Irizarry M, et al
    Stakeholder Insights in Alzheimer's Disease: Natural Language Processing of Social Media Conversations.
    J Alzheimers Dis. 2022 Jul 30. pii: JAD220422. doi: 10.3233/JAD-220422.
    PubMed     Abstract available


  96. HOFFMANN CM, Nianogo RA, Yaffe K, Rosenwohl-Mack A, et al
    Importance of Accounting for Regional Differences in Modifiable Risk Factors for Alzheimer's Disease and Related Dementias: The Case for Tailored Interventions.
    J Alzheimers Dis. 2022 Jul 30. pii: JAD220278. doi: 10.3233/JAD-220278.
    PubMed     Abstract available


  97. WANG L, Davis PB, Volkow ND, Berger NA, et al
    Association of COVID-19 with New-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2022 Jul 29. pii: JAD220717. doi: 10.3233/JAD-220717.
    PubMed     Abstract available


  98. CONTINI C, Serrao S, Manconi B, Olianas A, et al
    Salivary Proteomics Reveals Significant Changes in Relation to Alzheimer's Disease and Aging.
    J Alzheimers Dis. 2022 Jul 26. pii: JAD220246. doi: 10.3233/JAD-220246.
    PubMed     Abstract available


  99. CAPRIOGLIO C, Garibotto V, Jessen F, Frolich L, et al
    The Clinical Use of Alzheimer's Disease Biomarkers in Patients with Mild Cognitive Impairment: A European Alzheimer's Disease Consortium Survey.
    J Alzheimers Dis. 2022 Jul 25. pii: JAD220333. doi: 10.3233/JAD-220333.
    PubMed     Abstract available


  100. ZHONG S, Zhao B, Ma YH, Sun Y, et al
    Associations of Physical Activity with Alzheimer's Disease Pathologies and Cognition: The CABLE Study.
    J Alzheimers Dis. 2022 Jul 22. pii: JAD220389. doi: 10.3233/JAD-220389.
    PubMed     Abstract available


  101. ARIAS JJ, Lin GA, Tyler AM, Douglas MP, et al
    Geriatricians' Perspectives on the Multiple Dimensions of Utility of Genetic Testing for Alzheimer's Disease: A Qualitative Study.
    J Alzheimers Dis. 2022 Jul 20. pii: JAD220674. doi: 10.3233/JAD-220674.
    PubMed     Abstract available


  102. ZALLEN DT
    Alzheimer's Disease: Risk Tests and the Medical Record.
    J Alzheimers Dis. 2022 Jul 20. pii: JAD220584. doi: 10.3233/JAD-220584.
    PubMed     Abstract available


  103. LUO W, Pryzbyl KJ, Bigio EH, Weintraub S, et al
    Reduced Hippocampal and Anterior Cingulate Expression of Antioxidant Enzymes and Membrane Progesterone Receptors in Alzheimer's Disease with Depression.
    J Alzheimers Dis. 2022 Jul 20. pii: JAD220574. doi: 10.3233/JAD-220574.
    PubMed     Abstract available


  104. YAO W, Zhang X, Zhao H, Xu Y, et al
    Inflammation Disrupts Cognitive Integrity via Plasma Neurofilament Light Chain Coupling Brain Networks in Alzheimer's Disease.
    J Alzheimers Dis. 2022 Jul 20. pii: JAD220475. doi: 10.3233/JAD-220475.
    PubMed     Abstract available


  105. OMANA H, Madou E, Hunter SW
    The Effects on Gait of 4-Wheeled Walker Use in People with Alzheimer's Disease Dementia and Gait Impairment: A Pilot Study.
    J Alzheimers Dis. 2022 Jul 20. pii: JAD220331. doi: 10.3233/JAD-220331.
    PubMed     Abstract available


  106. CERESETTI R, Rouch I, Laurent B, Getenet JC, et al
    Processing of Facial Expressions of Emotions and Pain in Alzheimer's Disease.
    J Alzheimers Dis. 2022 Jul 20. pii: JAD220236. doi: 10.3233/JAD-220236.
    PubMed     Abstract available


  107. DRENTHEN GS, Backes WH, Freeze WM, Jacobs HIL, et al
    Rich-Club Connectivity of the Structural Covariance Network Relates to Memory Processes in Mild Cognitive Impairment and Alzheimer's Disease.
    J Alzheimers Dis. 2022 Jul 18. pii: JAD220175. doi: 10.3233/JAD-220175.
    PubMed     Abstract available


  108. SONG C, Li F, Wang LY, Shi YQ, et al
    Incidental Finding: Urine Alzheimer-Associated Neuronal Thread Protein (AD7c-NTP) and Serum Vitamin D25.
    J Alzheimers Dis. 2022 Jul 18. pii: JAD220165. doi: 10.3233/JAD-220165.
    PubMed     Abstract available


  109. TIMSINA J, Gomez-Fonseca D, Wang L, Do A, et al
    Comparative Analysis of Alzheimer's Disease Cerebrospinal Fluid Biomarkers Measurement by Multiplex SOMAscan Platform and Immunoassay-Based Approach.
    J Alzheimers Dis. 2022 Jul 16. pii: JAD220399. doi: 10.3233/JAD-220399.
    PubMed     Abstract available



  110. Janina Krell-Roesch, PhD, and Yonas E. Geda, MD recipients of the 2022 Alzheimer Award.
    J Alzheimers Dis. 2022 Jul 15. pii: JAD229009. doi: 10.3233/JAD-229009.
    PubMed    


  111. PEZZOLI S, Manca R, Cagnin A, Venneri A, et al
    A Multimodal Neuroimaging and Neuropsychological Study of Visual Hallucinations in Alzheimer's Disease.
    J Alzheimers Dis. 2022 Jul 15. pii: JAD215107. doi: 10.3233/JAD-215107.
    PubMed     Abstract available


  112. XUE F, Gao L, Chen T, Chen H, et al
    Parkinson's Disease rs117896735 Variant Regulates INPP5F Expression in Brain Tissues and Increases Risk of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Jul 13. pii: JAD220086. doi: 10.3233/JAD-220086.
    PubMed     Abstract available


  113. CLARK K, Yee Leung Y, Lee WP, Voight B, et al
    Polygenic Risk Scores in Alzheimer's Disease Genetics: Methodology, Applications, Inclusion, and Diversity.
    J Alzheimers Dis. 2022 Jul 12. pii: JAD220025. doi: 10.3233/JAD-220025.
    PubMed     Abstract available


  114. LIU Q, Liu H, Zhang S, Yang Q, et al
    Cerebrospinal Fluid Synaptosomal-Associated Protein 25 Levels in Patients with Alzheimer's Disease: A Meta-Analysis.
    J Alzheimers Dis. 2022 Jul 12. pii: JAD215696. doi: 10.3233/JAD-215696.
    PubMed     Abstract available


  115. WONG GC, Chow KH
    DNA Damage Response-Associated Cell Cycle Re-Entry and Neuronal Senescence in Brain Aging and Alzheimer's Disease.
    J Alzheimers Dis. 2022 Jul 11. pii: JAD220203. doi: 10.3233/JAD-220203.
    PubMed     Abstract available


  116. CARNEMOLLA S, Kumfor F, Liang CT, Foxe D, et al
    Olfactory Bulb Integrity in Frontotemporal Dementia and Alzheimer's Disease.
    J Alzheimers Dis. 2022 Jul 11. pii: JAD220080. doi: 10.3233/JAD-220080.
    PubMed     Abstract available


  117. VLEGELS N, Ossenkoppele R, van der Flier WM, Koek HL, et al
    Does Loss of Integrity of the Cingulum Bundle Link Amyloid-beta Accumulation and Neurodegeneration in Alzheimer's Disease?
    J Alzheimers Dis. 2022 Jul 11. pii: JAD220024. doi: 10.3233/JAD-220024.
    PubMed     Abstract available


  118. XUE C, Tang Y, Wang C, Yang H, et al
    The Effects of Normal Aging, Subjective Cognitive Decline, Mild Cognitive Impairment, or Alzheimer's Disease on Visual Search.
    J Alzheimers Dis. 2022 Jul 7. pii: JAD220209. doi: 10.3233/JAD-220209.
    PubMed     Abstract available


  119. RAMANAN VK, Heckman MG, Przybelski SA, Lesnick TG, et al
    Polygenic Scores of Alzheimer's Disease Risk Genes Add Only Modestly to APOE in Explaining Variation in Amyloid PET Burden.
    J Alzheimers Dis. 2022 Jul 7. pii: JAD220164. doi: 10.3233/JAD-220164.
    PubMed     Abstract available


  120. NABIROTCHKIN S, Bouaziz J, Glibert F, Mandel J, et al
    Combinational Drug Repurposing from Genetic Networks Applied to Alzheimer's Disease.
    J Alzheimers Dis. 2022 Jul 7. pii: JAD220120. doi: 10.3233/JAD-220120.
    PubMed     Abstract available


  121. KRISHNADAS N, Huang K, Schultz SA, Dore V, et al
    Visually Identified Tau 18F-MK6240 PET Patterns in Symptomatic Alzheimer's Disease.
    J Alzheimers Dis. 2022 Jul 7. pii: JAD215558. doi: 10.3233/JAD-215558.
    PubMed     Abstract available


  122. MOTAZEDI E, Cheng W, Thomassen JQ, Frei O, et al
    Using Polygenic Hazard Scores to Predict Age at Onset of Alzheimer's Disease in Nordic Populations.
    J Alzheimers Dis. 2022 Jul 7. pii: JAD220174. doi: 10.3233/JAD-220174.
    PubMed     Abstract available


  123. BLEAKLEY A, Maloney EK, Harkins K, Nelson MN, et al
    An Elicitation Study to Understand Black, Hispanic, and Male Older Adults' Willingness to Participate in Alzheimer's Disease-Focused Research Registries.
    J Alzheimers Dis. 2022 Jul 5. pii: JAD220196. doi: 10.3233/JAD-220196.
    PubMed     Abstract available


  124. CHIA SY, Vipin A, Ng KP, Tu H, et al
    Upregulated Blood miR-150-5p in Alzheimer's Disease Dementia Is Associated with Cognition, Cerebrospinal Fluid Amyloid-beta, and Cerebral Atrophy.
    J Alzheimers Dis. 2022 Jul 5. pii: JAD220116. doi: 10.3233/JAD-220116.
    PubMed     Abstract available


  125. SUN W, Wu Q, Chen H, Yu L, et al
    A Validation Study of the Hong Kong Brief Cognitive Test for Screening Patients with Mild Cognitive Impairment and Alzheimer's Disease.
    J Alzheimers Dis. 2022 Jul 4. pii: JAD220417. doi: 10.3233/JAD-220417.
    PubMed     Abstract available


  126. TOUPS K, Hathaway A, Gordon D, Chung H, et al
    Precision Medicine Approach to Alzheimer's Disease: Successful Pilot Project.
    J Alzheimers Dis. 2022 Jul 4. pii: JAD215707. doi: 10.3233/JAD-215707.
    PubMed     Abstract available


    June 2022
  127. HAN SW, Park YH, Jang ES, Nho K, et al
    Implications of Liver Enzymes in the Pathogenesis of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Jun 28. pii: JAD220343. doi: 10.3233/JAD-220343.
    PubMed     Abstract available


  128. WOJDALA AL, Chiasserini D, Bellomo G, Paciotti S, et al
    Phosphatidylethanolamine Binding Protein 1 (PEBP1) in Alzheimer's Disease: ELISA Development and Clinical Validation.
    J Alzheimers Dis. 2022 Jun 28. pii: JAD220323. doi: 10.3233/JAD-220323.
    PubMed     Abstract available


  129. ALMULLA AF, Supasitthumrong T, Amrapala A, Tunvirachaisakul C, et al
    The Tryptophan Catabolite or Kynurenine Pathway in Alzheimer's Disease: A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2022 Jun 28. pii: JAD220295. doi: 10.3233/JAD-220295.
    PubMed     Abstract available


  130. LUO A, Ning P, Lu H, Huang H, et al
    Association Between Metformin and Alzheimer's Disease: A Systematic Review and Meta-Analysis of Clinical Observational Studies.
    J Alzheimers Dis. 2022 Jun 28. pii: JAD220180. doi: 10.3233/JAD-220180.
    PubMed     Abstract available


  131. BABILONI C
    The Dark Side of Alzheimer's Disease: Neglected Physiological Biomarkers of Brain Hyperexcitability and Abnormal Consciousness Level.
    J Alzheimers Dis. 2022 Jun 24. pii: JAD220582. doi: 10.3233/JAD-220582.
    PubMed    


  132. KRANCE SH, Wu CY, Chan ACY, Kwong S, et al
    Endosomal-Lysosomal and Autophagy Pathway in Alzheimer's Disease: A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2022 Jun 23. pii: JAD220360. doi: 10.3233/JAD-220360.
    PubMed     Abstract available


  133. PLANTONE D, Pardini M, Locci S, Nobili F, et al
    B Lymphocytes in Alzheimer's Disease-A Comprehensive Review.
    J Alzheimers Dis. 2022 Jun 23. pii: JAD220261. doi: 10.3233/JAD-220261.
    PubMed     Abstract available


  134. ALI DG, Bahrani AA, Barber JM, El Khouli RH, et al
    Amyloid-PET Levels in the Precuneus and Posterior Cingulate Cortices Are Associated with Executive Function Scores in Preclinical Alzheimer's Disease Prior to Overt Global Amyloid Positivity.
    J Alzheimers Dis. 2022 Jun 20. pii: JAD220294. doi: 10.3233/JAD-220294.
    PubMed     Abstract available


  135. CAIRNS DM, Itzhaki RF, Kaplan DL
    Potential Involvement of Varicella Zoster Virus in Alzheimer's Disease via Reactivation of Quiescent Herpes Simplex Virus Type 1.
    J Alzheimers Dis. 2022 Jun 20. pii: JAD220287. doi: 10.3233/JAD-220287.
    PubMed     Abstract available


  136. KHEDR EM, Omeran N, Karam-Allah Ramadan H, Ahmed GK, et al
    Alteration of Gut Microbiota in Alzheimer's Disease and Their Relation to the Cognitive Impairment.
    J Alzheimers Dis. 2022 Jun 20. pii: JAD220176. doi: 10.3233/JAD-220176.
    PubMed     Abstract available


  137. PAN R, Luo S, Huang Q, Li W, et al
    The Associations of Cerebrospinal Fluid Ferritin with Neurodegeneration and Neuroinflammation Along the Alzheimer's Disease Continuum.
    J Alzheimers Dis. 2022 Jun 20. pii: JAD220002. doi: 10.3233/JAD-220002.
    PubMed     Abstract available


  138. GAN J, Liu S, Chen Z, Yang Y, et al
    Elevated Plasma Orexin-A Levels in Prodromal Dementia with Lewy Bodies.
    J Alzheimers Dis. 2022;1.
    PubMed     Abstract available


  139. TIAN J, Wang T, Jia K, Guo L, et al
    Nonobese Male Patients with Alzheimer's Disease Are Vulnerable to Decrease in Plasma Leptin.
    J Alzheimers Dis. 2022 Jun 13. pii: JAD220447. doi: 10.3233/JAD-220447.
    PubMed     Abstract available


  140. BUKHBINDER AS, Ling Y, Hasan O, Jiang X, et al
    Risk of Alzheimer's Disease Following Influenza Vaccination: A Claims-Based Cohort Study Using Propensity Score Matching.
    J Alzheimers Dis. 2022 Jun 13. pii: JAD220361. doi: 10.3233/JAD-220361.
    PubMed     Abstract available


  141. WEISSBERGER GH, Samek A, Mosqueda L, Nguyen AL, et al
    Increased Financial Altruism is Associated with Alzheimer's Disease Neurocognitive Profile in Older Adults.
    J Alzheimers Dis. 2022 Jun 13. pii: JAD220187. doi: 10.3233/JAD-220187.
    PubMed     Abstract available


  142. MIELKE MM, Ransom JE, Mandrekar J, Turcano P, et al
    Traumatic Brain Injury and Risk of Alzheimer's Disease and Related Dementias in the Population.
    J Alzheimers Dis. 2022 Jun 13. pii: JAD220159. doi: 10.3233/JAD-220159.
    PubMed     Abstract available


  143. KOBAYASHI M, Yamada Y, Shinkawa K, Nemoto M, et al
    Automated Early Detection of Alzheimer's Disease by Capturing Impairments in Multiple Cognitive Domains with Multiple Drawing Tasks.
    J Alzheimers Dis. 2022 Jun 13. pii: JAD215714. doi: 10.3233/JAD-215714.
    PubMed     Abstract available


  144. LEONHARDI J, Barthel H, Speerforck S, Dietzel J, et al
    Differential Diagnosis Between Alzheimer's Disease-Related Depression and Pseudo-Dementia in Depression: A New Indication for Amyloid-beta Imaging?
    J Alzheimers Dis. 2022 Jun 13. pii: JAD215619. doi: 10.3233/JAD-215619.
    PubMed     Abstract available


  145. JESTER H, Gosrani S, Ding H, Zhou X, et al
    Characterization of Early Alzheimer's Disease-Like Pathological Alterations in Non-Human Primates with Aging: A Pilot Study.
    J Alzheimers Dis. 2022 Jun 13. pii: JAD215303. doi: 10.3233/JAD-215303.
    PubMed     Abstract available


  146. ZHU LY, Shi L, Luo Y, Leung J, et al
    Brain MRI Biomarkers to Predict Cognitive Decline in Older People with Alzheimer's Disease.
    J Alzheimers Dis. 2022 Jun 13. pii: JAD215189. doi: 10.3233/JAD-215189.
    PubMed     Abstract available


  147. HORVATH A, Quinlan P, Eckerstrom C, Aberg ND, et al
    Low Serum Insulin-like Growth Factor-I Is Associated with Decline in Hippocampal Volume in Stable Mild Cognitive Impairment but not in Alzheimer's Disease.
    J Alzheimers Dis. 2022 Jun 11. pii: JAD220292. doi: 10.3233/JAD-220292.
    PubMed     Abstract available


  148. BABILONI C, Noce G, Di Bonaventura C, Lizio R, et al
    Alzheimer's Disease with Epileptiform EEG Activity: Abnormal Cortical Sources of Resting State Delta Rhythms in Patients with Amnesic Mild Cognitive Impairment.
    J Alzheimers Dis. 2022 Jun 9. pii: JAD220442. doi: 10.3233/JAD-220442.
    PubMed     Abstract available


  149. DUAN W, Sehrawat P, Zhou TD, Becker JT, et al
    Pattern of Altered Magnetization Transfer Rate in Alzheimer's Disease.
    J Alzheimers Dis. 2022 Jun 9. pii: JAD220335. doi: 10.3233/JAD-220335.
    PubMed     Abstract available


  150. MA X, Zhang Y, Gou D, Ma J, et al
    Metabolic Reprogramming of Microglia Enhances Proinflammatory Cytokine Release through EphA2/p38 MAPK Pathway in Alzheimer's Disease.
    J Alzheimers Dis. 2022 Jun 7. pii: JAD220227. doi: 10.3233/JAD-220227.
    PubMed     Abstract available


  151. GARCIA-ALBERCA JM, Gris E, de la Guia P, Mendoza S, et al
    Effects of Tianeptine Treatment on Depression and Cognitive Function in Patients with Alzheimer's Disease: A 12-Month Retrospective Observational Study.
    J Alzheimers Dis. 2022 Jun 6. pii: JAD215630. doi: 10.3233/JAD-215630.
    PubMed     Abstract available


  152. WESSELS AM, Belger M, Johnston JA, Yu Y, et al
    Demonstration of Clinical Meaningfulness of the Integrated Alzheimer's Disease Rating Scale (iADRS): Association Between Change in iADRS Scores and Patient and Caregiver Health Outcomes.
    J Alzheimers Dis. 2022 Jun 4. pii: JAD220303. doi: 10.3233/JAD-220303.
    PubMed     Abstract available


  153. SUN L, Guo C, Song Y, Sheng J, et al
    Blood BMP6 Associated with Cognitive Performance and Alzheimer's Disease Diagnosis: A Longitudinal Study of Elders.
    J Alzheimers Dis. 2022 Jun 4. pii: JAD220279. doi: 10.3233/JAD-220279.
    PubMed     Abstract available


  154. GOMEZ LR, Albers MW, Baena A, Vila-Castelar C, et al
    Olfactory Function and Markers of Brain Pathology in Non-Demented Individuals with Autosomal Dominant Alzheimer's Disease.
    J Alzheimers Dis. 2022 Jun 4. pii: JAD220075. doi: 10.3233/JAD-220075.
    PubMed     Abstract available


  155. AGARWAL P, Holland TM, James BD, Cherian LJ, et al
    Pelargonidin and Berry Intake Association with Alzheimer's Disease Neuropathology: A Community-Based Study.
    J Alzheimers Dis. 2022 Jun 4. pii: JAD215600. doi: 10.3233/JAD-215600.
    PubMed     Abstract available


  156. ARAUJO DC, Veloso AA, Gomes KB, Souza LC, et al
    A Novel Panel of Plasma Proteins Predicts Progression in Prodromal Alzheimer's Disease.
    J Alzheimers Dis. 2022 Jun 3. pii: JAD220256. doi: 10.3233/JAD-220256.
    PubMed     Abstract available


  157. WANG Q, Shi Y, Qi X, Qi L, et al
    Platelet-Derived Amyloid-beta Protein Precursor as a Biomarker of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Jun 3. pii: JAD220122. doi: 10.3233/JAD-220122.
    PubMed     Abstract available


  158. HUDA TI, Diaz MJ, Gozlan EC, Chobrutskiy A, et al
    Immunogenomics Parameters for Patient Stratification in Alzheimer's Disease.
    J Alzheimers Dis. 2022 Jun 3. pii: JAD220119. doi: 10.3233/JAD-220119.
    PubMed     Abstract available


  159. HANNONEN S, Andberg S, Karkkainen V, Rusanen M, et al
    Shortening of Saccades as a Possible Easy-to-Use Biomarker to Detect Risk of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Jun 3. pii: JAD215551. doi: 10.3233/JAD-215551.
    PubMed     Abstract available


    May 2022
  160. SERWER P, Wright ET, Hunter B
    Additions to Alpha-Sheet Based Hypotheses for the Cause of Alzheimer's Disease.
    J Alzheimers Dis. 2022 May 30. pii: JAD220311. doi: 10.3233/JAD-220311.
    PubMed     Abstract available


  161. WANG Y, Li L, Zhao X, Sui S, et al
    Intestinal Microflora Changes in Patients with Mild Alzheimer's Disease in a Chinese Cohort.
    J Alzheimers Dis. 2022 May 30. pii: JAD220076. doi: 10.3233/JAD-220076.
    PubMed     Abstract available


  162. RIPHAGEN JM, van Hooren RWE, Kenis G, Verhey FRJ, et al
    Distinct Patterns Link the BDNF Val66Met Polymorphism to Alzheimer's Disease Pathology.
    J Alzheimers Dis. 2022 May 28. pii: JAD215353. doi: 10.3233/JAD-215353.
    PubMed     Abstract available


  163. MCGRATTAN A, Stewart CJ, Cassidy A, Woodside JV, et al
    Diet Patterns, the Gut Microbiome, and Alzheimer's Disease.
    J Alzheimers Dis. 2022 May 23. pii: JAD220205. doi: 10.3233/JAD-220205.
    PubMed     Abstract available


  164. TSAI YL, Yen CT, Wang YF
    Astrocyte Dysregulation and Calcium Ion Imbalance May Link the Development of Osteoporosis and Alzheimer's Disease.
    J Alzheimers Dis. 2022 May 18. pii: JAD220218. doi: 10.3233/JAD-220218.
    PubMed     Abstract available


  165. FRAME G, Schuller A, Smith MA, Crish SD, et al
    Alterations in Retinal Signaling Across Age and Sex in 3xTg Alzheimer's Disease Mice.
    J Alzheimers Dis. 2022 May 18. pii: JAD220016. doi: 10.3233/JAD-220016.
    PubMed     Abstract available


  166. HAO J, Guo Y, Guo K, Yang Q, et al
    Peripheral Inflammatory Biomarkers of Alzheimer's Disease.
    J Alzheimers Dis. 2022 May 18. pii: JAD215422. doi: 10.3233/JAD-215422.
    PubMed     Abstract available


  167. WITTFELD K, Raman MR, Conner SC, Aslam A, et al
    Insulin-Like Growth Factor, Inflammation, and MRI Markers of Alzheimer's Disease in Predominantly Middle-Aged Adults.
    J Alzheimers Dis. 2022 May 16. pii: JAD220356. doi: 10.3233/JAD-220356.
    PubMed     Abstract available


  168. HOILUND-CARLSEN PF, Revheim ME, Alavi A
    Alzheimer's Disease at a Crossroad: Time to Part from Amyloid to More Promising Aspects- Atherosclerosis for a Start.
    J Alzheimers Dis. 2022 May 16. pii: JAD220190. doi: 10.3233/JAD-220190.
    PubMed     Abstract available


  169. CHENG Y, Jian JM, He CY, Ren JR, et al
    The Correlations of Plasma Liver-Type Fatty Acid-Binding Protein with Amyloid-beta and Tau Levels in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2022 May 16. pii: JAD220126. doi: 10.3233/JAD-220126.
    PubMed     Abstract available


  170. TANCHEVA L, Lazarova M, Velkova L, Dolashki A, et al
    Beneficial Effects of Snail Helix aspersa Extract in an Experimental Model of Alzheimer's Type Dementia.
    J Alzheimers Dis. 2022 May 16. pii: JAD215693. doi: 10.3233/JAD-215693.
    PubMed     Abstract available


  171. HELBOE L, Rosenqvist N, Volbracht C, Pedersen LO, et al
    Highly Specific and Sensitive Target Binding by the Humanized pS396-Tau Antibody hC10.2 Across a Wide Spectrum of Alzheimer's Disease and Primary Tauopathy Postmortem Brains.
    J Alzheimers Dis. 2022 May 9. pii: JAD220125. doi: 10.3233/JAD-220125.
    PubMed     Abstract available


  172. WELTY S, Thathiah A, Levine AS
    DNA Damage Increases Secreted Abeta40 and Abeta42 in Neuronal Progenitor Cells: Relevance to Alzheimer's Disease.
    J Alzheimers Dis. 2022 May 9. pii: JAD220030. doi: 10.3233/JAD-220030.
    PubMed     Abstract available


  173. ZHANG Y, Hu Y, Han Z, Geng Y, et al
    Cattle Encephalon Glycoside and Ignotin Ameliorate Palmitoylation of PSD-95 and Enhance Expression of Synaptic Proteins in the Frontal Cortex of a APPswe/PS1dE9 Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2022 May 9. pii: JAD220009. doi: 10.3233/JAD-220009.
    PubMed     Abstract available


  174. FERNANDES M, Chiaravalloti A, Manfredi N, Placidi F, et al
    Nocturnal Hypoxia and Sleep Fragmentation May Drive Neurodegenerative Processes: The Compared Effects of Obstructive Sleep Apnea Syndrome and Periodic Limb Movement Disorder on Alzheimer's Disease Biomarkers.
    J Alzheimers Dis. 2022 May 9. pii: JAD215734. doi: 10.3233/JAD-215734.
    PubMed     Abstract available


  175. ZHANG X, Guan Q, Li Y, Zhang J, et al
    Aberrant Cross-Tissue Functional Connectivity in Alzheimer's Disease: Static, Dynamic, and Directional Properties.
    J Alzheimers Dis. 2022 May 9. pii: JAD215649. doi: 10.3233/JAD-215649.
    PubMed     Abstract available


  176. DAS TK, Blasco-Conesa MP, Korf J, Honarpisheh P, et al
    Bacterial Amyloid Curli Associated Gut Epithelial Neuroendocrine Activation Predominantly Observed in Alzheimer's Disease Mice with Central Amyloid-beta Pathology.
    J Alzheimers Dis. 2022 May 6. pii: JAD220106. doi: 10.3233/JAD-220106.
    PubMed     Abstract available


  177. DUAN L, Qian X, Wang Q, Huang L, et al
    Experimental Periodontitis Deteriorates Cognitive Function and Impairs Insulin Signaling in a Streptozotocin-Induced Alzheimer's Disease Rat Model.
    J Alzheimers Dis. 2022 May 6. pii: JAD215720. doi: 10.3233/JAD-215720.
    PubMed     Abstract available


  178. KALARI M, Abbasi Z, Shasaltaneh MD, Khaleghian A, et al
    A Cobalt-Containing Compound as a Stronger Inhibitor than Galantamine to Inhibit Acetylcholinesterase Activity: A New Drug Candidate for Alzheimer's Disease Treatment.
    J Alzheimers Dis. 2022 May 6. pii: JAD215588. doi: 10.3233/JAD-215588.
    PubMed     Abstract available


  179. NARUKAWA M, Mori Y, Nishida R, Takahashi S, et al
    Expression of Olfactory-Related Genes in the Olfactory Epithelium of an Alzheimer's Disease Mouse Model.
    J Alzheimers Dis. 2022 May 4. pii: JAD220213. doi: 10.3233/JAD-220213.
    PubMed     Abstract available


  180. MANDAL PK, Dwivedi D, Shukla D, Samkaria A, et al
    Interplay Between Hippocampal Glutathione Depletion and pH Increment in Alzheimer's Disease.
    J Alzheimers Dis. 2022 May 4. pii: JAD215729. doi: 10.3233/JAD-215729.
    PubMed     Abstract available


  181. LIO CT, Kacprowski T, Klaedtke M, Jensen LR, et al
    Small RNA Sequencing in the Tg4-42 Mouse Model Suggests the Involvement of snoRNAs in the Etiology of Alzheimer's Disease.
    J Alzheimers Dis. 2022 May 2. pii: JAD220110. doi: 10.3233/JAD-220110.
    PubMed     Abstract available


    April 2022
  182. KIM H, Levine A, Cohen D, Gehrman P, et al
    The Role of Amyloid, Tau, and APOE Genotype on the Relationship Between Informant-Reported Sleep Disturbance and Alzheimer's Disease Risks.
    J Alzheimers Dis. 2022 Apr 28. pii: JAD215417. doi: 10.3233/JAD-215417.
    PubMed     Abstract available


  183. LENG F, Zhan Z, Sun Y, Liu F, et al
    Cerebrospinal Fluid sTREM2 Has Paradoxical Association with Brain Structural Damage Rate in Early- and Late-Stage Alzheimer's Disease.
    J Alzheimers Dis. 2022 Apr 27. pii: JAD220102. doi: 10.3233/JAD-220102.
    PubMed     Abstract available


  184. DIAS IHK, Shokr H, Shephard F, Chakrabarti L, et al
    Oxysterols and Oxysterol Sulfates in Alzheimer's Disease Brain and Cerebrospinal Fluid.
    J Alzheimers Dis. 2022 Apr 27. pii: JAD220083. doi: 10.3233/JAD-220083.
    PubMed     Abstract available


  185. SALEHIPOUR A, Bagheri M, Sabahi M, Dolatshahi M, et al
    Combination Therapy in Alzheimer's Disease: Is It Time?
    J Alzheimers Dis. 2022 Apr 27. pii: JAD215680. doi: 10.3233/JAD-215680.
    PubMed     Abstract available


  186. CHEN D, Yi F, Qin Y, Zhang J, et al
    A Stacking Framework for Multi-Classification of Alzheimer's Disease Using Neuroimaging and Clinical Features.
    J Alzheimers Dis. 2022 Apr 27. pii: JAD215654. doi: 10.3233/JAD-215654.
    PubMed     Abstract available


  187. TONGSIRI S, Levkoff S, Gallagher-Thompson D, Teri L, et al
    Cultural Adaptation of the Reducing Disability in Alzheimer's Disease (RDAD) Protocol for an Intervention to Reduce Behavioral and Psychological Symptoms of Dementia in Thailand.
    J Alzheimers Dis. 2022 Apr 27. pii: JAD215253. doi: 10.3233/JAD-215253.
    PubMed     Abstract available


  188. DONG L, Liu C, Sha L, Mao C, et al
    PSEN2 Mutation Spectrum and Novel Functionally Validated Mutations in Alzheimer's Disease: Data from PUMCH Dementia Cohort.
    J Alzheimers Dis. 2022 Apr 25. pii: JAD220194. doi: 10.3233/JAD-220194.
    PubMed     Abstract available


  189. BOSE A, Dutta M, Dash NS, Nandi R, et al
    Importance of Task Selection for Connected Speech Analysis in Patients with Alzheimer's Disease from an Ethnically Diverse Sample.
    J Alzheimers Dis. 2022 Apr 25. pii: JAD220166. doi: 10.3233/JAD-220166.
    PubMed     Abstract available


  190. LOBUE C, Kelley BJ, Hart J, Helphrey J, et al
    Mild Traumatic Brain Injury is Related to Elevated Cerebrospinal Fluid Tau in Alzheimer's Disease Dementia.
    J Alzheimers Dis. 2022 Apr 25. pii: JAD220112. doi: 10.3233/JAD-220112.
    PubMed     Abstract available


  191. GRAHAM A, Livingston G, Purnell L, Huntley J, et al
    Mild Traumatic Brain Injuries and Future Risk of Developing Alzheimer's Disease: Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2022 Apr 25. pii: JAD220069. doi: 10.3233/JAD-220069.
    PubMed     Abstract available


  192. LLAMAS-RODRIGUEZ J, Oltmer J, Greve DN, Williams E, et al
    Entorhinal Subfield Vulnerability to Neurofibrillary Tangles in Aging and the Preclinical Stage of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Apr 25. pii: JAD215567. doi: 10.3233/JAD-215567.
    PubMed     Abstract available


  193. SALAZAR CR, Ritchie M, Gillen DL, Grill JD, et al
    Strategies Associated with Retaining Participants in the Longitudinal National Alzheimer's Coordinating Center Uniform Data Set Study.
    J Alzheimers Dis. 2022 Apr 25. pii: JAD215537. doi: 10.3233/JAD-215537.
    PubMed     Abstract available


  194. KARIKARI TK
    Blood Tests for Alzheimer's Disease: Increasing Efforts to Expand and Diversify Research Participation Is Critical for Widespread Validation and Acceptance.
    J Alzheimers Dis. 2022 Apr 23. pii: JAD215730. doi: 10.3233/JAD-215730.
    PubMed     Abstract available


  195. CATO S, Ramer S, Hajjar I, Kulshreshtha A, et al
    Alzheimer's Disease Mortality as a Function of Urbanization Level: 1999-2019.
    J Alzheimers Dis. 2022 Apr 22. pii: JAD215586. doi: 10.3233/JAD-215586.
    PubMed     Abstract available


  196. HUTTEN DR, Bos JHJ, de Vos S, Hak E, et al
    Targeting the Beta-2-Adrenergic Receptor and the Risk of Developing Alzheimer's Disease: A Retrospective Inception Cohort Study.
    J Alzheimers Dis. 2022 Apr 18. pii: JAD215057. doi: 10.3233/JAD-215057.
    PubMed     Abstract available


  197. RAMSDEN CE, Keyes GS, Calzada E, Horowitz MS, et al
    Lipid Peroxidation Induced ApoE Receptor-Ligand Disruption as a Unifying Hypothesis Underlying Sporadic Alzheimer's Disease in Humans.
    J Alzheimers Dis. 2022 Apr 16. pii: JAD220071. doi: 10.3233/JAD-220071.
    PubMed     Abstract available


  198. MIRABNAHRAZAM G, Ma D, Lee S, Popuri K, et al
    Machine Learning Based Multimodal Neuroimaging Genomics Dementia Score for Predicting Future Conversion to Alzheimer's Disease.
    J Alzheimers Dis. 2022 Apr 16. pii: JAD220021. doi: 10.3233/JAD-220021.
    PubMed     Abstract available


  199. KETCHUM FB, Erickson CM, Chin NA, Gleason CE, et al
    What Influences the Willingness of Blacks and African Americans to Enroll in Preclinical Alzheimer's Disease Biomarker Research? A Qualitative Vignette Analysis.
    J Alzheimers Dis. 2022 Apr 16. pii: JAD215521. doi: 10.3233/JAD-215521.
    PubMed     Abstract available


  200. WONG HY, Zhong H, Zhong M, Zhou X, et al
    Demographics and Medication Use of Patients with Late-Onset Alzheimer's Disease in Hong Kong.
    J Alzheimers Dis. 2022 Apr 16. pii: JAD215312. doi: 10.3233/JAD-215312.
    PubMed     Abstract available


  201. DALY T, Mastroleo I
    The First Survivors of Alzheimer's: How Patients Recovered Life and Hope in Their Own Words by Dale Bredesen, Avery, 2021, 272 pp.
    J Alzheimers Dis. 2022 Apr 13. pii: JAD220185. doi: 10.3233/JAD-220185.
    PubMed    


  202. KAWARABAYASHI T, Nakamura T, Sato K, Seino Y, et al
    Lipid Rafts Act as a Common Platform for Amyloid-beta Oligomer-Induced Alzheimer's Disease Pathology.
    J Alzheimers Dis. 2022 Apr 12. pii: JAD215662. doi: 10.3233/JAD-215662.
    PubMed     Abstract available


  203. MARINELLI L, Trompetto C, Puce L, Monacelli F, et al
    Electromyographic Patterns of Paratonia in Normal Subjects and in Patients with Mild Cognitive Impairment or Alzheimer's Disease.
    J Alzheimers Dis. 2022 Apr 11. pii: JAD215526. doi: 10.3233/JAD-215526.
    PubMed     Abstract available


  204. HONE-BLANCHET A, Bhosali A, Krishnamurthy LC, Shahid SS, et al
    Frontal Metabolites and Alzheimer's Disease Biomarkers in Healthy Older Women and Women Diagnosed with Mild Cognitive Impairment.
    J Alzheimers Dis. 2022 Apr 11. pii: JAD215431. doi: 10.3233/JAD-215431.
    PubMed     Abstract available


  205. MOZERSKY J, Roberts SJ, Rumbaugh M, Chhatwal J, et al
    Spillover: The Approval of New Medications for Alzheimer's Disease Dementia Will Impact Biomarker Disclosure Among Asymptomatic Research Participants.
    J Alzheimers Dis. 2022 Apr 8. pii: JAD220113. doi: 10.3233/JAD-220113.
    PubMed     Abstract available


  206. ISELLA V, Rosazza C, Ferri F, Gazzotti M, et al
    Learning From Mistakes: Cognitive and Metabolic Correlates of Errors on Picture Naming in the Alzheimer's Disease Spectrum.
    J Alzheimers Dis. 2022 Apr 8. pii: JAD220053. doi: 10.3233/JAD-220053.
    PubMed     Abstract available


  207. GARCIA PRETELT FJ, Suarez Relevo JX, Aguillon D, Lopera F, et al
    Automatic Classification of Subjects of the PSEN1-E280A Family at Risk of Developing Alzheimer's Disease Using Machine Learning and Resting State Electroencephalography.
    J Alzheimers Dis. 2022 Apr 8. pii: JAD210148. doi: 10.3233/JAD-210148.
    PubMed     Abstract available


  208. GHERARDELLI C, Cisternas P, Vera-Salazar RF, Mendez-Orellana C, et al
    Age- and Sex-Associated Glucose Metabolism Decline in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Apr 7. pii: JAD215273. doi: 10.3233/JAD-215273.
    PubMed     Abstract available


  209. GABEL M, Bollinger RM, Coble DW, Grill JD, et al
    Retaining Participants in Longitudinal Studies of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Apr 5. pii: JAD215710. doi: 10.3233/JAD-215710.
    PubMed     Abstract available


  210. PILOTTO A, Parigi M, Bonzi G, Battaglio B, et al
    Differences Between Plasma and Cerebrospinal Fluid p-tau181 and p-tau231 in Early Alzheimer's Disease.
    J Alzheimers Dis. 2022 Apr 5. pii: JAD215646. doi: 10.3233/JAD-215646.
    PubMed     Abstract available


  211. UENO M, Yoshino Y, Mori H, Funahashi Y, et al
    Association Study and Meta-Analysis of Polymorphisms and Blood mRNA Expression of the ALDH2 Gene in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2022 Apr 5. pii: JAD215627. doi: 10.3233/JAD-215627.
    PubMed     Abstract available


  212. HANYU H, Koyama Y, Horita H, Aoki T, et al
    Characterization of Alzheimer's Disease Subtypes Based on Magnetic Resonance Imaging and Perfusion Single-Photon Emission Computed Tomography.
    J Alzheimers Dis. 2022 Apr 1. pii: JAD215674. doi: 10.3233/JAD-215674.
    PubMed     Abstract available


  213. LAZAROU I, Georgiadis K, Nikolopoulos S, Oikonomou VP, et al
    Exploring Network Properties Across Preclinical Stages of Alzheimer's Disease Using a Visual Short-Term Memory and Attention Task with High-Density Electroencephalography: A Brain-Connectome Neurophysiological Study.
    J Alzheimers Dis. 2022 Apr 1. pii: JAD215421. doi: 10.3233/JAD-215421.
    PubMed     Abstract available


    March 2022
  214. WEI T, Guo Z, Wang Z, Li C, et al
    Five Major Psychiatric Disorders and Alzheimer's Disease: A Bidirectional Mendelian Randomization Study.
    J Alzheimers Dis. 2022 Mar 31. pii: JAD220010. doi: 10.3233/JAD-220010.
    PubMed     Abstract available


  215. GONZALEZ CORDERO EM, Cuevas-Budhart MA, Perez-Moran D, Trejo Villeda MA, et al
    Relationship Between the Gut Microbiota and Alzheimer's Disease: A Systematic Review.
    J Alzheimers Dis. 2022 Mar 28. pii: JAD215224. doi: 10.3233/JAD-215224.
    PubMed     Abstract available



  216. Erratum to: Does Certainty of Genuine Treatment Increase the Drug Response in Alzheimer's Disease Patients: A Meta-Analysis and Critical Discussion.
    J Alzheimers Dis. 2022 Mar 25. pii: JAD229002. doi: 10.3233/JAD-229002.
    PubMed    


  217. KIM CK, Lee YR, Ong L, Gold M, et al
    Alzheimer's Disease: Key Insights from Two Decades of Clinical Trial Failures.
    J Alzheimers Dis. 2022 Mar 22. pii: JAD215699. doi: 10.3233/JAD-215699.
    PubMed     Abstract available


  218. ZHANG PF, Wang ZT, Liu Y, Hu H, et al
    Peripheral Immune Cells and Cerebrospinal Fluid Biomarkers of Alzheimer's Disease Pathology in Cognitively Intact Older Adults: The CABLE Study.
    J Alzheimers Dis. 2022 Mar 21. pii: JAD220057. doi: 10.3233/JAD-220057.
    PubMed     Abstract available


  219. JIAN JM, Fan DY, Cheng Y, Shen YY, et al
    Circulating Naturally Occurring Antibodies to P2RY2 Are Decreased in Alzheimer's Disease.
    J Alzheimers Dis. 2022 Mar 21. pii: JAD215611. doi: 10.3233/JAD-215611.
    PubMed     Abstract available


  220. MURCHISON CF, Jaeger BC, Szychowski JM, Cutter GR, et al
    Influence of Subject-Specific Effects in Longitudinal Modelling of Cognitive Decline in Alzheimer's Disease.
    J Alzheimers Dis. 2022 Mar 21. pii: JAD215553. doi: 10.3233/JAD-215553.
    PubMed     Abstract available


  221. WANG X, Sun H, Pan S, Bai X, et al
    Causal Relationships Between Relative Intake from the Macronutrients and Alzheimer's Disease: A Two-Sample Mendelian Randomization Study.
    J Alzheimers Dis. 2022 Mar 21. pii: JAD215535. doi: 10.3233/JAD-215535.
    PubMed     Abstract available


  222. LARGENT EA, Bhardwaj T, Clapp JT, Sykes OS, et al
    You've Got a Friend in Me: How Cognitively Unimpaired Older Adults Select a Study Partner to Participate with Them in Alzheimer's Disease Research.
    J Alzheimers Dis. 2022 Mar 18. pii: JAD220061. doi: 10.3233/JAD-220061.
    PubMed     Abstract available


  223. DOBROMYSLIN VI, Megherbi DB
    Augmenting Imaging Biomarker Performance with Blood-Based Gene Expression Levels for Predicting Alzheimer's Disease Progression.
    J Alzheimers Dis. 2022 Mar 15. pii: JAD215640. doi: 10.3233/JAD-215640.
    PubMed     Abstract available


  224. DE OLIVEIRA FF, Bertolucci PHF, Chen ES, Smith MC, et al
    Pharmacogenetic Analyses of Therapeutic Effects of Lipophilic Statins on Cognitive and Functional Changes in Alzheimer's Disease.
    J Alzheimers Dis. 2022 Mar 14. pii: JAD215735. doi: 10.3233/JAD-215735.
    PubMed     Abstract available


  225. DU XL, Song L, Schulz PE, Xu H, et al
    Risk of Developing Alzheimer's Disease and Related Dementias in Association with Cardiovascular Disease, Stroke, Hypertension, and Diabetes in a Large Cohort of Women with Breast Cancer and with up to 26 Years of Follow-Up.
    J Alzheimers Dis. 2022 Mar 14. pii: JAD215657. doi: 10.3233/JAD-215657.
    PubMed     Abstract available


  226. LUPPI JJ, Schoonhoven DN, van Nifterick AM, Gouw AA, et al
    Oscillatory Activity of the Hippocampus in Prodromal Alzheimer's Disease: A Source-Space Magnetoencephalography Study.
    J Alzheimers Dis. 2022 Mar 14. pii: JAD215464. doi: 10.3233/JAD-215464.
    PubMed     Abstract available


  227. HUANG SY, Yang YX, Zhang YR, Kuo K, et al
    Investigating Causal Relations Between Circulating Metabolites and Alzheimer's Disease: A Mendelian Randomization Study.
    J Alzheimers Dis. 2022 Mar 11. pii: JAD220050. doi: 10.3233/JAD-220050.
    PubMed     Abstract available


  228. TERNAK G, Nemeth M, Rozanovic M, Bogar L, et al
    Alzheimer's Disease-Related Dysbiosis Might Be Triggered by Certain Classes of Antibiotics with Time-Lapse: New Insights into the Pathogenesis?
    J Alzheimers Dis. 2022 Mar 11. pii: JAD220018. doi: 10.3233/JAD-220018.
    PubMed     Abstract available


  229. CAO M, Liu J, Zhang X, Yang T, et al
    ABI3 Is a Novel Early Biomarker of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Mar 11. pii: JAD215635. doi: 10.3233/JAD-215635.
    PubMed     Abstract available


  230. KRAUSE-SORIO B, Siddarth P, Kilpatrick L, Milillo MM, et al
    Yoga Prevents Gray Matter Atrophy in Women at Risk for Alzheimer's Disease: A Randomized Controlled Trial.
    J Alzheimers Dis. 2022 Mar 11. pii: JAD215563. doi: 10.3233/JAD-215563.
    PubMed     Abstract available


  231. NICSANU R, Cervellati C, Benussi L, Squitti R, et al
    Increased Serum Beta-Secretase 1 Activity is an Early Marker of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Mar 11. pii: JAD215542. doi: 10.3233/JAD-215542.
    PubMed     Abstract available


  232. WOLFSGRUBER S, Kleineidam L, Weyrauch AS, Barkhoff M, et al
    Relevance of Subjective Cognitive Decline in Older Adults with a First-Degree Family History of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Mar 11. pii: JAD215416. doi: 10.3233/JAD-215416.
    PubMed     Abstract available


  233. CHUNG SJ, Chang Y, Jeon J, Shin JI, et al
    Association of Alzheimer's Disease with COVID-19 Susceptibility and Severe Complications: A Nationwide Cohort Study.
    J Alzheimers Dis. 2022 Mar 10. pii: JAD220031. doi: 10.3233/JAD-220031.
    PubMed     Abstract available


  234. SHIM Y, Han HJ, Park KW, Kim BC, et al
    A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase IIb Clinical Study to Evaluate the Safety and Efficacy of DHP1401 in Patients with Mild to Moderate Alzheimer's Disease Treated with Donepezil: DHP1401 Randomized Trial in Mild to Mode
    J Alzheimers Dis. 2022 Mar 10. pii: JAD215277. doi: 10.3233/JAD-215277.
    PubMed     Abstract available



  235. Erratum to "Effects of Probiotic Supplementation on Short Chain Fatty Acids in the AppNL-G-F Mouse Model of Alzheimer's Disease".
    J Alzheimers Dis. 2022 Mar 8. pii: JAD229001. doi: 10.3233/JAD-229001.
    PubMed    


  236. ANDROUIN A, Thierry M, Boluda S, Baskaran A, et al
    Alterations of Neuronal Lysosomes in Alzheimer's Disease and in APPxPS1-KI Mice.
    J Alzheimers Dis. 2022 Mar 7. pii: JAD215692. doi: 10.3233/JAD-215692.
    PubMed     Abstract available


  237. CIRSTEA MS, Kliger D, MacLellan AD, Yu AC, et al
    The Oral and Fecal Microbiota in a Canadian Cohort of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Mar 7. pii: JAD215520. doi: 10.3233/JAD-215520.
    PubMed     Abstract available


  238. WANG X, Li F, Gao Q, Jiang Z, et al
    Evaluation of the Accuracy of Cognitive Screening Tests in Detecting Dementia Associated with Alzheimer's Disease: A Hierarchical Bayesian Latent Class Meta-Analysis.
    J Alzheimers Dis. 2022 Mar 7. pii: JAD215394. doi: 10.3233/JAD-215394.
    PubMed     Abstract available


  239. KOK FK, van Leerdam SL, de Lange ECM
    Potential Mechanisms Underlying Resistance to Dementia in Non-Demented Individuals with Alzheimer's Disease Neuropathology.
    J Alzheimers Dis. 2022 Mar 7. pii: JAD210607. doi: 10.3233/JAD-210607.
    PubMed     Abstract available


  240. LACORTE E, Ancidoni A, Zaccaria V, Remoli G, et al
    Safety and Efficacy of Monoclonal Antibodies for Alzheimer's Disease: A Systematic Review and Meta-Analysis of Published and Unpublished Clinical Trials.
    J Alzheimers Dis. 2022 Mar 5. pii: JAD220046. doi: 10.3233/JAD-220046.
    PubMed     Abstract available


  241. LIU Y, Han PR, Hu H, Wang ZT, et al
    A Multi-Dimensional Comparison of Alzheimer's Disease Neurodegenerative Biomarkers.
    J Alzheimers Dis. 2022 Mar 5. pii: JAD215724. doi: 10.3233/JAD-215724.
    PubMed     Abstract available


  242. XIAO Y, Gong X, Deng R, Liu W, et al
    Iron Chelation Remits Memory Deficits Caused by the High-Fat Diet in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Mar 3. pii: JAD215705. doi: 10.3233/JAD-215705.
    PubMed     Abstract available


  243. ARMSTRONG MJ, Song S, Kurasz AM, Li Z, et al
    Predictors of Mortality in Individuals with Dementia in the National Alzheimer's Coordinating Center.
    J Alzheimers Dis. 2022 Mar 3. pii: JAD215587. doi: 10.3233/JAD-215587.
    PubMed     Abstract available


  244. FENG T, Hu X, Fukui Y, Bian Z, et al
    Clinical and Pathological Benefits of Scallop-Derived Plasmalogen in a Novel Mouse Model of Alzheimer's Disease with Chronic Cerebral Hypoperfusion.
    J Alzheimers Dis. 2022 Mar 3. pii: JAD215246. doi: 10.3233/JAD-215246.
    PubMed     Abstract available


  245. BROUSSARD JI, Redell JB, Maynard ME, Zhao J, et al
    Impaired Experience-Dependent Refinement of Place Cells in a Rat Model of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Mar 3. pii: JAD215023. doi: 10.3233/JAD-215023.
    PubMed     Abstract available


  246. BABULAL GM, Chen L, Doherty JM, Murphy SA, et al
    Longitudinal Changes in Anger, Anxiety, and Fatigue Are Associated with Cerebrospinal Fluid Biomarkers of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Mar 2. pii: JAD215708. doi: 10.3233/JAD-215708.
    PubMed     Abstract available


  247. MEYSAMI S, Raji CA, Mendez MF
    Quantified Brain Magnetic Resonance Imaging Volumes Differentiates Behavioral Variant Frontotemporal Dementia from Early-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2022 Mar 2. pii: JAD215667. doi: 10.3233/JAD-215667.
    PubMed     Abstract available


  248. SHI Y, Bao Q, Chen W, Wang L, et al
    Potential Roles of Extracellular Vesicles as Diagnosis Biomarkers and Therapeutic Approaches for Cognitive Impairment in Alzheimer's Disease.
    J Alzheimers Dis. 2022 Mar 2. pii: JAD215666. doi: 10.3233/JAD-215666.
    PubMed     Abstract available


  249. MI Y, Qin Q, Xing Y, Tang Y, et al
    Capgras Syndrome as the Core Manifestation of Early-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2022 Mar 2. pii: JAD215565. doi: 10.3233/JAD-215565.
    PubMed     Abstract available


  250. JACUS JP, Voltzenlogel V, Antoine P, Cuervo-Lombard CV, et al
    Apathy Is the Best Dimension to Consider for Awareness Assessment in Alzheimer's Disease.
    J Alzheimers Dis. 2022 Mar 2. pii: JAD215550. doi: 10.3233/JAD-215550.
    PubMed     Abstract available


  251. ESCOBAR YH, O'Piela D, Wold LE, Mackos AR, et al
    Influence of the Microbiota-Gut-Brain Axis on Cognition in Alzheimer's Disease.
    J Alzheimers Dis. 2022 Mar 2. pii: JAD215290. doi: 10.3233/JAD-215290.
    PubMed     Abstract available


  252. ALVES SR, da Cruz E Silva C, Martins I, Henriques AG, et al
    A Bioinformatics Approach Toward Unravelling the Synaptic Molecular Crosstalk Between Alzheimer's Disease and Diabetes.
    J Alzheimers Dis. 2022 Mar 2. pii: JAD215059. doi: 10.3233/JAD-215059.
    PubMed     Abstract available


    February 2022
  253. KRISHNA-K K, Behnisch T, Sajikumar S
    Modulation of the Ubiquitin-Proteasome System Restores Plasticity in Hippocampal Pyramidal Neurons of the APP/PS1 Alzheimer's Disease-Like Mice.
    J Alzheimers Dis. 2022 Feb 28. pii: JAD215718. doi: 10.3233/JAD-215718.
    PubMed     Abstract available


  254. LI W, Yang D, Yan C, Chen M, et al
    Characterizing Network Selectiveness to the Dynamic Spreading of Neuropathological Events in Alzheimer's Disease.
    J Alzheimers Dis. 2022 Feb 28. pii: JAD215596. doi: 10.3233/JAD-215596.
    PubMed     Abstract available


  255. KALECKY K, German DC, Montillo AA, Bottiglieri T, et al
    Targeted Metabolomic Analysis in Alzheimer's Disease Plasma and Brain Tissue in Non-Hispanic Whites.
    J Alzheimers Dis. 2022 Feb 28. pii: JAD215448. doi: 10.3233/JAD-215448.
    PubMed     Abstract available


  256. CAO H, Zhou X, Chen Y, Ip FCF, et al
    Association of SPI1 Haplotypes with Altered SPI1 Gene Expression and Alzheimer's Disease Risk.
    J Alzheimers Dis. 2022 Feb 28. pii: JAD215311. doi: 10.3233/JAD-215311.
    PubMed     Abstract available


  257. COLVERSON AJ, Trifilio E, Williamson JB
    Music, Mind, Mood, and Mingling in Alzheimer's Disease and Related Dementias: A Scoping Review.
    J Alzheimers Dis. 2022 Feb 28. pii: JAD215199. doi: 10.3233/JAD-215199.
    PubMed     Abstract available


  258. PAYNE S, Shofer JB, Shutes-David A, Li G, et al
    Correlates of Conversion from Mild Cognitive Impairment to Dementia with Lewy Bodies: Data from the National Alzheimer Coordinating Center.
    J Alzheimers Dis. 2022 Feb 23. pii: JAD215428. doi: 10.3233/JAD-215428.
    PubMed     Abstract available


  259. CHOI H, Lee D, Mook-Jung I
    Gut Microbiota as a Hidden Player in the Pathogenesis of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Feb 22. pii: JAD215235. doi: 10.3233/JAD-215235.
    PubMed     Abstract available


  260. ALVAREZ-SANCHEZ L, Pena-Bautista C, Baquero M, Chafer-Pericas C, et al
    Novel Ultrasensitive Detection Technologies for the Identification of Early and Minimally Invasive Alzheimer's Disease Blood Biomarkers.
    J Alzheimers Dis. 2022 Feb 22. pii: JAD215093. doi: 10.3233/JAD-215093.
    PubMed     Abstract available


  261. SCHINDLER SE
    Predicting Symptom Onset in Sporadic Alzheimer's Disease: "How Long Do I Have?"
    J Alzheimers Dis. 2022 Feb 21. pii: JAD215722. doi: 10.3233/JAD-215722.
    PubMed     Abstract available


  262. AKSNES M, Aass HCD, Tiiman A, Terenius L, et al
    Serum Amyloidogenic Nanoplaques and Cytokines in Alzheimer's Disease: Pilot Study in a Small Naturalistic Memory Clinic Cohort.
    J Alzheimers Dis. 2022 Feb 21. pii: JAD215504. doi: 10.3233/JAD-215504.
    PubMed     Abstract available


  263. TSAMOU M, Carpi D, Pistollato F, Roggen EL, et al
    Sporadic Alzheimer's Disease- and Neurotoxicity-Related microRNAs Affecting Key Events of Tau-Driven Adverse Outcome Pathway Toward Memory Loss.
    J Alzheimers Dis. 2022 Feb 21. pii: JAD215434. doi: 10.3233/JAD-215434.
    PubMed     Abstract available


  264. JACOBS HIL, O'Donnell A, Satizabal CL, Lois C, et al
    Associations Between Brainstem Volume and Alzheimer's Disease Pathology in Middle-Aged Individuals of the Framingham Heart Study.
    J Alzheimers Dis. 2022 Feb 21. pii: JAD215372. doi: 10.3233/JAD-215372.
    PubMed     Abstract available


  265. LIU Z, Paek EJ, Yoon SO, Casenhiser D, et al
    Detecting Alzheimer's Disease Using Natural Language Processing of Referential Communication Task Transcripts.
    J Alzheimers Dis. 2022 Feb 21. pii: JAD215137. doi: 10.3233/JAD-215137.
    PubMed     Abstract available


  266. HUA X, Church K, Walker W, L'Hostis P, et al
    Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Positive Modulator of HGF/MET, Fosgonimeton, in Healthy Volunteers and Subjects with Alzheimer's Disease: Randomized, Placebo-Controlled, Double-Blind, Phase I Clinical Trial.
    J Alzheimers Dis. 2022 Feb 18. pii: JAD215511. doi: 10.3233/JAD-215511.
    PubMed     Abstract available


  267. SOARES JZ, Valeur J, Saltyte Benth J, Knapskog AB, et al
    Vitamin D in Alzheimer's Disease: Low Levels in Cerebrospinal Fluid Despite Normal Amounts in Serum.
    J Alzheimers Dis. 2022 Feb 15. pii: JAD215536. doi: 10.3233/JAD-215536.
    PubMed     Abstract available


  268. HANG Z, Cai S, Lei T, Zhang X, et al
    Transfer of Tumor-Bearing Mice Intestinal Flora Can Ameliorate Cognition in Alzheimer's Disease Mice.
    J Alzheimers Dis. 2022 Feb 15. pii: JAD215495. doi: 10.3233/JAD-215495.
    PubMed     Abstract available


  269. GALLUCCI M, Cenesi L, White C, Antuono P, et al
    Lights and Shadows of Cerebrospinal Fluid Biomarkers in the Current Alzheimer's Disease Framework.
    J Alzheimers Dis. 2022 Feb 14. pii: JAD215432. doi: 10.3233/JAD-215432.
    PubMed     Abstract available


  270. SUAREZ-MENDEZ I, Bruna R, Lopez-Sanz D, Montejo P, et al
    Cognitive Training Modulates Brain Hypersynchrony in a Population at Risk for Alzheimer's Disease.
    J Alzheimers Dis. 2022 Feb 14. pii: JAD215406. doi: 10.3233/JAD-215406.
    PubMed     Abstract available


  271. BIJU K, Oh E, Rosenberg P, Xue QL, et al
    Vestibular Function Predicts Balance and Fall Risk in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2022 Feb 14. pii: JAD215366. doi: 10.3233/JAD-215366.
    PubMed     Abstract available


  272. ATAYDE AL, Fischer CE, Schweizer TA, Munoz DG, et al
    Neuropsychiatric Inventory-Questionnaire Assessed Nighttime Behaviors in Cognitively Asymptomatic Patients with Pathologically Confirmed Alzheimer's Disease Predict More Rapid Cognitive Deterioration.
    J Alzheimers Dis. 2022 Feb 14. pii: JAD215276. doi: 10.3233/JAD-215276.
    PubMed     Abstract available


  273. WANG J, Ma SF, Yun Q, Liu WJ, et al
    FOXG1 as a Potential Therapeutic Target for Alzheimer's Disease with a Particular Focus on Cell Cycle Regulation.
    J Alzheimers Dis. 2022 Feb 14. pii: JAD215144. doi: 10.3233/JAD-215144.
    PubMed     Abstract available


  274. KELBERMAN MA, Anderson CR, Chlan E, Rorabaugh JM, et al
    Consequences of Hyperphosphorylated Tau in the Locus Coeruleus on Behavior and Cognition in a Rat Model of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Feb 9. pii: JAD215546. doi: 10.3233/JAD-215546.
    PubMed     Abstract available


  275. TICINESI A, Mancabelli L, Carnevali L, Nouvenne A, et al
    Interaction Between Diet and Microbiota in the Pathophysiology of Alzheimer's Disease: Focus on Polyphenols and Dietary Fibers.
    J Alzheimers Dis. 2022 Feb 9. pii: JAD215493. doi: 10.3233/JAD-215493.
    PubMed     Abstract available


  276. GALASKO DR, Grill JD, Lingler JH, Heidebrink JL, et al
    A Blood Test for Alzheimer's Disease: It's about Time or Not Ready for Prime Time?
    J Alzheimers Dis. 2022 Feb 9. pii: JAD215490. doi: 10.3233/JAD-215490.
    PubMed     Abstract available


  277. PARRA MA
    Barriers to Effective Memory Assessments for Alzheimer's Disease.
    J Alzheimers Dis. 2022 Feb 9. pii: JAD215445. doi: 10.3233/JAD-215445.
    PubMed     Abstract available


  278. DE PAULA FRANCA RESENDE E, Ketelle R, Karydas A, Allen I, et al
    Late-Onset Alcohol Abuse as a Presenting Symptom of Neurodegenerative Diseases.
    J Alzheimers Dis. 2022 Feb 9. pii: JAD215369. doi: 10.3233/JAD-215369.
    PubMed     Abstract available


  279. XU A, Kouznetsova VL, Tsigelny IF
    Alzheimer's Disease Diagnostics Using miRNA Biomarkers and Machine Learning.
    J Alzheimers Dis. 2022 Feb 5. pii: JAD215502. doi: 10.3233/JAD-215502.
    PubMed     Abstract available


  280. TU MC, Chung HW, Hsu YH, Yang JJ, et al
    Stage-Dependent Cerebral Blood Flow and Leukoaraiosis Couplings in Subcortical Ischemic Vascular Disease and Alzheimer's Disease.
    J Alzheimers Dis. 2022 Feb 3. pii: JAD215405. doi: 10.3233/JAD-215405.
    PubMed     Abstract available


  281. JANSSON D, Wang M, Thomas R, Erickson MA, et al
    Markers of Cerebrovascular Injury, Inflammation, and Plasma Lipids Are Associated with Alzheimer's Disease Cerebrospinal Fluid Biomarkers in Cognitively Normal Persons.
    J Alzheimers Dis. 2022 Feb 2. pii: JAD215400. doi: 10.3233/JAD-215400.
    PubMed     Abstract available


  282. ASSOGNA M, Motta C, Bonni S, Borghi I, et al
    Isolated Amyloid-beta Pathology Is Associated with Preserved Cortical Plasticity in APOE4 Alzheimer's Disease Patients.
    J Alzheimers Dis. 2022 Feb 2. pii: JAD215218. doi: 10.3233/JAD-215218.
    PubMed     Abstract available


  283. THOMPSON RE, Tuchman AJ, Alkon DL
    Bryostatin Placebo-Controlled Trials Indicate Cognitive Restoration Above Baseline for Advanced Alzheimer's Disease in the Absence of Memantine1.
    J Alzheimers Dis. 2022 Feb 1. pii: JAD215545. doi: 10.3233/JAD-215545.
    PubMed     Abstract available


    January 2022
  284. GEORGE DR, Whitehouse PJ
    How Not to Study a Disease: The Story of Alzheimer's by Karl Herrup, The MIT Press, 2021, 245 pp.
    J Alzheimers Dis. 2022 Jan 31. pii: JAD220035. doi: 10.3233/JAD-220035.
    PubMed    


  285. JUTTEN RJ, Thompson L, Sikkes SAM, Maruff P, et al
    A Neuropsychological Perspective on Defining Cognitive Impairment in the Clinical Study of Alzheimer's Disease: Towards a More Continuous Approach.
    J Alzheimers Dis. 2022 Jan 31. pii: JAD215098. doi: 10.3233/JAD-215098.
    PubMed     Abstract available


  286. UM YH, Wang SM, Kang DW, Kim NY, et al
    Subcortical and Cerebellar Neural Correlates of Prodromal Alzheimer's Disease with Prolonged Sleep Latency.
    J Alzheimers Dis. 2022 Jan 21. pii: JAD215460. doi: 10.3233/JAD-215460.
    PubMed     Abstract available


  287. MESA-HERRERA F, Marin R, Torrealba E, Diaz M, et al
    Multivariate Assessment of Lipoxidative Metabolites, Trace Biometals, and Antioxidant and Detoxifying Activities in the Cerebrospinal Fluid Define a Fingerprint of Preclinical Stages of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Jan 19. pii: JAD215437. doi: 10.3233/JAD-215437.
    PubMed     Abstract available


  288. ZHANG W, Zhang M, Wu Q, Shi JS, et al
    Dendrobium nobile Lindl. Alkaloids Ameliorate Abeta25-35-Induced Synaptic Deficits by Targeting Wnt/beta-Catenin Pathway in Alzheimer's Disease Models.
    J Alzheimers Dis. 2022 Jan 19. pii: JAD215433. doi: 10.3233/JAD-215433.
    PubMed     Abstract available


  289. TEIXEIRA AL, Salem H, Martins LB, Gonzales MM, et al
    Factors Associated with Apathy in Alzheimer's Disease: A Cross-Sectional Analysis of the Texas Alzheimer's Research and Care Consortium (TARCC) Study.
    J Alzheimers Dis. 2022 Jan 19. pii: JAD215314. doi: 10.3233/JAD-215314.
    PubMed     Abstract available


  290. PEDERSEN FN, Stokholm L, Pouwer F, Hass Rubin K, et al
    Diabetic Retinopathy Predicts Risk of Alzheimer's Disease: A Danish Registry-Based Nationwide Cohort Study.
    J Alzheimers Dis. 2022 Jan 19. pii: JAD215313. doi: 10.3233/JAD-215313.
    PubMed     Abstract available


  291. RICHTER N, David LS, Grothe MJ, Teipel S, et al
    Age and Anterior Basal Forebrain Volume Predict the Cholinergic Deficit in Patients with Mild Cognitive Impairment due to Alzheimer's Disease.
    J Alzheimers Dis. 2022 Jan 19. pii: JAD210261. doi: 10.3233/JAD-210261.
    PubMed     Abstract available


  292. MCNERNEY MW, Heath A, Narayanan S, Yesavage J, et al
    Repetitive Transcranial Magnetic Stimulation Improves Brain-Derived Neurotrophic Factor and Cholinergic Signaling in the 3xTgAD Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Jan 18. pii: JAD215361. doi: 10.3233/JAD-215361.
    PubMed     Abstract available


  293. KUKSA PP, Liu CL, Fu W, Qu L, et al
    Alzheimer's Disease Variant Portal: A Catalog of Genetic Findings for Alzheimer's Disease.
    J Alzheimers Dis. 2022 Jan 18. pii: JAD215055. doi: 10.3233/JAD-215055.
    PubMed     Abstract available


  294. MIRON J, Picard C, Labonte A, Auld D, et al
    MSR1 and NEP Are Correlated with Alzheimer's Disease Amyloid Pathology and Apolipoprotein Alterations.
    J Alzheimers Dis. 2022 Jan 13. pii: JAD215410. doi: 10.3233/JAD-215410.
    PubMed     Abstract available


  295. EASTMAN G, Sharlow ER, Lazo JS, Bloom GS, et al
    Transcriptome and Translatome Regulation of Pathogenesis in Alzheimer's Disease Model Mice.
    J Alzheimers Dis. 2022 Jan 13. pii: JAD215357. doi: 10.3233/JAD-215357.
    PubMed     Abstract available


  296. STEPLER KE, Gillyard TR, Reed CB, Avery TM, et al
    ABCA7, a Genetic Risk Factor Associated with Alzheimer's Disease Risk in African Americans.
    J Alzheimers Dis. 2022 Jan 13. pii: JAD215306. doi: 10.3233/JAD-215306.
    PubMed     Abstract available


  297. SCHAFFERT J, LoBue C, Hynan LS, Hart J, et al
    Predictors of Life Expectancy in Autopsy-Confirmed Alzheimer's Disease.
    J Alzheimers Dis. 2022 Jan 13. pii: JAD215200. doi: 10.3233/JAD-215200.
    PubMed     Abstract available


  298. PARK M, Baik K, Lee YG, Kang SW, et al
    Erratum to: Implication of Small Vessel Disease MRI Markers in Alzheimer's Disease and Lewy Body Disease.
    J Alzheimers Dis. 2022 Jan 11. pii: JAD219020. doi: 10.3233/JAD-219020.
    PubMed    


  299. BIAN Z, Liu X, Feng T, Yu H, et al
    Protective Effect of Rivaroxaban Against Amyloid Pathology and Neuroinflammation Through Inhibiting PAR-1 and PAR-2 in Alzheimer's Disease Mice.
    J Alzheimers Dis. 2022 Jan 5. pii: JAD215318. doi: 10.3233/JAD-215318.
    PubMed     Abstract available


  300. DALY T, Mastroleo I, Henry V, Bourdenx M, et al
    An Argument for Simple Tests of Treatment of Alzheimer's Disease.
    J Alzheimers Dis. 2022 Jan 4. pii: JAD215492. doi: 10.3233/JAD-215492.
    PubMed     Abstract available


  301. BENCA R, Herring WJ, Khandker R, Qureshi Z, et al
    Burden of Insomnia and Sleep Disturbances and the Impact of Sleep Treatments in Patients with Probable or Possible Alzheimer's Disease: A Structured Literature Review.
    J Alzheimers Dis. 2022 Jan 4. pii: JAD215324. doi: 10.3233/JAD-215324.
    PubMed     Abstract available


  302. CONTARINO VE, Siggillino S, Arighi A, Scola E, et al
    Association of Superficial White Matter Alterations with Cerebrospinal Fluid Biomarkers and Cognitive Decline in Neurodegenerative Dementia.
    J Alzheimers Dis. 2022;85:431-442.
    PubMed     Abstract available


  303. WILKINS HM, Troutwine BR, Menta BW, Manley SJ, et al
    Mitochondrial Membrane Potential Influences Amyloid-beta Protein Precursor Localization and Amyloid-beta Secretion.
    J Alzheimers Dis. 2022;85:381-394.
    PubMed     Abstract available


  304. YAN XD, Qu XS, Yin J, Qiao J, et al
    Adiponectin Ameliorates Cognitive Behaviors and in vivo Synaptic Plasticity Impairments in 3xTg-AD Mice.
    J Alzheimers Dis. 2022;85:343-357.
    PubMed     Abstract available


  305. SCHWARZ CG, Knopman DS, Ramanan VK, Lowe VJ, et al
    Longitudinally Increasing Elevated Asymmetric Flortaucipir Binding in a Cognitively Unimpaired Amyloid-Negative Older Individual.
    J Alzheimers Dis. 2022;85:59-64.
    PubMed     Abstract available


  306. SONG Y, Du Z, Chen X, Zhang W, et al
    Astrocytic N-Methyl-D-Aspartate Receptors Protect the Hippocampal Neurons Against Amyloid-beta142-Induced Synaptotoxicity by Regulating Nerve Growth Factor.
    J Alzheimers Dis. 2022;85:167-178.
    PubMed     Abstract available


  307. JUNG KH, Park KI, Lee WJ, Son H, et al
    Association of Plasma Oligomerized Amyloid-beta and Cerebral White Matter Lesions in a Health Screening Population.
    J Alzheimers Dis. 2022;85:1835-1844.
    PubMed     Abstract available


  308. STREIT WJ, Rotter J, Winter K, Muller W, et al
    Droplet Degeneration of Hippocampal and Cortical Neurons Signifies the Beginning of Neuritic Plaque Formation.
    J Alzheimers Dis. 2022;85:1701-1720.
    PubMed     Abstract available


  309. KURANO M, Tsukamoto K, Sakai E, Hara M, et al
    Isoform-Dependent Effects of Apolipoprotein E on Sphingolipid Metabolism in Neural Cells.
    J Alzheimers Dis. 2022;85:1529-1544.
    PubMed     Abstract available


  310. SUN Y, Wang M, Zhao Y, Hu K, et al
    A Pathway-Specific Polygenic Risk Score Is Associated with Tau Pathology and Cognitive Decline.
    J Alzheimers Dis. 2022;85:1745-1754.
    PubMed     Abstract available


  311. KHAN N, Alimova Y, Clark SJ, Vekaria HJ, et al
    Human APOE varepsilon3 and APOE varepsilon4 Alleles Have Differential Effects on Mouse Olfactory Epithelium.
    J Alzheimers Dis. 2022;85:1481-1494.
    PubMed     Abstract available


  312. KHORANI M, Bobe G, Matthews DG, Magana AA, et al
    The Impact of the hAPP695SW Transgene and Associated Amyloid-beta Accumulation on Murine Hippocampal Biochemical Pathways.
    J Alzheimers Dis. 2022;85:1601-1619.
    PubMed     Abstract available


  313. CHENG J, Fairchild JK, McNerney MW, Noda A, et al
    Repetitive Transcranial Magnetic Stimulation as a Treatment for Veterans with Cognitive Impairment and Multiple Comorbidities.
    J Alzheimers Dis. 2022;85:1593-1600.
    PubMed     Abstract available


  314. GAO Z, Zhang R, Jiang L, Zhou H, et al
    Administration of miR-195 Inhibitor Enhances Memory Function Through Improving Synaptic Degradation and Mitochondrial Dysfunction of the Hippocampal Neurons in SAMP8 Mice.
    J Alzheimers Dis. 2022;85:1495-1509.
    PubMed     Abstract available


  315. WANG G, Zhou W, Kong D, Qu Z, et al
    Studying APOE varepsilon4 Allele Dose Effects with a Univariate Morphometry Biomarker.
    J Alzheimers Dis. 2022;85:1233-1250.
    PubMed     Abstract available


  316. ZHOU AL, Sharda N, Sarma VV, Ahlschwede KM, et al
    Age-Dependent Changes in the Plasma and Brain Pharmacokinetics of Amyloid-beta Peptides and Insulin.
    J Alzheimers Dis. 2022;85:1031-1044.
    PubMed     Abstract available


  317. ZHANG XX, Ma YH, Hu HY, Ma LZ, et al
    Late-Life Obesity Associated with Tau Pathology in Cognitively Normal Individuals: The CABLE Study.
    J Alzheimers Dis. 2022;85:877-887.
    PubMed     Abstract available


  318. BAO J, Liang Z, Gong X, Yu J, et al
    High Fat Diet Mediates Amyloid-beta Cleaving Enzyme 1 Phosphorylation and SUMOylation, Enhancing Cognitive Impairment in APP/PS1 Mice.
    J Alzheimers Dis. 2022;85:863-876.
    PubMed     Abstract available


  319. KHAJEHPIRI B, Moghaddam HA, Forouzanfar M, Lashgari R, et al
    Survival Analysis in Cognitively Normal Subjects and in Patients with Mild Cognitive Impairment Using a Proportional Hazards Model with Extreme Gradient Boosting Regression.
    J Alzheimers Dis. 2022;85:837-850.
    PubMed     Abstract available


  320. SHANG X, Hill E, Zhu Z, Liu J, et al
    Macronutrient Intake and Risk of Dementia in Community-Dwelling Older Adults: A Nine-Year Follow-Up Cohort Study.
    J Alzheimers Dis. 2022;85:791-804.
    PubMed     Abstract available


  321. SIL A, Erfani A, Lamb N, Copland R, et al
    Sex Differences in Behavior and Molecular Pathology in the 5XFAD Model.
    J Alzheimers Dis. 2022;85:755-778.
    PubMed     Abstract available


  322. TALAN J
    Obituary for John Q. Trojanowski, leading Alzheimer's Disease Researcher.
    J Alzheimers Dis. 2022;86:1-3.
    PubMed    


  323. SHAFIR A, Ritchie CS, Garrett SB, Bernstein Sideman A, et al
    "Captive by the Uncertainty"-Experiences with Anticipatory Guidance for People Living with Dementia and Their Caregivers at a Specialty Dementia Clinic.
    J Alzheimers Dis. 2022;86:787-800.
    PubMed     Abstract available


  324. KUNDU P, Zimmerman B, Quinn JF, Kaye J, et al
    Serum Levels of alpha-Klotho Are Correlated with Cerebrospinal Fluid Levels and Predict Measures of Cognitive Function.
    J Alzheimers Dis. 2022;86:1471-1481.
    PubMed     Abstract available


  325. WEINSTEIN G, O'Donnell A, Davis-Plourde K, Zelber-Sagi S, et al
    Non-Alcoholic Fatty Liver Disease, Liver Fibrosis, and Regional Amyloid-beta and Tau Pathology in Middle-Aged Adults: The Framingham Study.
    J Alzheimers Dis. 2022;86:1371-1383.
    PubMed     Abstract available


  326. CHAN CK, Pettigrew C, Soldan A, Zhu Y, et al
    Association Between Late-Life Neuropsychiatric Symptoms and Cognitive Decline in Relation to White Matter Hyperintensities and Amyloid Burden.
    J Alzheimers Dis. 2022;86:1415-1426.
    PubMed     Abstract available


  327. OWENS L, Bracewell J, Benedetto A, Dawson N, et al
    BACE1 Overexpression Reduces SH-SY5Y Cell Viability Through a Mechanism Distinct from Amyloid-beta Peptide Accumulation: Beta Prime-Mediated Competitive Depletion of sAbetaPPalpha.
    J Alzheimers Dis. 2022;86:1201-1220.
    PubMed     Abstract available


  328. TANAKA T, Gyanwali B, Villaraza SG, Saridin FN, et al
    The Association Between Standard Electrocardiography and Cerebral Small Vessel Disease in a Memory Clinic Study.
    J Alzheimers Dis. 2022;86:1093-1105.
    PubMed     Abstract available


  329. SAJI N, Murotani K, Sato N, Tsuduki T, et al
    Relationship Between Plasma Neurofilament Light Chain, Gut Microbiota, and Dementia: A Cross-Sectional Study.
    J Alzheimers Dis. 2022;86:1323-1335.
    PubMed     Abstract available


  330. TIAN Q, Bilgel M, Moghekar AR, Ferrucci L, et al
    Olfaction, Cognitive Impairment, and PET Biomarkers in Community-Dwelling Older Adults.
    J Alzheimers Dis. 2022;86:1275-1285.
    PubMed     Abstract available


  331. O'BRYANT SE, Zhang F, Petersen M, Hall JR, et al
    Proteomic Profiles of Neurodegeneration Among Mexican Americans and Non-Hispanic Whites in the HABS-HD Study.
    J Alzheimers Dis. 2022;86:1243-1254.
    PubMed     Abstract available


  332. DORAISWAMY PM, Goldberg TE, Qian M, Linares AR, et al
    Validity of the Web-Based, Self-Directed, NeuroCognitive Performance Test in Mild Cognitive Impairment.
    J Alzheimers Dis. 2022;86:1131-1136.
    PubMed     Abstract available


  333. RICE M, Davalos D, Thomas ML
    A Systematic Review of Prospective Memory Interventions Across Stages of Dementia-Related Disorders.
    J Alzheimers Dis. 2022;86:1001-1024.
    PubMed     Abstract available


  334. ZHU Z, Zeng Q, Zhang R, Luo X, et al
    White Matter Free Water Outperforms Cerebral Small Vessel Disease Total Score in Predicting Cognitive Decline in Persons with Mild Cognitive Impairment.
    J Alzheimers Dis. 2022;86:741-751.
    PubMed     Abstract available


  335. CEYZERIAT K, Tournier BB, Millet P, Dipasquale G, et al
    Low-Dose Radiation Therapy Reduces Amyloid Load in Young 3xTg-AD Mice.
    J Alzheimers Dis. 2022;86:641-653.
    PubMed     Abstract available


  336. CHEN WT, Chi NF, Cheng HM, Ko YT, et al
    Associations Between Cerebral Vasoreactivity and Cognitive Function in the Middle-Aged Non-Demented Population.
    J Alzheimers Dis. 2022;86:679-690.
    PubMed     Abstract available


  337. HSU YH, Huang SM, Lin SY, Yang JJ, et al
    Prospective Memory and Default Mode Network Functional Connectivity in Normal and Pathological Aging.
    J Alzheimers Dis. 2022;86:753-762.
    PubMed     Abstract available


  338. CARDOSO S, Silva D, Alves L, Guerreiro M, et al
    The Outcome of Patients with Amyloid-Negative Amnestic Mild Cognitive Impairment.
    J Alzheimers Dis. 2022;86:629-640.
    PubMed     Abstract available


  339. YANG Z, Sheng X, Qin R, Chen H, et al
    Cognitive Improvement via Left Angular Gyrus-Navigated Repetitive Transcranial Magnetic Stimulation Inducing the Neuroplasticity of Thalamic System in Amnesic Mild Cognitive Impairment Patients.
    J Alzheimers Dis. 2022;86:537-551.
    PubMed     Abstract available


  340. JOSEPHS KA, Pham NTT, Graff-Radford J, Machulda MM, et al
    Medial Temporal Atrophy in Posterior Cortical Atrophy and Its Relationship to the Cingulate Island Sign.
    J Alzheimers Dis. 2022;86:491-498.
    PubMed     Abstract available


  341. LEVY B, Priest A, Delaney T, Hogan J, et al
    Toward Pre-Diagnostic Detection of Dementia in Primary Care.
    J Alzheimers Dis. 2022;86:479-490.
    PubMed     Abstract available


  342. SOHN BK, Byun MS, Yi D, Jeon SY, et al
    Late-Life Physical Activities Moderate the Relationship of Amyloid-beta Pathology with Neurodegeneration in Individuals Without Dementia.
    J Alzheimers Dis. 2022;86:441-450.
    PubMed     Abstract available


  343. LIU M, Guo S, Huang D, Hu D, et al
    Chronic Alcohol Exposure Alters Gene Expression and Neurodegeneration Pathways in the Brain of Adult Mice.
    J Alzheimers Dis. 2022;86:315-331.
    PubMed     Abstract available


  344. ZHANG LN, Li MJ, Shang YH, Liu YR, et al
    Zeaxanthin Attenuates the Vicious Circle Between Endoplasmic Reticulum Stress and Tau Phosphorylation: Involvement of GSK-3beta Activation.
    J Alzheimers Dis. 2022;86:191-204.
    PubMed     Abstract available


  345. DENNISON JL, Volmar CH, Ke D, Wang J, et al
    JOTROL, a Novel Formulation of Resveratrol, Shows Beneficial Effects in the 3xTg-AD Mouse Model.
    J Alzheimers Dis. 2022;86:173-190.
    PubMed     Abstract available


  346. LERCH O, Laczo M, Vyhnalek M, Nedelska Z, et al
    APOEvarepsilon4 Allele Moderates the Association Between Basal Forebrain Nuclei Volumes and Allocentric Navigation in Older Adults Without Dementia.
    J Alzheimers Dis. 2022;86:155-171.
    PubMed     Abstract available


  347. ZHANG Q, Zhang M, Chen Y, Cao Y, et al
    Nonlinear Relationship of Non-High-Density Lipoprotein Cholesterol and Cognitive Function in American Elders: A Cross-Sectional NHANES Study (2011-2014).
    J Alzheimers Dis. 2022;86:125-134.
    PubMed     Abstract available


  348. HENDERSON C, Knapp M, Martyr A, Gamble LD, et al
    The Use and Costs of Paid and Unpaid Care for People with Dementia: Longitudinal Findings from the IDEAL Cohort.
    J Alzheimers Dis. 2022;86:135-153.
    PubMed     Abstract available


  349. O'BRYANT SE, Petersen M, Hall J, Johnson L, et al
    Metabolic Factors Are Related to Brain Amyloid Among Mexican Americans: A HABS-HD Study.
    J Alzheimers Dis. 2022;86:1745-1750.
    PubMed     Abstract available


  350. HU H, Fu JT, Bi YL, Ma YH, et al
    Tau Pathologies Mediate the Association of Cigarette Smoking with Cognitive Impairment in Older Adults Without Dementia: The CABLE Study.
    J Alzheimers Dis. 2022;86:1849-1859.
    PubMed     Abstract available


  351. ZHANG L, Fu Y, Zhao Z, Cong Z, et al
    Analysis of Hippocampus Evolution Patterns and Prediction of Conversion in Mild Cognitive Impairment Using Multivariate Morphometry Statistics.
    J Alzheimers Dis. 2022;86:1695-1710.
    PubMed     Abstract available


  352. PARKER AF, Ohlhauser L, Scarapicchia V, Smart CM, et al
    A Systematic Review of Neuroimaging Studies Comparing Individuals with Subjective Cognitive Decline to Healthy Controls.
    J Alzheimers Dis. 2022;86:1545-1567.
    PubMed     Abstract available


  353. SANDBERG AA, Manning E, Wilkins HM, Mazzarino R, et al
    Mitochondrial Targeting of Amyloid-beta Protein Precursor Intracellular Domain Induces Hippocampal Cell Death via a Mechanism Distinct from Amyloid-beta.
    J Alzheimers Dis. 2022;86:1727-1744.
    PubMed     Abstract available


  354. LI C, Liu M, Xia J, Mei L, et al
    Predicting Brain Amyloid-beta PET Grades with Graph Convolutional Networks Based on Functional MRI and Multi-Level Functional Connectivity.
    J Alzheimers Dis. 2022;86:1679-1693.
    PubMed     Abstract available


  355. KONCZ R, Wen W, Makkar SR, Lam BCP, et al
    The Interaction Between Vascular Risk Factors, Cerebral Small Vessel Disease, and Amyloid Burden in Older Adults.
    J Alzheimers Dis. 2022;86:1617-1628.
    PubMed     Abstract available


  356. RAHMANI F, Wang Q, McKay NS, Keefe S, et al
    Sex-Specific Patterns of Body Mass Index Relationship with White Matter Connectivity.
    J Alzheimers Dis. 2022;86:1831-1848.
    PubMed     Abstract available


  357. ASHFORD JW, Schmitt FA, Bergeron MF, Bayley PJ, et al
    Now is the Time to Improve Cognitive Screening and Assessment for Clinical and Research Advancement.
    J Alzheimers Dis. 2022;87:305-315.
    PubMed     Abstract available


  358. MORTON H, Basu T, Bose C, Reddy PH, et al
    Impact of Chronic Conditions and Dementia in Rural West Texas: A Healthy Aging Study.
    J Alzheimers Dis. 2022;87:33-49.
    PubMed     Abstract available


  359. CLEMENT A, Madsen MJ, Kastaniegaard K, Wiborg O, et al
    Chronic Stress Induces Hippocampal Mitochondrial Damage in APPPS1 Model Mice and Wildtype Littermates.
    J Alzheimers Dis. 2022;87:259-272.
    PubMed     Abstract available


  360. SOO SA, Zailan FZ, Tan JY, Sandhu GK, et al
    Safety and Usefulness of Lumbar Puncture for the Diagnosis and Management of Young-Onset Cognitive Disorders.
    J Alzheimers Dis. 2022;87:479-488.
    PubMed     Abstract available


  361. NING J, Huang SY, Chen SD, Zhang YR, et al
    Investigating Casual Associations Among Gut Microbiota, Metabolites, and Neurodegenerative Diseases: A Mendelian Randomization Study.
    J Alzheimers Dis. 2022;87:211-222.
    PubMed     Abstract available


  362. KUCIKIENE D, Costa AS, Banning LCP, van Gils V, et al
    The Role of Vascular Risk Factors in Biomarker-Based AT(N) Groups: A German-Dutch Memory Clinic Study.
    J Alzheimers Dis. 2022;87:185-195.
    PubMed     Abstract available


  363. DHARMARAJ GL, Arigo FD, Young KA, Martins R, et al
    Novel Amylin Analogues Reduce Amyloid-beta Cross-Seeding Aggregation and Neurotoxicity.
    J Alzheimers Dis. 2022;87:373-390.
    PubMed     Abstract available


  364. MARINO GAMMAZZA A, Restivo V, Baschi R, Caruso Bavisotto C, et al
    Circulating Molecular Chaperones in Subjects with Amnestic Mild Cognitive Impairment and Alzheimer's Disease: Data from the Zabut Aging Project.
    J Alzheimers Dis. 2022;87:161-172.
    PubMed     Abstract available


  365. HOSSEINI AA, Brown T, Mannino L, Gran B, et al
    Clinical Utility of Cerebrospinal Fluid Abeta42 and Tau Measures in Diagnosing Mild Cognitive Impairment in Early Onset Dementia.
    J Alzheimers Dis. 2022;87:771-780.
    PubMed     Abstract available


  366. ZHANG R, Jiang L, Li G, Wu J, et al
    Advanced Glycosylation End Products Induced Synaptic Deficits and Cognitive Decline Through ROS-JNK-p53/miR-34c/SYT1 Axis in Diabetic Encephalopathy.
    J Alzheimers Dis. 2022;87:843-861.
    PubMed     Abstract available


  367. GIRTLER N, Chincarini A, Brugnolo A, Doglione E, et al
    The Free and Cued Selective Reminding Test: Discriminative Values in a Naturalistic Cohort.
    J Alzheimers Dis. 2022;87:887-899.
    PubMed     Abstract available


  368. LIU X, Yan J, Liu F, Zhou P, et al
    Overexpression of REST Causes Neuronal Injury and Decreases Cofilin Phosphorylation in Mice.
    J Alzheimers Dis. 2022;87:873-886.
    PubMed     Abstract available


  369. SOLOMON V, Hafez M, Xian H, Harrington MG, et al
    An Association Between Saturated Fatty Acid-Containing Phosphatidylcholine in Cerebrospinal Fluid with Tau Phosphorylation.
    J Alzheimers Dis. 2022;87:609-617.
    PubMed     Abstract available


  370. MARTINEZ-HERRERA M, Figueroa-Gerstenmaier S, Lopez-Camacho PY, Millan-Pacheco C, et al
    Multiadducts of C60 Modulate Amyloid-beta Fibrillation with Dual Acetylcholinesterase Inhibition and Antioxidant Properties: In Vitro and In Silico Studies.
    J Alzheimers Dis. 2022;87:741-759.
    PubMed     Abstract available


  371. GRANGEON L, Paquet C, Guey S, Zarea A, et al
    Cerebrospinal Fluid Profile of Tau, Phosphorylated Tau, Abeta42, and Abeta40 in Probable Cerebral Amyloid Angiopathy.
    J Alzheimers Dis. 2022;87:791-802.
    PubMed     Abstract available


  372. SIVASARAVANAPARAN M, Olesen LO, Severino M, von Linstow CU, et al
    Efficacy of Chronic Paroxetine Treatment in Mitigating Amyloid Pathology and Microgliosis in APPSWE/PS1DeltaE9 Transgenic Mice.
    J Alzheimers Dis. 2022;87:685-699.
    PubMed     Abstract available


  373. GE X, Qiao Y, Choi J, Raman R, et al
    Enhanced Association of Tau Pathology and Cognitive Impairment in Mild Cognitive Impairment Subjects with Behavior Symptoms.
    J Alzheimers Dis. 2022;87:557-568.
    PubMed     Abstract available


  374. ICHIMATA S, Yoshida K, Visanji NP, Lang AE, et al
    Patterns of Mixed Pathologies in Down Syndrome.
    J Alzheimers Dis. 2022;87:595-607.
    PubMed     Abstract available


  375. WHITEHOUSE PJ, Saini V
    Making the Case for the Accelerated Withdrawal of Aducanumab.
    J Alzheimers Dis. 2022;87:999-1001.
    PubMed     Abstract available


  376. SCHWERTNER E, Pereira JB, Xu H, Secnik J, et al
    Behavioral and Psychological Symptoms of Dementia in Different Dementia Disorders: A Large-Scale Study of 10,000 Individuals.
    J Alzheimers Dis. 2022;87:1307-1318.
    PubMed     Abstract available


  377. HAN SH, Noh DH, Jo EJ, Kam KY, et al
    Effects of Apolipoprotein E varepsilon4 and Risk Factors on Domains of Cognition in Mild Cognitive Impairment and Dementia.
    J Alzheimers Dis. 2022;87:1181-1188.
    PubMed     Abstract available


  378. RIPPON B, Palta P, Tahmi M, Sherwood G, et al
    Plasma Amyloid and in vivo Brain Amyloid in Late Middle-Aged Hispanics.
    J Alzheimers Dis. 2022;87:1229-1238.
    PubMed     Abstract available


  379. SHIMOSAKA M, Nishimoto H, Kinoshita A
    Analysis of the Clock-Reading Ability in Patients with Cognitive Impairment: Comparison of Analog Clocks and Digital Clocks.
    J Alzheimers Dis. 2022;87:1151-1165.
    PubMed     Abstract available


  380. SHENG C, Yang K, He B, Li T, et al
    Cross-Cultural Longitudinal Study on Cognitive Decline (CLoCODE) for Subjective Cognitive Decline in China and Germany: A Protocol for Study Design.
    J Alzheimers Dis. 2022;87:1319-1333.
    PubMed     Abstract available


  381. JEONG S, Huang LK, Tsai MJ, Liao YT, et al
    Cognitive Function Associated with Gut Microbial Abundance in Sucrose and S-Adenosyl-L-Methionine (SAMe) Metabolic Pathways.
    J Alzheimers Dis. 2022;87:1115-1130.
    PubMed     Abstract available


  382. WHITEHOUSE P, Gandy S, Saini V, George DR, et al
    Making the Case for Accelerated Withdrawal of Aducanumab.
    J Alzheimers Dis. 2022;87:1003-1007.
    PubMed     Abstract available


  383. SARTO J, Maya G, Molina-Porcel L, Balasa M, et al
    Evolution of Clinical-Pathological Correlations in Early-Onset Alzheimer's Disease Over a 25-Year Period in an Academic Brain Bank.
    J Alzheimers Dis. 2022;87:1659-1669.
    PubMed     Abstract available


  384. MCCARTER SJ, Lesnick TG, Lowe VJ, Rabinstein AA, et al
    Association Between Plasma Biomarkers of Amyloid, Tau, and Neurodegeneration with Cerebral Microbleeds.
    J Alzheimers Dis. 2022;87:1537-1547.
    PubMed     Abstract available


  385. SHAW BC, Snider HC, Turner AK, Zajac DJ, et al
    An Alternatively Spliced TREM2 Isoform Lacking the Ligand Binding Domain is Expressed in Human Brain.
    J Alzheimers Dis. 2022;87:1647-1657.
    PubMed     Abstract available


  386. ZHAO X, Du W, Jiang J, Han Y, et al
    Brain Photobiomodulation Improves Sleep Quality in Subjective Cognitive Decline: A Randomized, Sham-Controlled Study.
    J Alzheimers Dis. 2022;87:1581-1589.
    PubMed     Abstract available


  387. CASTILLO-PASSI RI, Vergara RC, Rogers NK, Ponce DP, et al
    Cancer History Is Associated with Slower Speed of Cognitive Decline in Patients with Amnestic Cognitive Impairment.
    J Alzheimers Dis. 2022;87:1695-1711.
    PubMed     Abstract available


  388. MCGRATH ER, Beiser AS, O'Donnell A, Yang Q, et al
    Blood Phosphorylated Tau 181 as a Biomarker for Amyloid Burden on Brain PET in Cognitively Healthy Adults.
    J Alzheimers Dis. 2022;87:1517-1526.
    PubMed     Abstract available


  389. BOMMARITO G, Garibotto V, Frisoni GB, Ribaldi F, et al
    The Biological Substrate of the Motoric Cognitive Risk Syndrome: A Pilot Study Using Amyloid-/Tau-PET and MR Imaging.
    J Alzheimers Dis. 2022;87:1483-1490.
    PubMed     Abstract available


  390. LIBON DJ, Swenson R, Lamar M, Price CC, et al
    The Boston Process Approach and Digital Neuropsychological Assessment: Past Research and Future Directions.
    J Alzheimers Dis. 2022;87:1419-1432.
    PubMed     Abstract available


  391. YEUNG MK, Lee TL, Chan AS
    Prefrontal Activation During Effortful Processing Differentiates Memory Abilities in Adults with Memory Complaints.
    J Alzheimers Dis. 2022;88:301-310.
    PubMed     Abstract available


  392. ZHANG K, Ma X, Zhang R, Liu Z, et al
    Crosstalk Between Gut Microflora and Vitamin D Receptor SNPs Are Associated with the Risk of Amnestic Mild Cognitive Impairment in a Chinese Elderly Population.
    J Alzheimers Dis. 2022;88:357-373.
    PubMed     Abstract available


  393. RODDICK KM, Fertan E, Schellinck HM, Brown RE, et al
    A Signal Detection Analysis of Olfactory Learning in 12-Month-Old 5xFAD Mice.
    J Alzheimers Dis. 2022;88:37-44.
    PubMed     Abstract available


  394. BLUJUS JK, Korthauer LE, Awe E, Frahmand M, et al
    BDNF and KIBRA Polymorphisms Are Related to Altered Resting State Network Connectivity in Middle Age.
    J Alzheimers Dis. 2022;88:323-334.
    PubMed     Abstract available


  395. AGGER MP, Carstensen MS, Henney MA, Hansen LS, et al
    Novel Invisible Spectral Flicker Induces 40 Hz Neural Entrainment with Similar Spatial Distribution as 40 Hz Stroboscopic Light.
    J Alzheimers Dis. 2022;88:335-344.
    PubMed     Abstract available


  396. DROUIN SM, McFall GP, Potvin O, Bellec P, et al
    Data-Driven Analyses of Longitudinal Hippocampal Imaging Trajectories: Discrimination and Biomarker Prediction of Change Classes.
    J Alzheimers Dis. 2022;88:97-115.
    PubMed     Abstract available


  397. HARPER JD, Fan KH, Aslam MM, Snitz BE, et al
    Genome-Wide Association Study of Incident Dementia in a Community-Based Sample of Older Subjects.
    J Alzheimers Dis. 2022;88:787-798.
    PubMed     Abstract available


  398. HAEHNER A, Chen B, Espin M, Haussmann R, et al
    Training with Odors Impacts Hippocampal Thickness in Patients with Mild Cognitive Impairment.
    J Alzheimers Dis. 2022;88:743-755.
    PubMed     Abstract available


  399. GARCIA-ROLDAN E, Arriola-Infante JE, Mendez-Barrio C, Montiel-Herrera F, et al
    Testing Visual Binding by the TMA-93 in People Aged 75 and Over.
    J Alzheimers Dis. 2022;88:503-512.
    PubMed     Abstract available


  400. WANIGATUNGA AA, Liu F, Wang H, Urbanek JK, et al
    Daily Physical Activity Patterns as a Window on Cognitive Diagnosis in the Baltimore Longitudinal Study of Aging (BLSA).
    J Alzheimers Dis. 2022;88:459-469.
    PubMed     Abstract available


  401. AGUILAR-CALVO P, Sevillano AM, Rasool S, Cao KJ, et al
    Noninvasive Antemortem Detection of Retinal Prions by a Fluorescent Tracer.
    J Alzheimers Dis. 2022;88:1137-1145.
    PubMed     Abstract available


  402. NOVOTNY JS, Gonzalez-Rivas JP, Vassilaki M, Krell-Roesch J, et al
    Natural Pattern of Cognitive Aging.
    J Alzheimers Dis. 2022;88:1147-1155.
    PubMed     Abstract available


  403. LORETO F, Fitzgerald A, Golemme M, Gunning S, et al
    Prevalence of Depressive Symptoms in a Memory Clinic Cohort: A Retrospective Study.
    J Alzheimers Dis. 2022;88:1179-1187.
    PubMed     Abstract available


  404. MABROUK R, Gotkiewicz M, Rauramaa T, Tanila H, et al
    DAPI (4',6-diamidino-2-phenylindole) Stains Compact Amyloid Plaques.
    J Alzheimers Dis. 2022;88:949-955.
    PubMed     Abstract available


  405. STOILJKOVIC M, Gutierrez KO, Kelley C, Horvath TL, et al
    TREM2 Deficiency Disrupts Network Oscillations Leading to Epileptic Activity and Aggravates Amyloid-beta-Related Hippocampal Pathophysiology in Mice.
    J Alzheimers Dis. 2022;88:837-847.
    PubMed     Abstract available


  406. BOUJELBANE MA, Trabelsi K, Boukhris O, Kacem FH, et al
    The Use of Digital Technology to Assess Cognitive Function in Tunisian Adults.
    J Alzheimers Dis. 2022;88:1545-1552.
    PubMed     Abstract available


  407. ZHU MH, Jogdand AH, Jang J, Nagella SC, et al
    Evoked Cortical Depolarizations Before and After the Amyloid Plaque Accumulation: Voltage Imaging Study.
    J Alzheimers Dis. 2022;88:1443-1458.
    PubMed     Abstract available


  408. ZHANG X, Cong R, Geng T, Zhang J, et al
    Assessment of the Causal Effect of IgG N-Glycosylation Level on Risk of Dementia: A 2-Sample Mendelian Randomization Study.
    J Alzheimers Dis. 2022;88:1435-1441.
    PubMed     Abstract available


  409. TSUJIMOTO M, Suzuki K, Saji N, Sakurai T, et al
    Organized Registration for the Assessment of Dementia by the Nationwide General Consortium Toward Effective Treatment (ORANGE) Registry: Current Status and Perspectives of Mild Cognitive Impairment.
    J Alzheimers Dis. 2022;88:1423-1433.
    PubMed     Abstract available


  410. POLCHER A, Wolfsgruber S, Peters O, Frolich L, et al
    A Comparison of Operational Definitions for Mild Cognitive Impairment.
    J Alzheimers Dis. 2022;88:1663-1678.
    PubMed     Abstract available


  411. HE XY, Dobkin C, Brown WT, Yang SY, et al
    3-Hydroxyacyl-CoA and Alcohol Dehydrogenase Activities of Mitochondrial Type 10 17beta-Hydroxysteroid Dehydrogenase in Neurodegeneration Study.
    J Alzheimers Dis. 2022;88:1487-1497.
    PubMed     Abstract available


  412. RUBIN-NOROWITZ M, Lipton RB, Petersen K, Ezzati A, et al
    Association of Depressive Symptoms and Cognition in Older Adults Without Dementia Across Different Biomarker Profiles.
    J Alzheimers Dis. 2022;88:1385-1395.
    PubMed     Abstract available


  413. GOLDBERG SM, Zhao Y, Cheng Y, Weinstein AM, et al
    Clinical Progression of Baseline Risk States for Mild Cognitive Impairment.
    J Alzheimers Dis. 2022;88:1377-1384.
    PubMed     Abstract available


  414. VYHNALEK M, Jester DJ, Andel R, Horakova H, et al
    Contribution of Memory Tests to Early Identification of Conversion from Amnestic Mild Cognitive Impairment to Dementia.
    J Alzheimers Dis. 2022;88:1397-1409.
    PubMed     Abstract available


  415. SAITO S, Yamashiro T, Yamauchi M, Yamamoto Y, et al
    Complement 3 Is a Potential Biomarker for Cerebral Amyloid Angiopathy.
    J Alzheimers Dis. 2022;89:381-387.
    PubMed     Abstract available


  416. ZHANG DD, Ou YN, Fu Y, Wang ZB, et al
    Risk of Dementia in Cancer Survivors: A Meta-Analysis of Population-Based Cohort Studies.
    J Alzheimers Dis. 2022;89:367-380.
    PubMed     Abstract available


  417. WANG S, Gustafson S, Deckelman C, Sampene E, et al
    Dysphagia Profiles Among Inpatients with Dementia Referred for Swallow Evaluation.
    J Alzheimers Dis. 2022;89:351-358.
    PubMed     Abstract available


  418. ZHANG Y, Yang Y, Hu Z, Zhu M, et al
    Long-Term Depression-Inducing Low Frequency Stimulation Enhances p-Tau181 and p-Tau217 in an Age-Dependent Manner in Live Rats.
    J Alzheimers Dis. 2022;89:335-350.
    PubMed     Abstract available


  419. HUFFELS CFM, van Dijk RE, Karst H, Meye FJ, et al
    Systemic Injection of Aged Blood Plasma in Adult C57BL/6 Mice Induces Neurophysiological Impairments in the Hippocampal CA1.
    J Alzheimers Dis. 2022;89:283-297.
    PubMed     Abstract available


  420. HEAL M, McFall GP, Vergote D, Jhamandas JH, et al
    Bridging Integrator 1 (BIN1, rs6733839) and Sex Are Moderators of Vascular Health Predictions of Memory Aging Trajectories.
    J Alzheimers Dis. 2022;89:265-281.
    PubMed     Abstract available


  421. KAMATH V, Senjem ML, Spychalla AJ, Chen H, et al
    The Neuroanatomic Correlates of Olfactory Identification Impairment in Healthy Older Adults and in Persons with Mild Cognitive Impairment.
    J Alzheimers Dis. 2022;89:233-245.
    PubMed     Abstract available


  422. CERAMI C, Perdixi E, Meli C, Marcone A, et al
    Early Identification of Different Behavioral Phenotypes in the Behavioral Variant of Frontotemporal Dementia with the Aid of the Mini-Frontal Behavioral Inventory (mini-FBI).
    J Alzheimers Dis. 2022;89:299-308.
    PubMed     Abstract available


  423. MIOTTO EC, Brucki SMD, Cerqueira CT, Bazan PR, et al
    Episodic Memory, Hippocampal Volume, and Function for Classification of Mild Cognitive Impairment Patients Regarding Amyloid Pathology.
    J Alzheimers Dis. 2022;89:181-192.
    PubMed     Abstract available


  424. FAN Y, Liu W, Chen S, Li M, et al
    Association Between High Serum Tetrahydrofolate and Low Cognitive Functions in the United States: A Cross-Sectional Study.
    J Alzheimers Dis. 2022;89:163-179.
    PubMed     Abstract available


  425. SANDHU GK, Zailan FZ, Vipin A, Ann SS, et al
    Correlation Between Plasma Oligomeric Amyloid-beta and Performance on the Language Neutral Visual Cognitive Assessment Test in a Southeast Asian Population.
    J Alzheimers Dis. 2022;89:25-29.
    PubMed     Abstract available


  426. ZHOU K, Wu P
    Osteoarthritis and APOE4 Interact to Influence Memory Decline in Non-Demented Older People.
    J Alzheimers Dis. 2022;89:79-86.
    PubMed     Abstract available


  427. LI C, Li Y, Wu J, Wu M, et al
    Triple Network Model-Based Analysis on Abnormal Core Brain Functional Network Dynamics in Different Stage of Amnestic Mild Cognitive Impairment.
    J Alzheimers Dis. 2022;89:519-533.
    PubMed     Abstract available


  428. WEIGAND AJ, Macomber AJ, Walker KS, Edwards L, et al
    Interactive Effects of Pulse Pressure and Tau Imaging on Longitudinal Cognition.
    J Alzheimers Dis. 2022;89:633-640.
    PubMed     Abstract available


  429. CAO QL, Sun Y, Hu H, Wang ZT, et al
    Association of Cerebral Small Vessel Disease Burden with Neuropsychiatric Symptoms in Non-Demented Elderly: A Longitudinal Study.
    J Alzheimers Dis. 2022;89:583-592.
    PubMed     Abstract available


  430. RUSSO M, Santilli M, De Rosa MA, Calisi D, et al
    A Young Man with Cognitive Impairment and a Heart Condition.
    J Alzheimers Dis. 2022;89:405-410.
    PubMed     Abstract available


  431. LIU S, Liu C, Hu W, Ji Y, et al
    Frequency, Severity, and Duration of Autonomic Symptoms in Patients of Prodromal Dementia with Lewy Bodies.
    J Alzheimers Dis. 2022;89:923-929.
    PubMed     Abstract available


  432. DARTORA CM, de Moura LV, Koole M, Marques da Silva AM, et al
    Discriminating Aging Cognitive Decline Spectrum Using PET and Magnetic Resonance Image Features.
    J Alzheimers Dis. 2022;89:977-991.
    PubMed     Abstract available


  433. ZHANG S, Wei D, Lv S, Wang L, et al
    Scutellarin Modulates the Microbiota-Gut-Brain Axis and Improves Cognitive Impairment in APP/PS1 Mice.
    J Alzheimers Dis. 2022;89:955-975.
    PubMed     Abstract available


  434. KANG DW, Wang SM, Um YH, Kim NY, et al
    Associations Between Sub-Threshold Amyloid-beta Deposition, Cortical Volume, and Cognitive Function Modulated by APOE varepsilon4 Carrier Status in Cognitively Normal Older Adults.
    J Alzheimers Dis. 2022;89:1003-1016.
    PubMed     Abstract available


  435. VASSILAKI M, Crowson CS, Davis Iii JM, Duong SQ, et al
    Rheumatoid Arthritis, Cognitive Impairment, and Neuroimaging Biomarkers: Results from the Mayo Clinic Study of Aging.
    J Alzheimers Dis. 2022;89:943-954.
    PubMed     Abstract available


  436. DIAZ A, Martin-Jimenez C, Woo Y, Merino P, et al
    Urokinase-Type Plasminogen Activator Triggers Wingless/Int1-Independent Phosphorylation of the Low-Density Lipoprotein Receptor-Related Protein-6 in Cerebral Cortical Neurons.
    J Alzheimers Dis. 2022;89:877-891.
    PubMed     Abstract available


  437. WATTS A, Chalise P, Hu J, Hui D, et al
    A Mitochondrial DNA Haplogroup Defines Patterns of Five-Year Cognitive Change.
    J Alzheimers Dis. 2022;89:913-922.
    PubMed     Abstract available


  438. PICCARDUCCI R, Caselli MC, Zappelli E, Ulivi L, et al
    The Role of Amyloid-beta, Tau, and alpha-Synuclein Proteins as Putative Blood Biomarkers in Patients with Cerebral Amyloid Angiopathy.
    J Alzheimers Dis. 2022;89:1039-1049.
    PubMed     Abstract available


  439. MATSUZAKI TADA A, Hamezah HS, Pahrudin Arrozi A, Abu Bakar ZH, et al
    Pharmaceutical Potential of Casein-Derived Tripeptide Met-Lys-Pro: Improvement in Cognitive Impairments and Suppression of Inflammation in APP/PS1 Mice.
    J Alzheimers Dis. 2022;89:835-848.
    PubMed     Abstract available


  440. JUAREZ-CEDILLO T, Gonzelez-Figueroa E, Gutierez-Gutierez L, Aguilar-Navarro SG, et al
    Prevalence of Dementia and Main Subtypes in Mexico: The Study on Aging and Dementia in Mexico (SADEM).
    J Alzheimers Dis. 2022;89:931-941.
    PubMed     Abstract available


  441. SANCHEZ-DE-LARA-SANCHEZ S, Sanchez-Perez AM
    Probiotics Treatment Can Improve Cognition in Patients with Mild Cognitive Impairment: A Systematic Review.
    J Alzheimers Dis. 2022;89:1173-1191.
    PubMed     Abstract available


  442. MORROW CB, Chaney GS, Capuzzi D, Bakker A, et al
    Hyperorality in Frontotemporal Dementia: Cognitive and Psychiatric Symptom Profiles in Early-Stage Disease.
    J Alzheimers Dis. 2022;89:1203-1209.
    PubMed     Abstract available


  443. NYHOLM E, Torkpoor R, Frolich K, Londos E, et al
    A Retrospective Study on Clinical Assessment of Cognitive Impairment in a Swedish Cohort: Is There Inequality Between Natives and Foreign-Born?
    J Alzheimers Dis. 2022;89:1403-1412.
    PubMed     Abstract available


  444. ZAWAR I, Mattos MK, Manning C, Quigg M, et al
    Sleep Disturbances, Cognitive Status, and Biomarkers of Dementia.
    J Alzheimers Dis. 2022;89:1367-1374.
    PubMed     Abstract available


  445. WEIBLE AP, Wehr M
    Amyloid Pathology in the Central Auditory Pathway of 5XFAD Mice Appears First in Auditory Cortex.
    J Alzheimers Dis. 2022;89:1385-1402.
    PubMed     Abstract available


  446. MICHOPOULOU S, Prosser A, Kipps C, Dickson J, et al
    Biomarkers of Inflammation Increase with Tau and Neurodegeneration but not with Amyloid-beta in a Heterogenous Clinical Cohort.
    J Alzheimers Dis. 2022;89:1303-1314.
    PubMed     Abstract available


  447. GENTREAU M, Reynes C, Sabatier R, Maller JJ, et al
    Glucometabolic Changes Are Associated with Structural Gray Matter Alterations in Prodromal Dementia.
    J Alzheimers Dis. 2022;89:1293-1302.
    PubMed     Abstract available


  448. KANAGASINGAM S, von Ruhland C, Welbury R, Singhrao SK, et al
    Antimicrobial, Polarizing Light, and Paired Helical Filament Properties of Fragmented Tau Peptides of Selected Putative Gingipains.
    J Alzheimers Dis. 2022;89:1279-1291.
    PubMed     Abstract available


  449. BERDYNSKI M, Ludwiczak J, Barczak A, Barcikowska-Kotowicz M, et al
    TREM2 Gene Compound Heterozygosity in Neurodegenerative Disorders.
    J Alzheimers Dis. 2022;89:1211-1219.
    PubMed     Abstract available


  450. MIAO Y, Cui L, Li J, Chen Y, et al
    Cognitive Improvement After Multi-Domain Lifestyle Interventions in an APOE varepsilon4 Homozygous Carrier with Mild Cognitive Impairment: A Case Report and Literature Review.
    J Alzheimers Dis. 2022;89:1131-1142.
    PubMed     Abstract available


  451. LACHNER C, Day GS, Camsari GB, Kouri N, et al
    Cancer and Vascular Comorbidity Effects on Dementia Risk and Neuropathology in the Oldest-Old.
    J Alzheimers Dis. 2022;90:405-417.
    PubMed     Abstract available


  452. MATTIOLI P, Pardini M, Girtler N, Brugnolo A, et al
    Cognitive and Brain Metabolism Profiles of Mild Cognitive Impairment in Prodromal Alpha-Synucleinopathy.
    J Alzheimers Dis. 2022;90:433-444.
    PubMed     Abstract available


  453. LOEWENSTEIN DA, Curiel Cid RE, Kitaigorodsky M, Ortega A, et al
    Persistent Failure to Recover from Proactive Semantic Interference on the Cognitive Stress Test Differentiates Between Amnestic Mild Cognitive Impairment, Pre-Mild Cognitive Impairment, and Cognitively Unimpaired Older Adults.
    J Alzheimers Dis. 2022;90:313-322.
    PubMed     Abstract available


  454. THOMAS KR, Bangen KJ, Weigand AJ, Ortiz G, et al
    Cognitive Heterogeneity and Risk of Progression in Data-Driven Subtle Cognitive Decline Phenotypes.
    J Alzheimers Dis. 2022;90:323-331.
    PubMed     Abstract available


  455. FU J, Zhu Y, Sun Y, Liu Q, et al
    Circulating Amyloid-beta and Methionine-Related Metabolites to Predict the Risk of Mild Cognitive Impairment: A Nested Case-Control Study.
    J Alzheimers Dis. 2022;90:389-404.
    PubMed     Abstract available


  456. VAN HARTEN TW, Heijmans A, van Rooden S, Wermer MJH, et al
    Brain Deep Medullary Veins on 7T MRI in Dutch-Type Hereditary Cerebral Amyloid Angiopathy.
    J Alzheimers Dis. 2022;90:381-388.
    PubMed     Abstract available


  457. BOLSEWIG K, Hok-A-Hin YS, Sepe FN, Boonkamp L, et al
    A Combination of Neurofilament Light, Glial Fibrillary Acidic Protein, and Neuronal Pentraxin-2 Discriminates Between Frontotemporal Dementia and Other Dementias.
    J Alzheimers Dis. 2022;90:363-380.
    PubMed     Abstract available


  458. WEI S, Dang L, Gao F, Wang J, et al
    Effects of Simvastatin on Plasma Amyloid-beta Transport in Patients with Hyperlipidemia: A 12-Week Randomized, Double-Blind, Placebo-Controlled Trial.
    J Alzheimers Dis. 2022;90:349-362.
    PubMed     Abstract available


  459. PENG Y, Zhang L, Zhou F, Wang Y, et al
    Scavenging Reactive Oxygen Species Decreases Amyloid-beta Levels via Activation of PI3K/Akt/GLUT1 Pathway in N2a/APP695swe Cells.
    J Alzheimers Dis. 2022;90:185-198.
    PubMed     Abstract available


  460. VALLES-SALGADO M, Cabrera-Martin MN, Curiel-Cid RE, Delgado-Alvarez A, et al
    Neuropsychological, Metabolic, and Connectivity Underpinnings of Semantic Interference Deficits Using the LASSI-L.
    J Alzheimers Dis. 2022;90:823-840.
    PubMed     Abstract available


  461. SHEPHERD-BANIGAN ME, Ford CB, Smith VA, Belanger E, et al
    Amyloid-beta PET Scan Results Disclosure and Care-Partner Emotional Well-Being Over Time.
    J Alzheimers Dis. 2022;90:775-782.
    PubMed     Abstract available


  462. RABI R, Chow R, Paracha S, Hasher L, et al
    Time of Day Effects on Inhibitory Functioning: Cognitive and Neural Evidence of Sundowning in Amnestic Mild Cognitive Impairment.
    J Alzheimers Dis. 2022;90:869-890.
    PubMed     Abstract available


  463. BLIVET G, Relano-Gines A, Wachtel M, Touchon J, et al
    A Randomized, Double-Blind, and Sham-Controlled Trial of an Innovative Brain-Gut Photobiomodulation Therapy: Safety and Patient Compliance.
    J Alzheimers Dis. 2022;90:811-822.
    PubMed     Abstract available


  464. AERQIN Q, Jia SS, Shen XN, Li Q, et al
    Serum Uric Acid Levels in Neurodegenerative Disorders: A Cross-Sectional Study.
    J Alzheimers Dis. 2022;90:761-773.
    PubMed     Abstract available


  465. YANG YH, Hsieh SW, Chang HW, Sung JL, et al
    Gamma Frequency Inhibits the Secretion and Aggregation of Amyloid-beta and Decreases the Phosphorylation of mTOR and Tau Proteins in vitro.
    J Alzheimers Dis. 2022;90:917-928.
    PubMed     Abstract available


  466. O'BRYANT SE, Petersen M, Hall J, Johnson LA, et al
    Characterization of Mild Cognitive Impairment and Dementia among Community-Dwelling Mexican Americans and Non-Hispanic Whites.
    J Alzheimers Dis. 2022;90:905-915.
    PubMed     Abstract available


  467. ROVCANIN DRAGOVIC I, Popovic N, Zdralevic M, Radulovic L, et al
    Inflammation-Related microRNAs-146a and -155 Are Upregulated in Mild Cognitive Impairment Subjects Among Older Age Population in Montenegro.
    J Alzheimers Dis. 2022;90:625-638.
    PubMed     Abstract available


  468. WANG Z, Wang J, Liu N, Liu C, et al
    Learning Cognitive-Test-Based Interpretable Rules for Prediction and Early Diagnosis of Dementia Using Neural Networks.
    J Alzheimers Dis. 2022;90:609-624.
    PubMed     Abstract available


  469. VIPIN A, Koh CL, Wong BYX, Zailan FZ, et al
    Amyloid-Tau-Neurodegeneration Profiles and Longitudinal Cognition in Sporadic Young-Onset Dementia.
    J Alzheimers Dis. 2022;90:543-551.
    PubMed     Abstract available


  470. SONG Y, Quan M, Li T, Jia J, et al
    Serum Homocysteine, Vitamin B12, Folate, and Their Association with Mild Cognitive Impairment and Subtypes of Dementia.
    J Alzheimers Dis. 2022;90:681-691.
    PubMed     Abstract available


  471. JOSHI MS, Galvin JE
    Cognitive Resilience in Brain Health and Dementia Research.
    J Alzheimers Dis. 2022;90:461-473.
    PubMed     Abstract available


    December 2021
  472. DAY S, Roberts S, Launder NH, Goh AMY, et al
    Age of Symptom Onset and Longitudinal Course of Sporadic Alzheimer's Disease, Frontotemporal Dementia, and Vascular Dementia: A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2021 Dec 23. pii: JAD215360. doi: 10.3233/JAD-215360.
    PubMed     Abstract available


  473. WANG J, Wang P, Jiang Y, Wang Z, et al
    Hippocampus-Based Dynamic Functional Connectivity Mapping in the Early Stages of Alzheimer's Disease.
    J Alzheimers Dis. 2021 Dec 23. pii: JAD215239. doi: 10.3233/JAD-215239.
    PubMed     Abstract available


  474. GIANNAKOPOULOS P, Rodriguez C, Montandon ML, Garibotto V, et al
    Personality Impact on Alzheimer's Disease-Signature and Vascular Imaging Markers: A PET-MRI Study.
    J Alzheimers Dis. 2021 Dec 23. pii: JAD215062. doi: 10.3233/JAD-215062.
    PubMed     Abstract available


  475. BLACK SAG, Stepanchuk AA, Templeton GW, Hernandez Y, et al
    Diagnosing Alzheimer's Disease from Circulating Blood Leukocytes Using a Fluorescent Amyloid Probe.
    J Alzheimers Dis. 2021 Dec 22. pii: JAD215402. doi: 10.3233/JAD-215402.
    PubMed     Abstract available


  476. LIU Q, Ling Z, Zhang J, Yu H, et al
    lncRNA MIR600HG Knockdown Alleviates Cognitive Impairment in Alzheimer's Disease Through NEDD4L Mediated PINK1 Degradation.
    J Alzheimers Dis. 2021 Dec 22. pii: JAD215194. doi: 10.3233/JAD-215194.
    PubMed     Abstract available


  477. BROBERG D, Wong D, Bellyou M, Montero-Odasso M, et al
    Effects of Memantine and High Dose Vitamin D on Gait in Male APP/PS1 Alzheimer's Disease Mice Following Vitamin D Deprivation.
    J Alzheimers Dis. 2021 Dec 22. pii: JAD215188. doi: 10.3233/JAD-215188.
    PubMed     Abstract available


  478. JANG H, Park YH, Choe YS, Kang SH, et al
    Amyloid Positive Hydrocephalus: A Hydrocephalic Variant of Alzheimer's Disease?
    J Alzheimers Dis. 2021 Dec 22. pii: JAD215110. doi: 10.3233/JAD-215110.
    PubMed     Abstract available


  479. DUNK MM, Driscoll I
    Total Cholesterol and APOE-Related Risk for Alzheimer's Disease in the Alzheimer's Disease Neuroimaging Initiative.
    J Alzheimers Dis. 2021 Dec 22. pii: JAD215091. doi: 10.3233/JAD-215091.
    PubMed     Abstract available


  480. AHN H, Yi D, Chu K, Joung H, et al
    Functional Neural Correlates of Semantic Fluency Task Performance in Mild Cognitive Impairment and Alzheimer's Disease: An FDG-PET Study.
    J Alzheimers Dis. 2021 Dec 21. pii: JAD215292. doi: 10.3233/JAD-215292.
    PubMed     Abstract available


  481. DHAYNAUT M, Sprugnoli G, Cappon D, Macone J, et al
    Impact of 40 Hz Transcranial Alternating Current Stimulation on Cerebral Tau Burden in Patients with Alzheimer's Disease: A Case Series.
    J Alzheimers Dis. 2021 Dec 21. pii: JAD215072. doi: 10.3233/JAD-215072.
    PubMed     Abstract available


  482. DONG L, Mao C, Liu C, Li J, et al
    Association Between Common Variants of APOE, ABCA7, A2M, BACE1, and Cerebrospinal Fluid Biomarkers in Alzheimer's Disease: Data from the PUMCH Dementia Cohort.
    J Alzheimers Dis. 2021 Dec 21. pii: JAD215067. doi: 10.3233/JAD-215067.
    PubMed     Abstract available


  483. ZHAO Y, Bao J, Liu W, Gong X, et al
    Spatial Training Attenuates Long-Term Alzheimer's Disease-Related Pathogenic Processes in APP/PS1 Mice.
    J Alzheimers Dis. 2021 Dec 21. pii: JAD215016. doi: 10.3233/JAD-215016.
    PubMed     Abstract available


  484. MASSETTI N, Russo M, Franciotti R, Nardini D, et al
    A Machine Learning-Based Holistic Approach to Predict the Clinical Course of Patients within the Alzheimer's Disease Spectrum.
    J Alzheimers Dis. 2021 Dec 21. pii: JAD210573. doi: 10.3233/JAD-210573.
    PubMed     Abstract available


  485. GOLDSMITH HS
    Alzheimer's Disease: A Decreased Cerebral Blood Flow to Critical Intraneuronal Elements is the Cause.
    J Alzheimers Dis. 2021 Dec 18. pii: JAD215479. doi: 10.3233/JAD-215479.
    PubMed     Abstract available


  486. ZHANG H, Lyu D, Jia J
    The Trajectory of Cerebrospinal Fluid Growth-Associated Protein 43 in the Alzheimer's Disease Continuum: A Longitudinal Study.
    J Alzheimers Dis. 2021 Dec 18. pii: JAD215456. doi: 10.3233/JAD-215456.
    PubMed     Abstract available


  487. SUO WZ
    GRK5 Deficiency Causes Mild Cognitive Impairment due to Alzheimer's Disease.
    J Alzheimers Dis. 2021 Dec 18. pii: JAD215379. doi: 10.3233/JAD-215379.
    PubMed     Abstract available


  488. SCHAEFER SY, Malek-Ahmadi M, Hooyman A, King JB, et al
    Association Between Motor Task Performance and Hippocampal Atrophy Across Cognitively Unimpaired, Amnestic Mild Cognitive Impairment, and Alzheimer's Disease Individuals.
    J Alzheimers Dis. 2021 Dec 18. pii: JAD210665. doi: 10.3233/JAD-210665.
    PubMed     Abstract available


  489. YUEN SC, Lee SM, Leung SW
    Putative Factors Interfering Cell Cycle Re-Entry in Alzheimer's Disease: An Omics Study with Differential Expression Meta-Analytics and Co-Expression Profiling.
    J Alzheimers Dis. 2021 Dec 17. pii: JAD215349. doi: 10.3233/JAD-215349.
    PubMed     Abstract available


  490. KWAK S, Oh DJ, Jeon YJ, Oh DY, et al
    Utility of Machine Learning Approach with Neuropsychological Tests in Predicting Functional Impairment of Alzheimer's Disease.
    J Alzheimers Dis. 2021 Dec 17. pii: JAD215244. doi: 10.3233/JAD-215244.
    PubMed     Abstract available


  491. TROPEA MR, Sanfilippo G, Giannino F, Davi V, et al
    Innate Preferences Affect Results of Object Recognition Task in Wild Type and Alzheimer's Disease Mouse Models.
    J Alzheimers Dis. 2021 Dec 17. pii: JAD215209. doi: 10.3233/JAD-215209.
    PubMed     Abstract available


  492. RAMOS C, Villalba C, Garcia J, Lanata S, et al
    Substance Use-Related Cognitive Decline in Families with Autosomal Dominant Alzheimer's Disease: A Cohort Study.
    J Alzheimers Dis. 2021 Dec 17. pii: JAD215169. doi: 10.3233/JAD-215169.
    PubMed     Abstract available


  493. YANG L, Xuan C, Yu C, Zheng P, et al
    Diagnostic Model of Alzheimer's Disease in the Elderly Based on Protein and Metabolic Biomarkers.
    J Alzheimers Dis. 2021 Dec 17. pii: JAD215119. doi: 10.3233/JAD-215119.
    PubMed     Abstract available


  494. SUN HL, Zhou FY, Chen DW, Tan CR, et al
    The Correlation of Tau Levels with Blood Monocyte Count in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2021 Dec 17. pii: JAD210692. doi: 10.3233/JAD-210692.
    PubMed     Abstract available


  495. SALAMI A, Adolfsson R, Andersson M, Blennow K, et al
    Association of APOE varepsilon4 and Plasma p-tau181 with Preclinical Alzheimer's Disease and Longitudinal Change in Hippocampus Function.
    J Alzheimers Dis. 2021 Dec 16. pii: JAD210673. doi: 10.3233/JAD-210673.
    PubMed     Abstract available


  496. VON LINSTOW CU, Waider J, Bergh MS, Anzalone M, et al
    The Combined Effects of Amyloidosis and Serotonin Deficiency by Tryptophan Hydroxylase-2 Knockout Impacts Viability of the APP/PS1 Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2021 Dec 16. pii: JAD210581. doi: 10.3233/JAD-210581.
    PubMed     Abstract available


  497. FAN F, Liu H, Shi X, Ai Y, et al
    The Efficacy and Safety of Alzheimer's Disease Therapies: An Updated Umbrella Review.
    J Alzheimers Dis. 2021 Dec 15. pii: JAD215423. doi: 10.3233/JAD-215423.
    PubMed     Abstract available


  498. CHAUDHARY S, Zhornitsky S, Chao HH, van Dyck CH, et al
    Cerebral Volumetric Correlates of Apathy in Alzheimer's Disease and Cognitively Normal Older Adults: Meta-Analysis, Label-Based Review, and Study of an Independent Cohort.
    J Alzheimers Dis. 2021 Dec 15. pii: JAD215316. doi: 10.3233/JAD-215316.
    PubMed     Abstract available


  499. TEIPEL SJ, Dyrba M, Ballarini T, Brosseron F, et al
    Association of Cholinergic Basal Forebrain Volume and Functional Connectivity with Markers of Inflammatory Response in the Alzheimer's Disease Spectrum.
    J Alzheimers Dis. 2021 Dec 15. pii: JAD215196. doi: 10.3233/JAD-215196.
    PubMed     Abstract available


  500. SMITH CA, Smith H, Roberts L, Coward L, et al
    Probiotic Releasing Angiotensin (1-7) in a Drosophila Model of Alzheimer's Disease Produces Sex-Specific Effects on Cognitive Function.
    J Alzheimers Dis. 2021 Dec 15. pii: JAD210464. doi: 10.3233/JAD-210464.
    PubMed     Abstract available


  501. SUN X, Zhang H, Yao D, Xu Y, et al
    Integrated Bioinformatics Analysis Identifies Hub Genes Associated with Viral Infection and Alzheimer's Disease.
    J Alzheimers Dis. 2021 Dec 11. pii: JAD215232. doi: 10.3233/JAD-215232.
    PubMed     Abstract available


  502. WEN C, Bi YL, Hu H, Huang SY, et al
    Association of Subjective Cognitive Decline with Cerebrospinal Fluid Biomarkers of Alzheimer's Disease Pathology in Cognitively Intact Older Adults: The CABLE Study.
    J Alzheimers Dis. 2021 Dec 11. pii: JAD215178. doi: 10.3233/JAD-215178.
    PubMed     Abstract available


  503. SCHUBERT CR, Paulsen AJ, Pinto AA, Merten N, et al
    Effect of Long-Term Storage on the Reliability of Blood Biomarkers for Alzheimer's Disease and Neurodegeneration.
    J Alzheimers Dis. 2021 Dec 11. pii: JAD215096. doi: 10.3233/JAD-215096.
    PubMed     Abstract available


  504. LI W, Zhao Z, Liu M, Yan S, et al
    Multimodal Classification of Alzheimer's Disease and Amnestic Mild Cognitive Impairment: Integrated 18F-FDG PET and DTI Study.
    J Alzheimers Dis. 2021 Dec 10. pii: JAD215338. doi: 10.3233/JAD-215338.
    PubMed     Abstract available


  505. TALAN J
    Reactive Astrocytes and Alzheimer's Disease.
    J Alzheimers Dis. 2021 Dec 9. pii: JAD215436. doi: 10.3233/JAD-215436.
    PubMed    


  506. YOO TJ
    Anti-Inflammatory Gene Therapy Improves Spatial Memory Performance in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2021 Dec 9. pii: JAD215270. doi: 10.3233/JAD-215270.
    PubMed     Abstract available


  507. CUTULI D, Landolfo E, Petrosini L, Gelfo F, et al
    Environmental Enrichment Effects on the Brain-Derived Neurotrophic Factor Expression in Healthy Condition, Alzheimer's Disease, and Other Neurodegenerative Disorders.
    J Alzheimers Dis. 2021 Dec 9. pii: JAD215193. doi: 10.3233/JAD-215193.
    PubMed     Abstract available


  508. KOUKI MA, Pritchard AB, Alder JE, Crean S, et al
    Do Periodontal Pathogens or Associated Virulence Factors Have a Deleterious Effect on the Blood-Brain Barrier, Contributing to Alzheimer's Disease?
    J Alzheimers Dis. 2021 Dec 9. pii: JAD215103. doi: 10.3233/JAD-215103.
    PubMed     Abstract available


  509. BRITZ J, Ojo E, Dhukhwa A, Saito T, et al
    Assessing Sex-Specific Circadian, Metabolic, and Cognitive Phenotypes in the AbetaPP/PS1 and APPNL - F/NL - F Models of Alzheimer's Disease.
    J Alzheimers Dis. 2021 Dec 9. pii: JAD210629. doi: 10.3233/JAD-210629.
    PubMed     Abstract available


  510. SACCHI L, Carandini T, Fumagalli GG, Pietroboni AM, et al
    Unravelling the Association Between Amyloid-PET and Cerebrospinal Fluid Biomarkers in the Alzheimer's Disease Spectrum: Who Really Deserves an A+?
    J Alzheimers Dis. 2021 Dec 9. pii: JAD210593. doi: 10.3233/JAD-210593.
    PubMed     Abstract available


  511. KOTHAPALLI SVVN, Benzinger TL, Aschenbrenner AJ, Perrin RJ, et al
    Quantitative Gradient Echo MRI Identifies Dark Matter as a New Imaging Biomarker of Neurodegeneration that Precedes Tisssue Atrophy in Early Alzheimer's Disease.
    J Alzheimers Dis. 2021 Dec 9. pii: JAD210503. doi: 10.3233/JAD-210503.
    PubMed     Abstract available


  512. SAKR F, Dyrba M, Brauer AU, Teipel S, et al
    Association of Lipidomics Signatures in Blood with Clinical Progression in Preclinical and Prodromal Alzheimer's Disease.
    J Alzheimers Dis. 2021 Dec 9. pii: JAD201504. doi: 10.3233/JAD-201504.
    PubMed     Abstract available


  513. SENEJANI AG, Maghsoudlou J, El-Zohiry D, Gaur G, et al
    Borrelia burgdorferi Co-Localizing with Amyloid Markers in Alzheimer's Disease Brain Tissues.
    J Alzheimers Dis. 2021 Dec 5. pii: JAD215398. doi: 10.3233/JAD-215398.
    PubMed     Abstract available


  514. KURODA T, Honma M, Mori Y, Futamura A, et al
    White Matter Lesions May Aid in Differentiating Idiopathic Normal Pressure Hydrocephalus and Alzheimer's Disease.
    J Alzheimers Dis. 2021 Dec 2. pii: JAD215187. doi: 10.3233/JAD-215187.
    PubMed     Abstract available


  515. LIU XX, Wu PF, Liu YZ, Jiang YL, et al
    Association Between Serum Vitamins and the Risk of Alzheimer's Disease in Chinese Populatio.
    J Alzheimers Dis. 2021 Dec 2. pii: JAD215104. doi: 10.3233/JAD-215104.
    PubMed     Abstract available


    November 2021
  516. METSLA K, Kirss S, Laks K, Sildnik G, et al
    alpha-Lipoic Acid Has the Potential to Normalize Copper Metabolism, Which Is Dysregulated in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Nov 30. pii: JAD215026. doi: 10.3233/JAD-215026.
    PubMed     Abstract available


  517. CHEN L, Shen Q, Xu S, Yu H, et al
    5-Hydroxymethylcytosine Signatures in Circulating Cell-Free DNA as Diagnostic Biomarkers for Late-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2021 Nov 29. pii: JAD215217. doi: 10.3233/JAD-215217.
    PubMed     Abstract available


  518. CRESTINI A, Santilli F, Martellucci S, Carbone E, et al
    Prions and Neurodegenerative Diseases: A Focus on Alzheimer's Disease.
    J Alzheimers Dis. 2021 Nov 29. pii: JAD215171. doi: 10.3233/JAD-215171.
    PubMed     Abstract available


  519. SAPKOTA S, McFall GP, Masellis M, Dixon RA, et al
    Differential Cognitive Decline in Alzheimer's Disease Is Predicted by Changes in Ventricular Size but Moderated by Apolipoprotein E and Pulse Pressure.
    J Alzheimers Dis. 2021 Nov 29. pii: JAD215068. doi: 10.3233/JAD-215068.
    PubMed     Abstract available


  520. HAOUDY S, Jonveaux T, Puisieux S, Epstein J, et al
    Epilepsy in Early Onset Alzheimer's Disease.
    J Alzheimers Dis. 2021 Nov 29. pii: JAD210681. doi: 10.3233/JAD-210681.
    PubMed     Abstract available


  521. NESHAN M, Malakouti SK, Kamalzadeh L, Makvand M, et al
    Alterations in T-Cell Transcription Factors and Cytokine Gene Expression in Late-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2021 Nov 29. pii: JAD210480. doi: 10.3233/JAD-210480.
    PubMed     Abstract available


  522. GE F, Dong L, Zhu D, Lin X, et al
    Comparison of Serum Triiodothyronine with Biomarkers for Alzheimer's Disease Continuum in Euthyroid Subjects.
    J Alzheimers Dis. 2021 Nov 27. pii: JAD215092. doi: 10.3233/JAD-215092.
    PubMed     Abstract available


  523. ALTOMARI N, Bruno F, Lagana V, Smirne N, et al
    A Comparison of Behavioral and Psychological Symptoms of Dementia (BPSD) and BPSD Sub-Syndromes in Early-Onset and Late-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2021 Nov 27. pii: JAD215061. doi: 10.3233/JAD-215061.
    PubMed     Abstract available


  524. WANG L, Chen H, Tang J, Guo Z, et al
    Peptidylarginine Deiminase and Alzheimer's Disease.
    J Alzheimers Dis. 2021 Nov 23. pii: JAD215302. doi: 10.3233/JAD-215302.
    PubMed     Abstract available


  525. LARNER AJ, Marson AG
    Epileptic Seizures in Alzheimer's Disease: What Are the Implications of SANAD II?
    J Alzheimers Dis. 2021 Nov 23. pii: JAD215154. doi: 10.3233/JAD-215154.
    PubMed     Abstract available


  526. BROD SA
    Anti-Inflammatory Agents: An Approach to Prevent Cognitive Decline in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Nov 21. pii: JAD215125. doi: 10.3233/JAD-215125.
    PubMed     Abstract available


  527. SUN X, Suo X, Xia X, Yu C, et al
    Dimethyl Fumarate is a Potential Therapeutic Option for Alzheimer's Disease.
    J Alzheimers Dis. 2021 Nov 21. pii: JAD215074. doi: 10.3233/JAD-215074.
    PubMed     Abstract available


  528. LYNN J, Park M, Ogunwale C, Acquaah-Mensah GK, et al
    A Tale of Two Diseases: Exploring Mechanisms Linking Diabetes Mellitus with Alzheimer's Disease.
    J Alzheimers Dis. 2021 Nov 21. pii: JAD210612. doi: 10.3233/JAD-210612.
    PubMed     Abstract available


  529. QIAO Y, Sun Y, Guo J, Chen Y, et al
    Disrupted White Matter Integrity and Cognitive Functions in Amyloid-beta Positive Alzheimer's Disease with Concomitant Lobar Cerebral Microbleeds.
    J Alzheimers Dis. 2021 Nov 20. pii: JAD215251. doi: 10.3233/JAD-215251.
    PubMed     Abstract available


  530. BERGAMINO M, Keeling EG, Baxter LC, Sisco NJ, et al
    Sex Differences in Alzheimer's Disease Revealed by Free-Water Diffusion Tensor Imaging and Voxel-Based Morphometry.
    J Alzheimers Dis. 2021 Nov 20. pii: JAD210406. doi: 10.3233/JAD-210406.
    PubMed     Abstract available


  531. REALE M, Carrarini C, Russo M, Dono F, et al
    Muscarinic Receptors Expression in the Peripheral Blood Cells Differentiate Dementia with Lewy Bodies from Alzheimer's Disease.
    J Alzheimers Dis. 2021 Nov 18. pii: JAD215285. doi: 10.3233/JAD-215285.
    PubMed     Abstract available


  532. BARTHELEMY NR, Toth B, Manser PT, Sanabria-Bohorquez S, et al
    Site-Specific Cerebrospinal Fluid Tau Hyperphosphorylation in Response to Alzheimer's Disease Brain Pathology: Not All Tau Phospho-Sites are Hyperphosphorylated.
    J Alzheimers Dis. 2021 Nov 18. pii: JAD210677. doi: 10.3233/JAD-210677.
    PubMed     Abstract available


  533. HOY KE, Emonson MRL, Bailey NW, Humble G, et al
    Investigating Neurophysiological Markers of Symptom Severity in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Nov 18. pii: JAD210401. doi: 10.3233/JAD-210401.
    PubMed     Abstract available


  534. NOGUCHI-SHINOHARA M, Yuki-Nozaki S, Abe C, Mori A, et al
    Diabetes Mellitus, Elevated Hemoglobin A1c, and Glycated Albumin Are Associated with the Presence of All-Cause Dementia and Alzheimer's Disease: The JPSC-AD Study.
    J Alzheimers Dis. 2021 Nov 15. pii: JAD215153. doi: 10.3233/JAD-215153.
    PubMed     Abstract available


  535. CHUM PP, Hakim MA, Behringer EJ
    Cerebrovascular microRNA Expression Profile During Early Development of Alzheimer's Disease in a Mouse Model.
    J Alzheimers Dis. 2021 Nov 12. pii: JAD215223. doi: 10.3233/JAD-215223.
    PubMed     Abstract available


  536. KUMARI S, Singh A, Singh AK, Yadav Y, et al
    Circulatory GSK-3beta: Blood-Based Biomarker and Therapeutic Target for Alzheimer's Disease.
    J Alzheimers Dis. 2021 Nov 11. pii: JAD215347. doi: 10.3233/JAD-215347.
    PubMed     Abstract available


  537. MULLER EG, Edwin TH, Strand BH, Stokke C, et al
    Is Amyloid Burden Measured by 18F-Flutemetamol PET Associated with Progression in Clinical Alzheimer's Disease?
    J Alzheimers Dis. 2021 Nov 11. pii: JAD215046. doi: 10.3233/JAD-215046.
    PubMed     Abstract available


  538. NIHASHI T, Sakurai K, Kato T, Iwata K, et al
    Patterns of Distribution of 18F-THK5351 Positron Emission Tomography in Alzheimer's Disease Continuum.
    J Alzheimers Dis. 2021 Nov 11. pii: JAD215024. doi: 10.3233/JAD-215024.
    PubMed     Abstract available


  539. TAN Y, Zhang J, Yang K, Xu Z, et al
    Anti-Stroke Chinese Herbal Medicines Inhibit Abnormal Amyloid-beta Protein Precursor Processing in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Nov 11. pii: JAD210652. doi: 10.3233/JAD-210652.
    PubMed     Abstract available


  540. DIPROSPERO ND, Keator DB, Phelan M, van Erp TGM, et al
    Selective Impairment of Long-Range Default Mode Network Functional Connectivity as a Biomarker for Preclinical Alzheimer's Disease in People with Down Syndrome.
    J Alzheimers Dis. 2021 Nov 11. pii: JAD210572. doi: 10.3233/JAD-210572.
    PubMed     Abstract available


  541. FRANKLIN GL, Meira AT, Barbosa MT, Teive HAG, et al
    When My Child Has Alzheimer's Disease.
    J Alzheimers Dis. 2021 Nov 8. pii: JAD215234. doi: 10.3233/JAD-215234.
    PubMed     Abstract available


  542. FATIMA SHAD K, Soubra W, Cordato DJ
    The Auditory Afferent Pathway as a Clinical Marker of Alzheimer's Disease.
    J Alzheimers Dis. 2021 Nov 8. pii: JAD215206. doi: 10.3233/JAD-215206.
    PubMed     Abstract available


  543. CHEN KL, Li PX, Sun YM, Chen SF, et al
    Very Early-Onset Alzheimer's Disease in the Third Decade of Life with de novo PSEN1 Mutations.
    J Alzheimers Dis. 2021 Nov 8. pii: JAD215167. doi: 10.3233/JAD-215167.
    PubMed     Abstract available


  544. WANG F, Xu J, Xu SJ, Guo JJ, et al
    Analysis and Identification Genetic Effect of SARS-CoV-2 Infections to Alzheimer's Disease Patients by Integrated Bioinformatics.
    J Alzheimers Dis. 2021 Nov 8. pii: JAD215086. doi: 10.3233/JAD-215086.
    PubMed     Abstract available


  545. PAVLIK VN, Burnham SC, Kass JS, Helmer C, et al
    Connecting Cohorts to Diminish Alzheimer's Disease (CONCORD-AD): A Report of an International Research Collaboration Network.
    J Alzheimers Dis. 2021 Nov 8. pii: JAD210525. doi: 10.3233/JAD-210525.
    PubMed     Abstract available


  546. FU X, Liu Q, Sun X, Chang H, et al
    Research Advances in the Treatment of Alzheimer's Disease with Polysaccharides of Danggui-Shaoyao-San.
    J Alzheimers Dis. 2021 Nov 7. pii: JAD210656. doi: 10.3233/JAD-210656.
    PubMed     Abstract available


    October 2021
  547. MANDAL PK, Perry G
    SWADESH: A Comprehensive Platform for Multimodal Data and Analytics for Advanced Research in Alzheimer's Disease and Other Brain Disorders.
    J Alzheimers Dis. 2021 Oct 30. pii: JAD215354. doi: 10.3233/JAD-215354.
    PubMed    


  548. SAKURAI K, Iwase T, Kaneda D, Uchida Y, et al
    Sloping Shoulders Sign: A Practical Radiological Sign for the Differentiation of Alzheimer's Disease and Argyrophilic Grain Disease.
    J Alzheimers Dis. 2021 Oct 30. pii: JAD210638. doi: 10.3233/JAD-210638.
    PubMed    


  549. MATTHIESEN ST, Rosenkjaer S, Ponten M, Jensen KB, et al
    Does Certainty of Genuine Treatment Increase the Drug Response in Alzheimer's Disease Patients: A Meta-Analysis and Critical Discussion.
    J Alzheimers Dis. 2021 Oct 30. pii: JAD210108. doi: 10.3233/JAD-210108.
    PubMed     Abstract available


  550. BJORKLI C, Louet C, Flo TH, Hemler M, et al
    In Vivo Microdialysis in Mice Captures Changes in Alzheimer's Disease Cerebrospinal Fluid Biomarkers Consistent with Developing Pathology.
    J Alzheimers Dis. 2021 Oct 29. pii: JAD210715. doi: 10.3233/JAD-210715.
    PubMed     Abstract available


  551. JEONG HJ, Lee YM, Park JM, Lee BD, et al
    Reduced Thickness of the Anterior Cingulate Cortex as a Predictor of Amnestic-Mild Cognitive Impairment Conversion to Alzheimer's Disease with Psychosis.
    J Alzheimers Dis. 2021 Oct 26. pii: JAD215005. doi: 10.3233/JAD-215005.
    PubMed     Abstract available


  552. SCHULTZ B, Taday J, Menezes L, Cigerce A, et al
    Calpain-Mediated Alterations in Astrocytes Before and During Amyloid Chaos in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Oct 25. pii: JAD215182. doi: 10.3233/JAD-215182.
    PubMed     Abstract available


  553. TORRES AK, Jara C, Park-Kang HS, Polanco CM, et al
    Synaptic Mitochondria: An Early Target of Amyloid-beta and Tau in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Oct 25. pii: JAD215139. doi: 10.3233/JAD-215139.
    PubMed     Abstract available


  554. RUSANEN M, Selander T, Karkkainen V, Koivisto A, et al
    The Positive Effects of Pet Ownership on Alzheimer's Disease.
    J Alzheimers Dis. 2021 Oct 25. pii: JAD210557. doi: 10.3233/JAD-210557.
    PubMed     Abstract available


  555. HIN N, Newman M, Pederson S, Lardelli M, et al
    Iron Responsive Element-Mediated Responses to Iron Dyshomeostasis in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Oct 25. pii: JAD210200. doi: 10.3233/JAD-210200.
    PubMed     Abstract available


  556. SHOJAIE M, Tabarestani S, Cabrerizo M, DeKosky ST, et al
    PET Imaging of Tau Pathology and Amyloid-beta, and MRI for Alzheimer's Disease Feature Fusion and Multimodal Classification.
    J Alzheimers Dis. 2021 Oct 25. pii: JAD210064. doi: 10.3233/JAD-210064.
    PubMed     Abstract available


  557. KARAMI V, Nittari G, Traini E, Amenta F, et al
    An Optimized Decision Tree with Genetic Algorithm Rule-Based Approach to Reveal the Brain's Changes During Alzheimer's Disease Dementia.
    J Alzheimers Dis. 2021 Oct 23. pii: JAD210626. doi: 10.3233/JAD-210626.
    PubMed     Abstract available


  558. ZHANG Q, Schultz JL, Aldridge GM, Simmering JE, et al
    COVID-19 Case Fatality and Alzheimer's Disease.
    J Alzheimers Dis. 2021 Oct 20. pii: JAD215161. doi: 10.3233/JAD-215161.
    PubMed     Abstract available


  559. BRUUS AE, Waldemar G, Vogel A
    Impairment of Episodic-Specific Autobiographical Memory in Individuals with Subjective Cognitive Decline and in Patients with Prodromal or Mild Alzheimer's Disease.
    J Alzheimers Dis. 2021 Oct 20. pii: JAD215113. doi: 10.3233/JAD-215113.
    PubMed     Abstract available


  560. CLUTE-REINIG N, Jayadev S, Rhoads K, Ny AL, et al
    Alzheimer's Disease Diagnostics Must Be Globally Accessible.
    J Alzheimers Dis. 2021 Oct 20. pii: JAD210663. doi: 10.3233/JAD-210663.
    PubMed     Abstract available


  561. VRILLON A, Deramecourt V, Pasquier F, Magnin E, et al
    Association of Amyotrophic Lateral Sclerosis and Alzheimer's Disease: New Entity or Coincidence? A Case Series.
    J Alzheimers Dis. 2021 Oct 19. pii: JAD215226. doi: 10.3233/JAD-215226.
    PubMed     Abstract available


  562. ISMAEL S, Mirzahosseini G, Ahmed HA, Yoo A, et al
    Renin-Angiotensin System Alterations in the Human Alzheimer's Disease Brain.
    J Alzheimers Dis. 2021 Oct 19. pii: JAD215051. doi: 10.3233/JAD-215051.
    PubMed     Abstract available


  563. SWERDLOW NR, Kotz JE, Joshi YB, Talledo J, et al
    Using Biomarkers to Predict Memantine Effects in Alzheimer's Disease: A Proposal and Proof-Of-Concept Demonstration.
    J Alzheimers Dis. 2021 Oct 19. pii: JAD215029. doi: 10.3233/JAD-215029.
    PubMed     Abstract available


  564. HAN F, Zhao J, Zhao G
    Prolonged Volatile Anesthetic Exposure Exacerbates Cognitive Impairment and Neuropathology in the 5xFAD Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2021 Oct 19. pii: JAD210374. doi: 10.3233/JAD-210374.
    PubMed     Abstract available


  565. HU D, Liu C, Xia K, Abramowitz A, et al
    Characterizing the Resilience Effect of Neurodegeneration for the Mechanistic Pathway of Alzheimer's Disease.
    J Alzheimers Dis. 2021 Oct 13. pii: JAD215160. doi: 10.3233/JAD-215160.
    PubMed     Abstract available


  566. LIU H, Lutz M, Luo S
    Association Between Polygenic Risk Score and the Progression from Mild Cognitive Impairment to Alzheimer's Disease.
    J Alzheimers Dis. 2021 Oct 13. pii: JAD210700. doi: 10.3233/JAD-210700.
    PubMed     Abstract available


  567. HOFMANN C, Sander A, Wang XX, Buerge M, et al
    Inhalational Anesthetics Do Not Deteriorate Amyloid-beta-Derived Pathophysiology in Alzheimer's Disease: Investigations on the Molecular, Neuronal, and Behavioral Level.
    J Alzheimers Dis. 2021 Oct 13. pii: JAD201185. doi: 10.3233/JAD-201185.
    PubMed     Abstract available


  568. KURKINEN M, Tran L
    Aduhelm: The Best Hope for Alzheimer's Disease Patients or the Worst Decision the FDA Has Ever Made?
    J Alzheimers Dis. 2021 Oct 10. pii: JAD215105. doi: 10.3233/JAD-215105.
    PubMed    


  569. ARANDELOVIC J, Santrac A, Batinic B, Todorovic L, et al
    Positive and Negative Selective Allosteric Modulators of alpha5 GABAA Receptors: Effects on Emotionality, Motivation, and Motor Function in the 5xFAD Model of Alzheimer's Disease.
    J Alzheimers Dis. 2021 Oct 10. pii: JAD215079. doi: 10.3233/JAD-215079.
    PubMed     Abstract available


  570. OH C
    Single-Task or Dual-Task? Gait Assessment as a Potential Diagnostic Tool for Alzheimer's Disease.
    J Alzheimers Dis. 2021 Oct 8. pii: JAD210690. doi: 10.3233/JAD-210690.
    PubMed     Abstract available


  571. SILHAN D, Pashkovska O, Bartos A
    Hippocampo-Horn Percentage and Parietal Atrophy Score for Easy Visual Assessment of Brain Atrophy on Magnetic Resonance Imaging in Early- and Late-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2021 Oct 8. pii: JAD210372. doi: 10.3233/JAD-210372.
    PubMed     Abstract available


  572. SHUKLA D, Mandal PK, Mishra R, Punjabi K, et al
    Hippocampal Glutathione Depletion and pH Increment in Alzheimer's Disease: An in vivo MRS Study.
    J Alzheimers Dis. 2021 Oct 4. pii: JAD215032. doi: 10.3233/JAD-215032.
    PubMed     Abstract available


  573. WASHIDA K, Kitajima E, Tanaka T, Ikeda S, et al
    A Nationwide Multi-Center Questionnaire Survey on the Real-World State and Clinical Management of Poststroke Dementia in Japan.
    J Alzheimers Dis. 2021 Oct 4. pii: JAD215006. doi: 10.3233/JAD-215006.
    PubMed     Abstract available


  574. KIM H, Jun S, Kim BS, Kim IJ, et al
    Serum Adiponectin in Alzheimer's Disease (AD): Association with AD Biomarkers and Cognitive Outcome.
    J Alzheimers Dis. 2021 Oct 4. pii: JAD210722. doi: 10.3233/JAD-210722.
    PubMed     Abstract available


  575. PACHECO-HERRERO M, Soto-Rojas LO, Reyes-Sabater H, Garces-Ramirez L, et al
    Current Status and Challenges of Stem Cell Treatment for Alzheimer's Disease.
    J Alzheimers Dis. 2021 Oct 4. pii: JAD200863. doi: 10.3233/JAD-200863.
    PubMed     Abstract available


  576. SHAFIEE N, Dadar M, Ducharme S, Collins DL, et al
    Automatic Prediction of Cognitive and Functional Decline Can Significantly Decrease the Number of Subjects Required for Clinical Trials in Early Alzheimer's Disease.
    J Alzheimers Dis. 2021 Oct 1. pii: JAD210664. doi: 10.3233/JAD-210664.
    PubMed     Abstract available


    September 2021
  577. PANDEY JP, Namboodiri AM, Nietert PJ, Barnes LL, et al
    Inhibitory Fcgamma Receptor and Paired Immunoglobulin Type 2 Receptor Alpha Genotypes in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Sep 30. pii: JAD215174. doi: 10.3233/JAD-215174.
    PubMed     Abstract available


  578. ROBINSON AC, Davidson YS, Roncaroli F, Minshull J, et al
    Telephone Interview for Cognitive Status Scores Associate with Cognitive Impairment and Alzheimer's Disease Pathology at Death.
    J Alzheimers Dis. 2021 Sep 30. pii: JAD215102. doi: 10.3233/JAD-215102.
    PubMed     Abstract available


  579. LARGENT EA, Bhardwaj T, Abera M, Stites SD, et al
    Disclosing Genetic Risk of Alzheimer's Disease to Cognitively Unimpaired Older Adults: Findings from the Study of Knowledge and Reactions to APOE Testing (SOKRATES II).
    J Alzheimers Dis. 2021 Sep 30. pii: JAD210675. doi: 10.3233/JAD-210675.
    PubMed     Abstract available


  580. STANITSA E, Economou A, Beratis I, Kontaxopoulou D, et al
    Effect of Apolipoprotein E4 on the Driving Behavior of Patients with Amnestic Mild Cognitive Impairment or Mild Alzheimer's Disease Dementia.
    J Alzheimers Dis. 2021 Sep 29. pii: JAD210622. doi: 10.3233/JAD-210622.
    PubMed     Abstract available


  581. SONG XJ, Zhou HY, Sun YY, Huang HC, et al
    Phosphorylation and Glycosylation of Amyloid-beta Protein Precursor: The Relationship to Trafficking and Cleavage in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Sep 29. pii: JAD210337. doi: 10.3233/JAD-210337.
    PubMed     Abstract available


  582. SONG J, Yang X, Zhang M, Wang C, et al
    Glutamate Metabolism in Mitochondria is Closely Related to Alzheimer's Disease.
    J Alzheimers Dis. 2021 Sep 25. pii: JAD210595. doi: 10.3233/JAD-210595.
    PubMed     Abstract available


  583. HAO J, Qiao Y, Li T, Yang J, et al
    Investigating Changes in the Serum Inflammatory Factors in Alzheimer's Disease and Their Correlation with Cognitive Function.
    J Alzheimers Dis. 2021 Sep 25. pii: JAD210552. doi: 10.3233/JAD-210552.
    PubMed     Abstract available


  584. MATSUZONO K, Suzuki M, Miura K, Ozawa T, et al
    Internal Jugular Vein Velocity and Spontaneous Echo Contrast Correlate with Alzheimer's Disease and Cognitive Function.
    J Alzheimers Dis. 2021 Sep 25. pii: JAD210490. doi: 10.3233/JAD-210490.
    PubMed     Abstract available


  585. FUKUDA H, Ono R, Maeda M, Murata F, et al
    Medical Care and Long-Term Care Expenditures Attributable to Alzheimer's Disease Onset: Results from the LIFE Study.
    J Alzheimers Dis. 2021 Sep 25. pii: JAD201508. doi: 10.3233/JAD-201508.
    PubMed     Abstract available


  586. LENNON MJ, Rigney G, Raymont V, Sachdev P, et al
    Genetic Therapies for Alzheimer's Disease: A Scoping Review.
    J Alzheimers Dis. 2021 Sep 23. pii: JAD215145. doi: 10.3233/JAD-215145.
    PubMed     Abstract available


  587. WANG Q, Dong X, Zhang R, Zhao C, et al
    Flavonoids with Potential Anti-Amyloidogenic Effects as Therapeutic Drugs for Treating Alzheimer's Disease.
    J Alzheimers Dis. 2021 Sep 23. pii: JAD210735. doi: 10.3233/JAD-210735.
    PubMed     Abstract available


  588. NAN H, Kim YJ, Tsuchiya M, Fukao T, et al
    A Novel Heterozygous Missense Variant in the CIAO1 Gene in a Family with Alzheimer's Disease: The Val67Ile Variant Promotes the Interaction of CIAO1 and Amyloid-beta Protein Precursor.
    J Alzheimers Dis. 2021 Sep 23. pii: JAD210706. doi: 10.3233/JAD-210706.
    PubMed     Abstract available


  589. BLOCK ML, Kodavanti UP
    The Use of Standardized Diesel Exhaust Particles in Alzheimer's Disease Research.
    J Alzheimers Dis. 2021 Sep 22. pii: JAD215201. doi: 10.3233/JAD-215201.
    PubMed     Abstract available


  590. CULIBRK RA, Arabiyat AS, DeKalb CA, Hahn MS, et al
    Modeling Sympathetic Hyperactivity in Alzheimer's Related Bone Loss.
    J Alzheimers Dis. 2021 Sep 22. pii: JAD215007. doi: 10.3233/JAD-215007.
    PubMed     Abstract available


  591. KATZ J, Gao H
    The Alzheimer-E. coli Axis: What Can We Learn from an Electronic Health Record Platform.
    J Alzheimers Dis. 2021 Sep 22. pii: JAD215004. doi: 10.3233/JAD-215004.
    PubMed     Abstract available


  592. CHEN H, Chen F, Zhang M, Chen Y, et al
    A Review of APOE Genotype-Dependent Autophagic Flux Regulation in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Sep 22. pii: JAD210602. doi: 10.3233/JAD-210602.
    PubMed     Abstract available


  593. KANG SH, Cho H, Shin J, Kim HR, et al
    Clinical Characteristic in Primary Progressive Aphasia in Relation to Alzheimer's Disease Biomarkers.
    J Alzheimers Dis. 2021 Sep 22. pii: JAD210392. doi: 10.3233/JAD-210392.
    PubMed     Abstract available


  594. GOLZARI-SORKHEH M, Brown C, Weaver DF, Reed M, et al
    The NLRP3 Inflammasome in the Pathogenesis and Treatment of Alzheimer's Disease.
    J Alzheimers Dis. 2021 Sep 21. pii: JAD210660. doi: 10.3233/JAD-210660.
    PubMed     Abstract available


  595. MULAK A
    Bile Acids as Key Modulators of the Brain-Gut-Microbiota Axis in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Sep 21. pii: JAD210608. doi: 10.3233/JAD-210608.
    PubMed     Abstract available


  596. SEO SJ, Chang WS, Jeon JG, Choi Y, et al
    Proton Stimulation Targeting Plaque Magnetite Reduces Amyloid-beta Plaque and Iron Redox Toxicity and Improves Memory in an Alzheimer's Disease Mouse Model.
    J Alzheimers Dis. 2021 Sep 18. pii: JAD210739. doi: 10.3233/JAD-210739.
    PubMed     Abstract available


  597. BRUGULAT-SERRAT A, Canas A, Canals L, Marne P, et al
    Enhancing the Sensitivity of Memory Tests: Reference Data for the Free and Cued Selective Reminding Test and the Logical Memory Task from Cognitively Healthy Subjects with Normal Alzheimer's Disease Cerebrospinal Fluid Biomarker Levels.
    J Alzheimers Dis. 2021 Sep 18. pii: JAD210640. doi: 10.3233/JAD-210640.
    PubMed     Abstract available


  598. TARAWNEH HY, Mulders WHAM, Sohrabi HR, Martins RN, et al
    Investigating Auditory Electrophysiological Measures of Participants with Mild Cognitive Impairment and Alzheimer's Disease: A Systematic Review and Meta-Analysis of Event-Related Potential Studies.
    J Alzheimers Dis. 2021 Sep 18. pii: JAD210556. doi: 10.3233/JAD-210556.
    PubMed     Abstract available


  599. CIANFLONE A, Coppola L, Mirabelli P, Salvatore M, et al
    Predictive Accuracy of Blood-Derived Biomarkers for Amyloid-beta Brain Deposition Along with the Alzheimer's Disease Continuum: A Systematic Review.
    J Alzheimers Dis. 2021 Sep 17. pii: JAD210496. doi: 10.3233/JAD-210496.
    PubMed     Abstract available


  600. YAMADA Y, Shinkawa K, Kobayashi M, Caggiano V, et al
    Combining Multimodal Behavioral Data of Gait, Speech, and Drawing for Classification of Alzheimer's Disease and Mild Cognitive Impairment.
    J Alzheimers Dis. 2021 Sep 16. pii: JAD210684. doi: 10.3233/JAD-210684.
    PubMed     Abstract available


  601. ALLEN HB
    A Novel Approach to the Treatment and Prevention of Alzheimer's Disease Based on the Pathology and Microbiology.
    J Alzheimers Dis. 2021 Sep 14. pii: JAD210429. doi: 10.3233/JAD-210429.
    PubMed     Abstract available


  602. KOLINKO Y, Marsalova L, Pena SP, Kralickova M, et al
    Stereological Changes in Microvascular Parameters in Hippocampus of a Transgenic Rat Model of Alzheimer's Disease.
    J Alzheimers Dis. 2021 Sep 10. pii: JAD210738. doi: 10.3233/JAD-210738.
    PubMed     Abstract available


  603. SATO T, Hanyu H, Koyama Y, Horita H, et al
    Discrepancy Between the Degree of Cognitive Impairment and Brain Imaging Abnormalities in Alzheimer's Disease Patients Is Associated with Cognitive Reserve.
    J Alzheimers Dis. 2021 Sep 10. pii: JAD210728. doi: 10.3233/JAD-210728.
    PubMed     Abstract available


  604. ABDULKADIR TS, Dawud FA, Isa AS, Ayo JO, et al
    Taurine and Camel Milk Modulate Neurobehavioral and Biochemical Changes in Aluminum Chloride-Induced Alzheimer's Disease in Rats.
    J Alzheimers Dis. 2021 Sep 10. pii: JAD210130. doi: 10.3233/JAD-210130.
    PubMed     Abstract available


  605. SRIWICHAIIN S, Chattipakorn N, Chattipakorn SC
    Metabolomic Alterations in the Blood and Brain in Association with Alzheimer's Disease: Evidence from in vivo to Clinical Studies.
    J Alzheimers Dis. 2021 Sep 9. pii: JAD210737. doi: 10.3233/JAD-210737.
    PubMed     Abstract available


  606. COLATO E, Chiotis K, Ferreira D, Mazrina MS, et al
    Assessment of Tau Pathology as Measured by 18F-THK5317 and 18F-Flortaucipir PET and Their Relation to Brain Atrophy and Cognition in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Sep 9. pii: JAD210614. doi: 10.3233/JAD-210614.
    PubMed     Abstract available


  607. WERBER T, Bata Z, Vaszine ES, Berente DB, et al
    The Association of Periodontitis and Alzheimer's Disease: How to Hit Two Birds with One Stone.
    J Alzheimers Dis. 2021 Sep 8. pii: JAD210491. doi: 10.3233/JAD-210491.
    PubMed     Abstract available


  608. ZHANG XQ, Xu L, Yang SY, Hu LB, et al
    Reduced Synaptic and Intrinsic Excitability of a Subtype of Pyramidal Neurons in the Medial Prefrontal Cortex in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2021 Sep 2. pii: JAD210585. doi: 10.3233/JAD-210585.
    PubMed     Abstract available


  609. CALDIERARO MA, Laufer-Silva T, Cassano P
    Dosimetry and Clinical Efficacy of Transcranial Photobiomodulation for Major Depression Disorder: Could they Guide Dosimetry for Alzheimer's Disease?
    J Alzheimers Dis. 2021 Sep 1. pii: JAD210586. doi: 10.3233/JAD-210586.
    PubMed     Abstract available


  610. HE F, Zhang Y, Wu X, Li Y, et al
    Early Microstructure Changes of White Matter Fiber Bundles in Patients with Amnestic Mild Cognitive Impairment Predicts Progression of Mild Cognitive Impairment to Alzheimer's Disease.
    J Alzheimers Dis. 2021 Sep 1. pii: JAD210495. doi: 10.3233/JAD-210495.
    PubMed     Abstract available


  611. HADDAD M, Perrotte M, Ben Khedher MR, Madec E, et al
    Levels of Receptor for Advanced Glycation End Products and Glyoxalase-1 in the Total Circulating Extracellular Vesicles from Mild Cognitive Impairment and Different Stages of Alzheimer's Disease Patients.
    J Alzheimers Dis. 2021 Sep 1. pii: JAD210441. doi: 10.3233/JAD-210441.
    PubMed     Abstract available


    August 2021
  612. FARACE P, Tamburin S
    Combining Low-Dose Radiation Therapy and Magnetic Resonance Guided Focused Ultrasound to Reduce Amyloid-beta Deposition in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Aug 30. pii: JAD215041. doi: 10.3233/JAD-215041.
    PubMed     Abstract available


  613. KATZOUROU I, Leonenko G, Ivanov D, Meggy A, et al
    Cognitive Decline in Alzheimer's Disease Is Not Associated with APOE.
    J Alzheimers Dis. 2021 Aug 30. pii: JAD210685. doi: 10.3233/JAD-210685.
    PubMed     Abstract available


  614. PIEVANI M, Mega A, Quattrini G, Guidali G, et al
    Targeting Default Mode Network Dysfunction in Persons at Risk of Alzheimer's Disease with Transcranial Magnetic Stimulation (NEST4AD): Rationale and Study Design.
    J Alzheimers Dis. 2021 Aug 27. pii: JAD210659. doi: 10.3233/JAD-210659.
    PubMed     Abstract available


  615. HANDY A, Lord J, Green R, Xu J, et al
    Assessing Genetic Overlap and Causality Between Blood Plasma Proteins and Alzheimer's Disease.
    J Alzheimers Dis. 2021 Aug 25. pii: JAD210462. doi: 10.3233/JAD-210462.
    PubMed     Abstract available


  616. LIU Z, Maiti T, Bender AR
    A Role for Prior Knowledge in Statistical Classification of the Transition from Mild Cognitive Impairment to Alzheimer's Disease.
    J Alzheimers Dis. 2021 Aug 25. pii: JAD201398. doi: 10.3233/JAD-201398.
    PubMed     Abstract available


  617. HAMBLIN MR, Salehpour F
    Photobiomodulation of the Brain: Shining Light on Alzheimer's and Other Neuropathological Diseases.
    J Alzheimers Dis. 2021 Aug 24. pii: JAD210743. doi: 10.3233/JAD-210743.
    PubMed    


  618. ZHANG Z, Wang M, Yuan S, Cai H, et al
    Genetically Predicted Coffee Consumption and Risk of Alzheimer's Disease and Stroke.
    J Alzheimers Dis. 2021 Aug 24. pii: JAD210678. doi: 10.3233/JAD-210678.
    PubMed     Abstract available


  619. BOMMARITO G, Van De Ville D, Frisoni GB, Garibotto V, et al
    Alzheimer's Disease Biomarkers in Idiopathic Normal Pressure Hydrocephalus: Linking Functional Connectivity and Clinical Outcome.
    J Alzheimers Dis. 2021 Aug 24. pii: JAD210534. doi: 10.3233/JAD-210534.
    PubMed     Abstract available


  620. SYVERSTAD SKAARAAS GHE, Melbye C, Puchades MA, Yi Leung DS, et al
    Cerebral Amyloid Angiopathy in a Mouse Model of Alzheimer's Disease Associates with Upregulated Angiopoietin and Downregulated Hypoxia-Inducible Factor.
    J Alzheimers Dis. 2021 Aug 21. pii: JAD210571. doi: 10.3233/JAD-210571.
    PubMed     Abstract available


  621. QURESHI ZP, Thiel E, Nelson J, Khandker R, et al
    Incremental Healthcare Utilization and Cost Burden of Comorbid Insomnia in Alzheimer's Disease Patients.
    J Alzheimers Dis. 2021 Aug 20. pii: JAD210713. doi: 10.3233/JAD-210713.
    PubMed     Abstract available


  622. TOK S, Ahnaou A, Drinkenburg W
    Functional Neurophysiological Biomarkers of Early-Stage Alzheimer's Disease: A Perspective of Network Hyperexcitability in Disease Progression.
    J Alzheimers Dis. 2021 Aug 20. pii: JAD210397. doi: 10.3233/JAD-210397.
    PubMed     Abstract available


  623. GE F, Zhu D, Tian M, Shi J, et al
    The Role of Thyroid Function in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Aug 20. pii: JAD210339. doi: 10.3233/JAD-210339.
    PubMed     Abstract available


  624. TOFIQ A, Zetterberg H, Blennow K, Basun H, et al
    Effects of Peroral Omega-3 Fatty Acid Supplementation on Cerebrospinal Fluid Biomarkers in Patients with Alzheimer's Disease: A Randomized Controlled Trial-The OmegAD Study.
    J Alzheimers Dis. 2021 Aug 20. pii: JAD210007. doi: 10.3233/JAD-210007.
    PubMed     Abstract available


  625. ROBAKIS NK
    On the Nomenclature of the Alzheimer's Disease Amyloid and Its Precursor1.
    J Alzheimers Dis. 2021 Aug 17. pii: JAD215138. doi: 10.3233/JAD-215138.
    PubMed    


  626. CIOFFI F, Ibrahim Adam RH, Bansal R, Broersen K, et al
    A Review of Oxidative Stress Products and Related Genes in Early Alzheimer's Disease.
    J Alzheimers Dis. 2021 Aug 17. pii: JAD210497. doi: 10.3233/JAD-210497.
    PubMed     Abstract available


  627. MOMMAERTS K, Willemse EAJ, Marchese M, Larue C, et al
    A Cystatin C Cleavage ELISA Assay as a Quality Control Tool for Determining Sub-Optimal Storage Conditions of Cerebrospinal Fluid Samples in Alzheimer's Disease Research.
    J Alzheimers Dis. 2021 Aug 16. pii: JAD210741. doi: 10.3233/JAD-210741.
    PubMed     Abstract available


  628. ZANGROSSI A, Montemurro S, Altoe G, Mondini S, et al
    Heterogeneity and Factorial Structure in Alzheimer's Disease: A Cognitive Perspective.
    J Alzheimers Dis. 2021 Aug 16. pii: JAD210719. doi: 10.3233/JAD-210719.
    PubMed     Abstract available


  629. WANG H, Xu Y, Ren R, Yao F, et al
    Ambulatory Blood Pressure Characteristics of Patients with Alzheimer's Disease: A Multicenter Study from China.
    J Alzheimers Dis. 2021 Aug 16. pii: JAD210679. doi: 10.3233/JAD-210679.
    PubMed     Abstract available


  630. YANG HJ, Lee S, Koh MJ, Lee HK, et al
    The Association of White Matter Hyperintensities with Frailty in Patients with Very Mild to Moderate Alzheimer's Disease.
    J Alzheimers Dis. 2021 Aug 16. pii: JAD210494. doi: 10.3233/JAD-210494.
    PubMed     Abstract available


  631. WIMO A, Belger M, Bon J, Jessen F, et al
    A Cost-Consequence Analysis of Different Screening Procedures in Alzheimer's Disease: Results from the MOPEAD Project.
    J Alzheimers Dis. 2021 Aug 16. pii: JAD210303. doi: 10.3233/JAD-210303.
    PubMed     Abstract available


  632. BARTHOLD D, Gibbons LE, Marcum ZA, Gray SL, et al
    Alzheimer's Disease-Related Neuropathology Among Patients with Medication Treated Type 2 Diabetes in a Community-Based Autopsy Cohort.
    J Alzheimers Dis. 2021 Aug 14. pii: JAD210059. doi: 10.3233/JAD-210059.
    PubMed     Abstract available


  633. SCARTH M, Rissanen I, Scholten RJPM, Geerlings MI, et al
    Biomarkers of Alzheimer's Disease and Cerebrovascular Lesions and Clinical Progression in Patients with Subjective Cognitive Decline: A Systematic Review.
    J Alzheimers Dis. 2021 Aug 13. pii: JAD210218. doi: 10.3233/JAD-210218.
    PubMed     Abstract available


  634. SCHILD AK, Volk J, Scharfenberg D, Schuermann K, et al
    Social Cognition in Patients with Amnestic Mild Cognitive Impairment and Mild Dementia of the Alzheimer Type.
    J Alzheimers Dis. 2021 Aug 13. pii: JAD201126. doi: 10.3233/JAD-201126.
    PubMed     Abstract available


  635. REHAN S, Giroud N, Al-Yawer F, Wittich W, et al
    Visual Performance and Cortical Atrophy in Vision-Related Brain Regions Differ Between Older Adults with (or at Risk for) Alzheimer's Disease.
    J Alzheimers Dis. 2021 Aug 11. pii: JAD201521. doi: 10.3233/JAD-201521.
    PubMed     Abstract available


  636. FOTE G, Wu J, Mapstone M, Macciardi F, et al
    Plasma Sphingomyelins in Late-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2021 Aug 11. pii: JAD200871. doi: 10.3233/JAD-200871.
    PubMed     Abstract available


  637. YU Y, Gao Y, Winblad B, Tjernberg L, et al
    A Super-Resolved View of the Alzheimer's Disease-Related Amyloidogenic Pathway in Hippocampal Neurons.
    J Alzheimers Dis. 2021 Aug 6. pii: JAD215008. doi: 10.3233/JAD-215008.
    PubMed     Abstract available


  638. PARK M, Baik K, Lee YG, Kang SW, et al
    Implication of Small Vessel Disease MRI Markers in Alzheimer's Disease and Lewy Body Disease.
    J Alzheimers Dis. 2021 Aug 6. pii: JAD210669. doi: 10.3233/JAD-210669.
    PubMed     Abstract available


  639. PUDUMJEE SB, Lundt ES, Albertson SM, Machulda MM, et al
    A Comparison of Cross-Sectional and Longitudinal Methods of Defining Objective Subtle Cognitive Decline in Preclinical Alzheimer's Disease Based on Cogstate One Card Learning Accuracy Performance.
    J Alzheimers Dis. 2021 Aug 6. pii: JAD210251. doi: 10.3233/JAD-210251.
    PubMed     Abstract available


  640. KIM HR, Jang JH, Ham H, Choo SH, et al
    A Case of Early-Onset Alzheimer's Disease Mimicking Schizophrenia in a Patient with Presenilin 1 Mutation (S170P).
    J Alzheimers Dis. 2021 Aug 5. pii: JAD210650. doi: 10.3233/JAD-210650.
    PubMed     Abstract available


  641. AGUERO P, Sainz MJ, Tellez R, Lorda I, et al
    De Novo PS1 Mutation (Pro436Gln) in a Very Early-Onset Posterior Variant of Alzheimer's Disease Associated with Spasticity: A Case Report.
    J Alzheimers Dis. 2021 Aug 5. pii: JAD210420. doi: 10.3233/JAD-210420.
    PubMed     Abstract available


  642. LI Y, Wang R, Li Q, Wang YJ, et al
    Gut Microbiota and Alzheimer's Disease: Pathophysiology and Therapeutic Perspectives.
    J Alzheimers Dis. 2021 Aug 5. pii: JAD210381. doi: 10.3233/JAD-210381.
    PubMed     Abstract available


  643. RASMUSSEN ID, Boayue NM, Mittner M, Bystad M, et al
    High-Definition Transcranial Direct Current Stimulation Improves Delayed Memory in Alzheimer's Disease Patients: A Pilot Study Using Computational Modeling to Optimize Electrode Position.
    J Alzheimers Dis. 2021 Aug 5. pii: JAD210378. doi: 10.3233/JAD-210378.
    PubMed     Abstract available


  644. TADOKORO K, Yamashita T, Kimura S, Nomura E, et al
    Retinal Amyloid Imaging for Screening Alzheimer's Disease.
    J Alzheimers Dis. 2021 Aug 5. pii: JAD210327. doi: 10.3233/JAD-210327.
    PubMed     Abstract available


  645. HE H, Liu A, Zhang W, Yang H, et al
    Novel Plasma miRNAs as Biomarkers and Therapeutic Targets of Alzheimer's Disease at the Prodromal Stage.
    J Alzheimers Dis. 2021 Aug 5. pii: JAD210307. doi: 10.3233/JAD-210307.
    PubMed     Abstract available


  646. VAN ZELLER M, Dias DM, Sebastiao AM, Valente CA, et al
    NLRP3 Inflammasome: A Starring Role in Amyloid-beta- and Tau-Driven Pathological Events in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Aug 4. pii: JAD210268. doi: 10.3233/JAD-210268.
    PubMed     Abstract available


  647. CAI HY, Yang D, Qiao J, Yang JT, et al
    A GLP-1/GIP Dual Receptor Agonist DA4-JC Effectively Attenuates Cognitive Impairment and Pathology in the APP/PS1/Tau Model of Alzheimer's Disease.
    J Alzheimers Dis. 2021 Aug 4. pii: JAD210256. doi: 10.3233/JAD-210256.
    PubMed     Abstract available


  648. MUKHOPADHYAY S, Banerjee D
    A Primer on the Evolution of Aducanumab: The First Antibody Approved for Treatment of Alzheimer's Disease.
    J Alzheimers Dis. 2021 Aug 2. pii: JAD215065. doi: 10.3233/JAD-215065.
    PubMed     Abstract available


  649. NOUS A, Wittens MMJ, Vermeiren Y, De Deyn PP, et al
    Serum Daytime Melatonin Levels Reflect Cerebrospinal Fluid Melatonin Levels in Alzheimer's Disease but Are Not Correlated with Cognitive Decline.
    J Alzheimers Dis. 2021 Aug 2. pii: JAD210562. doi: 10.3233/JAD-210562.
    PubMed     Abstract available


  650. VAN DE MORTEL LA, Thomas RM, van Wingen GA
    Grey Matter Loss at Different Stages of Cognitive Decline: A Role for the Thalamus in Developing Alzheimer's Disease.
    J Alzheimers Dis. 2021 Aug 2. pii: JAD210173. doi: 10.3233/JAD-210173.
    PubMed     Abstract available


  651. CARCAMO J, Kociolek AJ, Fernandez KK, Gu Y, et al
    Neuropsychological Predictors of Severe Functional Dependency in a Multiethnic Community Cohort of Individuals with Alzheimer's Disease.
    J Alzheimers Dis. 2021 Aug 2. pii: JAD210019. doi: 10.3233/JAD-210019.
    PubMed     Abstract available


    July 2021
  652. QIN W, Li W, Wang Q, Gong M, et al
    Race-Related Association between APOE Genotype and Alzheimer's Disease: A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2021 Jul 27. pii: JAD210549. doi: 10.3233/JAD-210549.
    PubMed     Abstract available


  653. WATSON Y, Nelson B, Kluesner JH, Tanzy C, et al
    Aggregate Trends of Apolipoprotein E on Cognition in Transgenic Alzheimer's Disease Mice.
    J Alzheimers Dis. 2021 Jul 27. pii: JAD210492. doi: 10.3233/JAD-210492.
    PubMed     Abstract available


  654. LIU P, Yang Q, Yu N, Cao Y, et al
    Phenylalanine Metabolism is Dysregulated in Human Hippocampus with Alzheimer's Disease Related Pathological Changes.
    J Alzheimers Dis. 2021 Jul 27. pii: JAD210461. doi: 10.3233/JAD-210461.
    PubMed     Abstract available


  655. WITTENS MMJ, Sima DM, Houbrechts R, Ribbens A, et al
    Diagnostic Performance of Automated MRI Volumetry by icobrain dm for Alzheimer's Disease in a Clinical Setting: A REMEMBER Study.
    J Alzheimers Dis. 2021 Jul 27. pii: JAD210450. doi: 10.3233/JAD-210450.
    PubMed     Abstract available


  656. LUCKEY AM, Robertson IH, Lawlor B, Mohan A, et al
    Sex Differences in Locus Coeruleus: A Heuristic Approach That May Explain the Increased Risk of Alzheimer's Disease in Females.
    J Alzheimers Dis. 2021 Jul 27. pii: JAD210404. doi: 10.3233/JAD-210404.
    PubMed     Abstract available


  657. WALDEN LM, Hu S, Madabhushi A, Prescott JW, et al
    Amyloid Deposition Is Greater in Cerebral Gyri than in Cerebral Sulci with Worsening Clinical Diagnosis Across the Alzheimer's Disease Spectrum.
    J Alzheimers Dis. 2021 Jul 27. pii: JAD210308. doi: 10.3233/JAD-210308.
    PubMed     Abstract available


  658. HLAVKA JP, Kinoshita AT, Fang S, Hunt A, et al
    Clinical Outcome Measure Crosswalks in Alzheimer's Disease: A Systematic Review.
    J Alzheimers Dis. 2021 Jul 27. pii: JAD210060. doi: 10.3233/JAD-210060.
    PubMed     Abstract available


  659. SMAILOVIC U, Kareholt I, Koenig T, Ashton NJ, et al
    Synaptic Molecular and Neurophysiological Markers Are Independent Predictors of Progression in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jul 25. pii: JAD201234. doi: 10.3233/JAD-201234.
    PubMed     Abstract available


  660. CROSS DJ, Huber BR, Silverman MA, Cline MM, et al
    Intranasal Paclitaxel Alters Alzheimer's Disease Phenotypic Features in 3xTg-AD Mice.
    J Alzheimers Dis. 2021 Jul 23. pii: JAD210109. doi: 10.3233/JAD-210109.
    PubMed     Abstract available


  661. WANG F, Xu CS, Chen WH, Duan SW, et al
    Identification of Blood-Based Glycolysis Gene Associated with Alzheimer's Disease by Integrated Bioinformatics Analysis.
    J Alzheimers Dis. 2021 Jul 19. pii: JAD210540. doi: 10.3233/JAD-210540.
    PubMed     Abstract available


  662. NARA PL, Sindelar D, Penn MS, Potempa J, et al
    Porphyromonas gingivalis Outer Membrane Vesicles as the Major Driver of and Explanation for Neuropathogenesis, the Cholinergic Hypothesis, Iron Dyshomeostasis, and Salivary Lactoferrin in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jul 16. pii: JAD210448. doi: 10.3233/JAD-210448.
    PubMed     Abstract available


  663. ALEXOPOULOS P, Skondra M, Kontogianni E, Vratsista A, et al
    Validation of the Cognitive Telephone Screening Instruments COGTEL and COGTEL+ in Identifying Clinically Diagnosed Neurocognitive Disorder Due to Alzheimer's Disease in a Naturalistic Clinical Setting.
    J Alzheimers Dis. 2021 Jul 15. pii: JAD210477. doi: 10.3233/JAD-210477.
    PubMed     Abstract available


  664. DE LA TORRE JC, Gonzalez-Lima F
    The FDA Approves Aducanumab for Alzheimer's Disease, Raising Important Scientific Questions1.
    J Alzheimers Dis. 2021 Jul 9. pii: JAD210736. doi: 10.3233/JAD-210736.
    PubMed    


  665. CHEN S, Song Y, Xu W, Hu G, et al
    Impaired Memory Awareness and Loss Integration in Self-Referential Network Across the Progression of Alzheimer's Disease Spectrum.
    J Alzheimers Dis. 2021 Jul 9. pii: JAD210541. doi: 10.3233/JAD-210541.
    PubMed     Abstract available


  666. SIBLE IJ, Bangen KJ, Blanken AE, Ho JK, et al
    Antemortem Visit-To-Visit Blood Pressure Variability Predicts Cerebrovascular Lesion Burden in Autopsy-Confirmed Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jul 7. pii: JAD210435. doi: 10.3233/JAD-210435.
    PubMed     Abstract available


  667. JOSEPH S, Patterson R, Wang W, Blumberger DM, et al
    Quantitative Assessment of Cortical Excitability in Alzheimer's Dementia and Its Association with Clinical Symptoms: A Systematic Review and Meta-Analyses.
    J Alzheimers Dis. 2021 Jul 2. pii: JAD210311. doi: 10.3233/JAD-210311.
    PubMed     Abstract available


  668. BEARDMORE R, Hou R, Darekar A, Holmes C, et al
    The Locus Coeruleus in Aging and Alzheimer's Disease: A Postmortem and Brain Imaging Review.
    J Alzheimers Dis. 2021 Jul 2. pii: JAD210191. doi: 10.3233/JAD-210191.
    PubMed     Abstract available


  669. SQUITTI R, Faller P, Hureau C, Granzotto A, et al
    Copper Imbalance in Alzheimer's Disease and Its Link with the Amyloid Hypothesis: Towards a Combined Clinical, Chemical, and Genetic Etiology.
    J Alzheimers Dis. 2021 Jul 2. pii: JAD201556. doi: 10.3233/JAD-201556.
    PubMed     Abstract available


  670. HOJJATI SH, Feiz F, Ozoria S, Razlighi QR, et al
    Topographical Overlapping of the Amyloid-beta and Tau Pathologies in the Default Mode Network Predicts Alzheimer's Disease with Higher Specificity.
    J Alzheimers Dis. 2021 Jul 1. pii: JAD210419. doi: 10.3233/JAD-210419.
    PubMed     Abstract available


  671. KUWAR R, Rolfe A, Di L, Blevins H, et al
    A Novel Inhibitor Targeting NLRP3 Inflammasome Reduces Neuropathology and Improves Cognitive Function in Alzheimer's Disease Transgenic Mice.
    J Alzheimers Dis. 2021 Jul 1. pii: JAD210400. doi: 10.3233/JAD-210400.
    PubMed     Abstract available


    June 2021
  672. GABRIEL A, Lehner CT, Hohler C, Schneider T, et al
    Anticipatory and Reactive Grip Force Control in Patients with Alzheimer's Disease: A Pilot Study.
    J Alzheimers Dis. 2021 Jun 30. pii: JAD210387. doi: 10.3233/JAD-210387.
    PubMed     Abstract available


  673. BAENA A, Bocanegra Y, Torres V, Vila-Castelar C, et al
    Neuroticism Is Associated with Tau Pathology in Cognitively Unimpaired Individuals with Autosomal Dominant Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jun 30. pii: JAD210185. doi: 10.3233/JAD-210185.
    PubMed     Abstract available


  674. FRANK M, Hensel J, Baak L, Schramm S, et al
    Interaction of Alzheimer's Disease-Associated Genetic Risk with Indicators of Socioeconomic Position on Mild Cognitive Impairment in the Heinz Nixdorf Recall Study.
    J Alzheimers Dis. 2021 Jun 28. pii: JAD210244. doi: 10.3233/JAD-210244.
    PubMed     Abstract available


  675. MANCINI G, Dias C, Lourenco CF, Laranjinha J, et al
    A High Fat/Cholesterol Diet Recapitulates Some Alzheimer's Disease-Like Features in Mice: Focus on Hippocampal Mitochondrial Dysfunction.
    J Alzheimers Dis. 2021 Jun 28. pii: JAD210122. doi: 10.3233/JAD-210122.
    PubMed     Abstract available


  676. YAO W, Chen H, Sheng X, Zhao H, et al
    Core-Centered Connection Abnormalities Associated with Pathological Features Mediate the Progress of Cognitive Impairments in Alzheimer's Disease Spectrum Patients.
    J Alzheimers Dis. 2021 Jun 22. pii: JAD210481. doi: 10.3233/JAD-210481.
    PubMed     Abstract available


  677. CHAUDHARY S, Ashok A, McDonald D, Wise AS, et al
    Upregulation of Local Hepcidin Contributes to Iron Accumulation in Alzheimer's Disease Brains.
    J Alzheimers Dis. 2021 Jun 19. pii: JAD210221. doi: 10.3233/JAD-210221.
    PubMed     Abstract available


  678. KANG S, Gim J, Lee J, Gunasekaran TI, et al
    Potential Novel Genes for Late-Onset Alzheimer's Disease in East-Asian Descent Identified by APOE-Stratified Genome-Wide Association Study.
    J Alzheimers Dis. 2021 Jun 18. pii: JAD210145. doi: 10.3233/JAD-210145.
    PubMed     Abstract available


  679. XU LZ, Li FY, Li BQ, Cao SM, et al
    Decreased Levels of Insulin-Like Growth Factor-1 Are Associated with Alzheimer's Disease: A Meta-Analysis.
    J Alzheimers Dis. 2021 Jun 17. pii: JAD210516. doi: 10.3233/JAD-210516.
    PubMed     Abstract available


  680. MITOLO M, Stanzani-Maserati M, Manners DN, Capellari S, et al
    The Combination of Metabolic Posterior Cingulate Cortical Abnormalities and Structural Asymmetries Improves the Differential Diagnosis Between Primary Progressive Aphasia and Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jun 17. pii: JAD210211. doi: 10.3233/JAD-210211.
    PubMed     Abstract available


  681. TARGUM SD, Fosdick L, Drake KE, Rosenberg PB, et al
    Effect of Age on Clinical Trial Outcome in Participants with Probable Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jun 16. pii: JAD210530. doi: 10.3233/JAD-210530.
    PubMed     Abstract available


  682. BAHAR B, Kanagasingam S, Tambuwala MM, Aljabali AAA, et al
    Porphyromonas gingivalis (W83) Infection Induces Alzheimer's Disease-Like Pathophysiology in Obese and Diabetic Mice.
    J Alzheimers Dis. 2021 Jun 16. pii: JAD210465. doi: 10.3233/JAD-210465.
    PubMed     Abstract available


  683. FRANCOIS M, Karpe A, Liu JW, Beale D, et al
    Salivaomics as a Potential Tool for Predicting Alzheimer's Disease During the Early Stages of Neurodegeneration.
    J Alzheimers Dis. 2021 Jun 15. pii: JAD210283. doi: 10.3233/JAD-210283.
    PubMed     Abstract available


  684. AKUSHEVICH I, Yashkin AP, Kravchenko J, Yashin AI, et al
    Analysis of Time Trends in Alzheimer's Disease and Related Dementias Using Partitioning Approach.
    J Alzheimers Dis. 2021 Jun 15. pii: JAD210273. doi: 10.3233/JAD-210273.
    PubMed     Abstract available


  685. PAULO SL, Ribeiro-Rodrigues L, Rodrigues RS, Mateus JM, et al
    Sustained Hippocampal Neural Plasticity Questions the Reproducibility of an Amyloid-beta-Induced Alzheimer's Disease Model.
    J Alzheimers Dis. 2021 Jun 15. pii: JAD201567. doi: 10.3233/JAD-201567.
    PubMed     Abstract available


  686. FERNANDEZ G, Parra MA
    Oculomotor Behaviors and Integrative Memory Functions in the Alzheimer's Clinical Syndrome.
    J Alzheimers Dis. 2021 Jun 15. pii: JAD201189. doi: 10.3233/JAD-201189.
    PubMed     Abstract available


  687. ESPAY AJ, Sturchio A, Schneider LS, Ezzat K, et al
    Soluble Amyloid-beta Consumption in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jun 12. pii: JAD210415. doi: 10.3233/JAD-210415.
    PubMed     Abstract available


  688. QU M, Shi H, Wang K, Wang X, et al
    The Associations of Plasma/Serum Carotenoids with Alzheimer's Disease: A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2021 Jun 12. pii: JAD210384. doi: 10.3233/JAD-210384.
    PubMed     Abstract available


  689. LOURENCO MV, Ribeiro FC, Santos LE, Beckman D, et al
    Cerebrospinal Fluid Neurotransmitters, Cytokines, and Chemokines in Alzheimer's and Lewy Body Diseases.
    J Alzheimers Dis. 2021 Jun 12. pii: JAD210147. doi: 10.3233/JAD-210147.
    PubMed     Abstract available


  690. WANG ZT, Li KY, Tan CC, Xu W, et al
    Associations of Alcohol Consumption with Cerebrospinal Fluid Biomarkers of Alzheimer's Disease Pathology in Cognitively Intact Older Adults: The CABLE Study.
    J Alzheimers Dis. 2021 Jun 12. pii: JAD210140. doi: 10.3233/JAD-210140.
    PubMed     Abstract available


  691. BABILONI C, Ferri R, Noce G, Lizio R, et al
    Resting State Alpha Electroencephalographic Rhythms Are Differently Related to Aging in Cognitively Unimpaired Seniors and Patients with Alzheimer's Disease and Amnesic Mild Cognitive Impairment.
    J Alzheimers Dis. 2021 Jun 12. pii: JAD201271. doi: 10.3233/JAD-201271.
    PubMed     Abstract available


  692. CASTILLO-MENDIETA T, Arana-Lechuga Y, Campos-Pena V, Sosa AL, et al
    Plasma Levels of Amyloid-beta Peptides and Tau Protein in Mexican Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jun 11. pii: JAD200912. doi: 10.3233/JAD-200912.
    PubMed     Abstract available


  693. SERRA L, D'Amelio M, Esposito S, Domenico CD, et al
    Ventral Tegmental Area Disconnection Contributes Two Years Early to Correctly Classify Patients Converted to Alzheimer's Disease: Implications for Treatment.
    J Alzheimers Dis. 2021 Jun 9. pii: JAD210171. doi: 10.3233/JAD-210171.
    PubMed     Abstract available


  694. DARMANTHE N, Tabatabaei-Jafari H, Cherbuin N
    Combination of Plasma Neurofilament Light Chain and Mini-Mental State Examination Score Predicts Progression from Mild Cognitive Impairment to Alzheimer's Disease within 5 Years.
    J Alzheimers Dis. 2021 Jun 9. pii: JAD210092. doi: 10.3233/JAD-210092.
    PubMed     Abstract available


  695. KVELLO-ALME M, Brathen G, White LR, Sando SB, et al
    Time to Diagnosis in Young Onset Alzheimer's Disease: A Population-Based Study from Central Norway.
    J Alzheimers Dis. 2021 Jun 9. pii: JAD210090. doi: 10.3233/JAD-210090.
    PubMed     Abstract available


  696. SAMARA M, Levine SZ, Yoshida K, Goldberg Y, et al
    Linking the Clinical Dementia Rating Scale-Sum of Boxes, the Clinician's Interview-Based Impression Plus Caregiver Input, and the Clinical Global Impression Scale: Evidence based on Individual Participant Data from Five Randomized Clinical Trials of D
    J Alzheimers Dis. 2021 Jun 9. pii: JAD201541. doi: 10.3233/JAD-201541.
    PubMed     Abstract available


  697. RICHARD CHEN X, Shao Y, Sadowski MJ
    Segmented Linear Mixed Model Analysis Reveals Association of the APOEvarepsilon4 Allele with Faster Rate of Alzheimer's Disease Dementia Progression.
    J Alzheimers Dis. 2021 Jun 7. pii: JAD210434. doi: 10.3233/JAD-210434.
    PubMed     Abstract available


  698. COVATTI MALCORRA BL, Mota NB, Weissheimer J, Schilling LP, et al
    Low Speech Connectedness in Alzheimer's Disease is Associated with Poorer Semantic Memory Performance.
    J Alzheimers Dis. 2021 Jun 7. pii: JAD210134. doi: 10.3233/JAD-210134.
    PubMed     Abstract available


  699. VECCHIO F, Miraglia F, Alu F, Orticoni A, et al
    Contribution of Graph Theory Applied to EEG Data Analysis for Alzheimer's Disease versus Vascular Dementia Diagnosis.
    J Alzheimers Dis. 2021 Jun 3. pii: JAD210394. doi: 10.3233/JAD-210394.
    PubMed     Abstract available


  700. SCHOEMAKER D, Velilla L, Zuluaga Y, Baena A, et al
    Global Cardiovascular Risk Profile and Cerebrovascular Abnormalities in Presymptomatic Individuals with CADASIL or Autosomal Dominant Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jun 3. pii: JAD210313. doi: 10.3233/JAD-210313.
    PubMed     Abstract available


  701. ZHAO X, Li C, Ding G, Heng Y, et al
    The Burden of Alzheimer's Disease Mortality in the United States, 1999-2018.
    J Alzheimers Dis. 2021 Jun 3. pii: JAD210225. doi: 10.3233/JAD-210225.
    PubMed     Abstract available


  702. SPERA V, Sitnikova T, Ward MJ, Farzam P, et al
    Pilot Study on Dose-Dependent Effects of Transcranial Photobiomodulation on Brain Electrical Oscillations: A Potential Therapeutic Target in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jun 3. pii: JAD210058. doi: 10.3233/JAD-210058.
    PubMed     Abstract available


  703. BEN AYED I, Castor-Guyonvarch N, Amimour S, Naija S, et al
    Acute Exercise and Cognitive Function in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jun 1. pii: JAD201317. doi: 10.3233/JAD-201317.
    PubMed     Abstract available


  704. GRECO FA, McKee AC, Kowall NW, Hanlon EB, et al
    Near-Infrared Optical Spectroscopy In Vivo Distinguishes Subjects with Alzheimer's Disease from Age-Matched Controls.
    J Alzheimers Dis. 2021 Jun 1. pii: JAD201021. doi: 10.3233/JAD-201021.
    PubMed     Abstract available


    May 2021
  705. JIN N, Babiloni C, Drinkenburg WH, Hajos M, et al
    Recommendations for Preclinical Testing of Treatments Against Alzheimer's Disease-Related Epileptiform Spikes in Transgenic Rodent Models.
    J Alzheimers Dis. 2021 May 29. pii: JAD210209. doi: 10.3233/JAD-210209.
    PubMed     Abstract available


  706. DELAZER M, Zamarian L, Djamshidian A
    Handwriting in Alzheimer's Disease.
    J Alzheimers Dis. 2021 May 28. pii: JAD210279. doi: 10.3233/JAD-210279.
    PubMed     Abstract available


  707. JEONG W, Joo JH, Kim H, Kim YK, et al
    Association Between the Use of Hypnotics and the Risk of Alzheimer's Disease.
    J Alzheimers Dis. 2021 May 27. pii: JAD201319. doi: 10.3233/JAD-201319.
    PubMed     Abstract available


  708. BABIC LEKO M, Jurasovic J, Nikolac Perkovic M, Spanic E, et al
    The Association of Essential Metals with APOE Genotype in Alzheimer's Disease.
    J Alzheimers Dis. 2021 May 27. pii: JAD210158. doi: 10.3233/JAD-210158.
    PubMed     Abstract available


  709. WEI W, Liu Y, Dai C, Baazaoui N, et al
    Neurotrophic Treatment Initiated During Early Postnatal Development Prevents the Alzheimer-Like Behavior and Synaptic Dysfunction.
    J Alzheimers Dis. 2021 May 27. pii: JAD201599. doi: 10.3233/JAD-201599.
    PubMed     Abstract available


  710. THOMSEN BB, Madsen C, Krohn KT, Thygesen C, et al
    Mild Microglial Responses in the Cortex and Perivascular Macrophage Infiltration in Subcortical White Matter in Dogs with Age-Related Dementia Modelling Prodromal Alzheimer's Disease.
    J Alzheimers Dis. 2021 May 26. pii: JAD210040. doi: 10.3233/JAD-210040.
    PubMed     Abstract available


  711. KING-ROBSON J, Wilson H, Politis M
    Associations Between Amyloid and Tau Pathology, and Connectome Alterations, in Alzheimer's Disease and Mild Cognitive Impairment.
    J Alzheimers Dis. 2021 May 22. pii: JAD201457. doi: 10.3233/JAD-201457.
    PubMed     Abstract available


  712. BARRIO JR, Whitehouse P, Alavi A, Hoilund-Carlsen PF, et al
    New IDEAS Amyloid Imaging 2021 Study: Running in Place with Ineffective Anti-Amyloid Treatments for Alzheimer's Disease Patients.
    J Alzheimers Dis. 2021 May 20. pii: JAD210383. doi: 10.3233/JAD-210383.
    PubMed    


  713. LI X, Tian Y, Yang YX, Ma YH, et al
    Life Course Adiposity and Alzheimer's Disease: A Mendelian Randomization Study.
    J Alzheimers Dis. 2021 May 20. pii: JAD210345. doi: 10.3233/JAD-210345.
    PubMed     Abstract available


  714. LAURIOLA M, D'Onofrio G, Ciccone F, Germano C, et al
    Relationship of Homocysteine Plasma Levels with Mild Cognitive Impairment, Alzheimer's Disease, Vascular Dementia, Psychobehavioral, and Functional Complications.
    J Alzheimers Dis. 2021 May 20. pii: JAD210166. doi: 10.3233/JAD-210166.
    PubMed     Abstract available


  715. YANG H, Luo Y, Hu Q, Tian X, et al
    Benefits in Alzheimer's Disease of Sensory and Multisensory Stimulation.
    J Alzheimers Dis. 2021 May 20. pii: JAD201554. doi: 10.3233/JAD-201554.
    PubMed     Abstract available


  716. BARTHELSON K, Dong Y, Newman M, Lardelli M, et al
    PRESENILIN 1 Mutations Causing Early-Onset Familial Alzheimer's Disease or Familial Acne Inversa Differ in Their Effects on Genes Facilitating Energy Metabolism and Signal Transduction.
    J Alzheimers Dis. 2021 May 19. pii: JAD210128. doi: 10.3233/JAD-210128.
    PubMed     Abstract available


  717. HAN H, Wang F, Chen J, Li X, et al
    Changes in Biothiol Levels Are Closely Associated with Alzheimer's Disease.
    J Alzheimers Dis. 2021 May 19. pii: JAD210021. doi: 10.3233/JAD-210021.
    PubMed     Abstract available



  718. Cognition at Each Stage of Lewy Body Disease with Co-occurring Alzheimer's Disease Pathology.
    J Alzheimers Dis. 2021 May 18. pii: JAD219004. doi: 10.3233/JAD-219004.
    PubMed    


  719. FERNANDEZ-AGUILAR L, Lora Y, Satorres E, Ros L, et al
    Dimensional and Discrete Emotional Reactivity in Alzheimer's Disease: Film Clips as a Research Tool in Dementia.
    J Alzheimers Dis. 2021 May 18. pii: JAD210233. doi: 10.3233/JAD-210233.
    PubMed     Abstract available


  720. RODRIGO-HERRERO S, Luque-Tirado A, Mendez-Barrio C, Garcia-Solis D, et al
    TMA-93 Validation by Alzheimer's Disease Biomarkers: A Comparison with the Free and Cued Selective Reminding Test on a Biobank Sample.
    J Alzheimers Dis. 2021 May 18. pii: JAD210115. doi: 10.3233/JAD-210115.
    PubMed     Abstract available


  721. PISTONO A, Senoussi M, Guerrier L, Rafiq M, et al
    Language Network Connectivity Increases in Early Alzheimer's Disease.
    J Alzheimers Dis. 2021 May 18. pii: JAD201584. doi: 10.3233/JAD-201584.
    PubMed     Abstract available


  722. BERNSTEIN AS, Rapcsak SZ, Hornberger M, Saranathan M, et al
    Structural Changes in Thalamic Nuclei Across Prodromal and Clinical Alzheimer's Disease.
    J Alzheimers Dis. 2021 May 18. pii: JAD201583. doi: 10.3233/JAD-201583.
    PubMed     Abstract available


  723. MAO C, Sha L, Li J, Huang X, et al
    Relationship Between General Cognition, Visual Assessed Cortical Atrophy, and Cerebrospinal Fluid Biomarkers in Alzheimer's Disease: A Cross-Sectional Study from a Chinese PUMCH Cohort.
    J Alzheimers Dis. 2021 May 16. pii: JAD210344. doi: 10.3233/JAD-210344.
    PubMed     Abstract available


  724. DUAN W, Zhou GD, Balachandrasekaran A, Bhumkar AB, et al
    Cerebral Blood Flow Predicts Conversion of Mild Cognitive Impairment into Alzheimer's Disease and Cognitive Decline: An Arterial Spin Labeling Follow-up Study.
    J Alzheimers Dis. 2021 May 16. pii: JAD210199. doi: 10.3233/JAD-210199.
    PubMed     Abstract available


  725. JIMENEZ EC, Sierra-Marcos A, Romeo A, Hashemi A, et al
    Altered Vergence Eye Movements and Pupil Response of Patients with Alzheimer's Disease and Mild Cognitive Impairment During an Oddball Task.
    J Alzheimers Dis. 2021 May 16. pii: JAD201301. doi: 10.3233/JAD-201301.
    PubMed     Abstract available


  726. ALVES SS, Silva-Junior RMPD, Servilha-Menezes G, Homolak J, et al
    Insulin Resistance as a Common Link Between Current Alzheimer's Disease Hypotheses.
    J Alzheimers Dis. 2021 May 15. pii: JAD210234. doi: 10.3233/JAD-210234.
    PubMed     Abstract available


  727. YIN X, Xie Q, Huang L, Liu L, et al
    Assessment of the Psychological Burden Among Family Caregivers of People Living with Alzheimer's Disease Using the Zarit Burden Interview.
    J Alzheimers Dis. 2021 May 15. pii: JAD210025. doi: 10.3233/JAD-210025.
    PubMed     Abstract available


  728. DU F, Yu Q, Yan SS
    PINK1 Activation Attenuates Impaired Neuronal-Like Differentiation and Synaptogenesis and Mitochondrial Dysfunction in Alzheimer's Disease Trans-Mitochondrial Cybrid Cells.
    J Alzheimers Dis. 2021 May 14. pii: JAD210095. doi: 10.3233/JAD-210095.
    PubMed     Abstract available


  729. YE F, Wu A
    The Protective Mechanism of SIRT1 in the Regulation of Mitochondrial Biogenesis and Mitochondrial Autophagy in Alzheimer's Disease.
    J Alzheimers Dis. 2021 May 11. pii: JAD210132. doi: 10.3233/JAD-210132.
    PubMed     Abstract available


  730. MASSETT HA, Mitchell AK, Alley L, Simoneau E, et al
    Facilitators, Challenges, and Messaging Strategies for Hispanic/Latino Populations Participating in Alzheimer's Disease and Related Dementias Clinical Research: A Literature Review.
    J Alzheimers Dis. 2021 May 11. pii: JAD201463. doi: 10.3233/JAD-201463.
    PubMed     Abstract available


  731. OU GY, Lin WW, Zhao WJ
    Construction of Long Noncoding RNA-Associated ceRNA Networks Reveals Potential Biomarkers in Alzheimer's Disease.
    J Alzheimers Dis. 2021 May 11. pii: JAD210068. doi: 10.3233/JAD-210068.
    PubMed     Abstract available


  732. CAMARGO A, Wang Z
    Longitudinal Cerebral Blood Flow Changes in Normal Aging and the Alzheimer's Disease Continuum Identified by Arterial Spin Labeling MRI.
    J Alzheimers Dis. 2021 May 5. pii: JAD210116. doi: 10.3233/JAD-210116.
    PubMed     Abstract available


  733. DU Y, Dennis B, Liu J, Meyer K, et al
    A Conceptual Model to Improve Care for Individuals with Alzheimer's Disease and Related Dementias and Their Caregivers: Qualitative Findings in an Online Caregiver Forum.
    J Alzheimers Dis. 2021 May 3. pii: JAD210167. doi: 10.3233/JAD-210167.
    PubMed     Abstract available


  734. HANNESTAD J, Duclos T, Chao W, Koborsi K, et al
    Safety and Tolerability of GRF6019 Infusions in Severe Alzheimer's Disease: A Phase II Double-Blind Placebo-Controlled Trial.
    J Alzheimers Dis. 2021 May 3. pii: JAD210011. doi: 10.3233/JAD-210011.
    PubMed     Abstract available


    April 2021
  735. SERPENTE M, Fenoglio C, Arighi A, Fumagalli GG, et al
    Analysis of C9orf72 Intermediate Alleles in a Retrospective Cohort of Neurological Patients: Risk Factors for Alzheimer's Disease?
    J Alzheimers Dis. 2021 Apr 28. pii: JAD210249. doi: 10.3233/JAD-210249.
    PubMed     Abstract available


  736. SOMAA F
    A Review of the Application of Hyperbaric Oxygen Therapy in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Apr 28. pii: JAD210157. doi: 10.3233/JAD-210157.
    PubMed     Abstract available


  737. SMIRNI D, Oliveri M, Misuraca E, Catania A, et al
    Verbal Fluency in Mild Alzheimer's Disease: Transcranial Direct Current Stimulation over the Dorsolateral Prefrontal Cortex.
    J Alzheimers Dis. 2021 Apr 28. pii: JAD210003. doi: 10.3233/JAD-210003.
    PubMed     Abstract available


  738. DE LA FUENTE M
    The Role of the Microbiota-Gut-Brain Axis in the Health and Illness Condition: A Focus on Alzheimer's Disease.
    J Alzheimers Dis. 2021 Apr 28. pii: JAD201587. doi: 10.3233/JAD-201587.
    PubMed     Abstract available


  739. BERTRAND E, van Duinkerken E, Laks J, Dourado MCN, et al
    Structural Gray and White Matter Correlates of Awareness in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Apr 28. pii: JAD201246. doi: 10.3233/JAD-201246.
    PubMed     Abstract available


  740. DE OLIVEIRA FF, Miraldo MC, de Castro-Neto EF, de Almeida SS, et al
    Associations of Neuropsychiatric Features with Cerebrospinal Fluid Biomarkers of Amyloidogenesis and Neurodegeneration in Dementia with Lewy Bodies Compared with Alzheimer's Disease and Cognitively Healthy People.
    J Alzheimers Dis. 2021 Apr 27. pii: JAD210272. doi: 10.3233/JAD-210272.
    PubMed     Abstract available


  741. PLACIDO J, Ferreira JV, Araujo J, de Oliveira Silva F, et al
    Beyond the Mini-Mental State Examination: The Use of Physical and Spatial Navigation Tests to Help to Screen for Mild Cognitive Impairment and Alzheimer's Disease.
    J Alzheimers Dis. 2021 Apr 27. pii: JAD210106. doi: 10.3233/JAD-210106.
    PubMed     Abstract available


  742. GUZMAN-MARTINEZ L, Farias GA, Tapia JP, Sanchez MP, et al
    Interventional Study to Evaluate the Clinical Effects and Safety of the Nutraceutical Compound BrainUp-10(R) in a Cohort of Patients with Alzheimer's Disease: A Multicenter, Randomized, Double-Blind, and Placebo-Controlled Trial.
    J Alzheimers Dis. 2021 Apr 27. pii: JAD201501. doi: 10.3233/JAD-201501.
    PubMed     Abstract available


  743. ZUPANIC E, von Euler M, Winblad B, Xu H, et al
    Mortality After Ischemic Stroke in Patients with Alzheimer's Disease Dementia and Other Dementia Disorders.
    J Alzheimers Dis. 2021 Apr 27. pii: JAD201459. doi: 10.3233/JAD-201459.
    PubMed     Abstract available


  744. LIN Y, Zeng Q, Hu M, Peng G, et al
    Temporal Dynamic Changes of Intrinsic Brain Activity Associated with Cognitive Reserve in Prodromal Alzheimer's Disease.
    J Alzheimers Dis. 2021 Apr 27. pii: JAD201244. doi: 10.3233/JAD-201244.
    PubMed     Abstract available


  745. XU L, Li T, Xiong L, Wang X, et al
    Reliability and Validity of the Chinese Version of Mild Behavioral Impairment Checklist in Mild Cognitive Impairment and Mild Alzheimer's Disease.
    J Alzheimers Dis. 2021 Apr 26. pii: JAD210098. doi: 10.3233/JAD-210098.
    PubMed     Abstract available


  746. REN D, Lopez OL, Lingler JH, Conley Y, et al
    Association Between the APOEvarepsilon2/varepsilon4 Genotype and Alzheimer's Disease and Mild Cognitive Impairment Among African Americans.
    J Alzheimers Dis. 2021 Apr 26. pii: JAD201613. doi: 10.3233/JAD-201613.
    PubMed     Abstract available


  747. HAJ ME, Moustafa AA, Gallouj K
    Higher Depression of Patients with Alzheimer's Disease During than Before the Lockdown.
    J Alzheimers Dis. 2021 Apr 21. pii: JAD210190. doi: 10.3233/JAD-210190.
    PubMed     Abstract available


  748. NERG O, Junkkari A, Hallikainen I, Rauramaa T, et al
    The CERAD Neuropsychological Battery in Patients with Idiopathic Normal Pressure Hydrocephalus Compared with Normal Population and Patients with Mild Alzheimer's Disease.
    J Alzheimers Dis. 2021 Apr 21. pii: JAD201363. doi: 10.3233/JAD-201363.
    PubMed     Abstract available


  749. SZEGECZKI V, Perenyi H, Horvath G, Hinnah B, et al
    Physical Training Inhibits the Fibrosis Formation in Alzheimer's Disease Kidney Influencing the TGFbeta Signaling Pathways.
    J Alzheimers Dis. 2021 Apr 19. pii: JAD201206. doi: 10.3233/JAD-201206.
    PubMed     Abstract available


  750. GOTTESMAN RT, Kociolek A, Fernandez K, Cosentino S, et al
    Association Between Early Psychotic Symptoms and Alzheimer's Disease Prognosis in a Community-Based Cohort.
    J Alzheimers Dis. 2021 Apr 19. pii: JAD200729. doi: 10.3233/JAD-200729.
    PubMed     Abstract available



  751. Erratum Why Inclusion Matters for Alzheimer's Disease Biomarker Discovery in Plasma.
    J Alzheimers Dis. 2021 Apr 5. pii: JAD219318. doi: 10.3233/JAD-219318.
    PubMed    


  752. FELDMAN R
    Physicians Treating Alzheimer's Disease Patients Should Be Aware that Televised Direct-to-Consumer Advertising Links More Strongly to Drug Utilization in Older Patients.
    J Alzheimers Dis. 2021 Apr 5. pii: JAD210294. doi: 10.3233/JAD-210294.
    PubMed     Abstract available


  753. LI J, Bur AM, Villwock MR, Shankar S, et al
    Olfactory Phenotypes Differentiate Cognitively Unimpaired Seniors from Alzheimer's Disease and Mild Cognitive Impairment: A Combined Machine Learning and Traditional Statistical Approach.
    J Alzheimers Dis. 2021 Apr 5. pii: JAD210175. doi: 10.3233/JAD-210175.
    PubMed     Abstract available


  754. NORINS LC
    Repurposing Licensed Drugs for Use Against Alzheimer's Disease.
    J Alzheimers Dis. 2021 Apr 5. pii: JAD210080. doi: 10.3233/JAD-210080.
    PubMed     Abstract available


  755. SAKURAI K, Kaneda D, Inui S, Uchida Y, et al
    Simple Quantitative Indices for the Differentiation of Advanced-Stage Alzheimer's Disease and Other Limbic Tauopathies.
    J Alzheimers Dis. 2021 Apr 5. pii: JAD210043. doi: 10.3233/JAD-210043.
    PubMed     Abstract available


  756. MULLER L, Kirschstein T, Kohling R, Kuhla A, et al
    Neuronal Hyperexcitability in APPSWE/PS1dE9 Mouse Models of Alzheimer's Disease.
    J Alzheimers Dis. 2021 Apr 5. pii: JAD201540. doi: 10.3233/JAD-201540.
    PubMed     Abstract available


  757. BEUCKMANN CT, Suzuki H, Musiek ES, Ueno T, et al
    Evaluation of SAMP8 Mice as a Model for Sleep-Wake and Rhythm Disturbances Associated with Alzheimer's Disease: Impact of Treatment with the Dual Orexin (Hypocretin) Receptor Antagonist Lemborexant.
    J Alzheimers Dis. 2021 Apr 5. pii: JAD201054. doi: 10.3233/JAD-201054.
    PubMed     Abstract available


  758. EEZA MNH, Singer R, Hofling C, Matysik J, et al
    Metabolic Profiling of Suprachiasmatic Nucleus Reveals Multifaceted Effects in an Alzheimer's Disease Mouse Model.
    J Alzheimers Dis. 2021 Apr 3. pii: JAD201575. doi: 10.3233/JAD-201575.
    PubMed     Abstract available


  759. HALMINEN O, Vesikansa A, Mehtala J, Horhammer I, et al
    Early Start of Anti-Dementia Medication Delays Transition to 24-Hour Care in Alzheimer's Disease Patients: A Finnish Nationwide Cohort Study.
    J Alzheimers Dis. 2021 Apr 3. pii: JAD201502. doi: 10.3233/JAD-201502.
    PubMed     Abstract available


  760. TSAMOU M, Pistollato F, Roggen EL
    A Tau-Driven Adverse Outcome Pathway Blueprint Toward Memory Loss in Sporadic (Late-Onset) Alzheimer's Disease with Plausible Molecular Initiating Event Plug-Ins for Environmental Neurotoxicants.
    J Alzheimers Dis. 2021 Apr 3. pii: JAD201418. doi: 10.3233/JAD-201418.
    PubMed     Abstract available


  761. HASHIMOTO M, Ho G, Sugama S, Takenouchi T, et al
    Possible Role of Activin in the Adiponectin Paradox-Induced Progress of Alzheimer's Disease.
    J Alzheimers Dis. 2021 Apr 2. pii: JAD210206. doi: 10.3233/JAD-210206.
    PubMed     Abstract available


  762. MARRA C, Piccininni C, Iacobucci GM, Caprara A, et al
    Semantic Memory as an Early Cognitive Marker of Alzheimer's Disease: Role of Category and Phonological Verbal Fluency Tasks.
    J Alzheimers Dis. 2021 Apr 2. pii: JAD201452. doi: 10.3233/JAD-201452.
    PubMed     Abstract available


  763. O'BRYANT S, Zhang F, Petersen M, Johnson L, et al
    A Precision Medicine Approach to Treating Alzheimer's Disease Using Rosiglitazone Therapy: A Biomarker Analysis of the REFLECT Trials.
    J Alzheimers Dis. 2021 Apr 1. pii: JAD201610. doi: 10.3233/JAD-201610.
    PubMed     Abstract available


  764. BOSTROM G, Freyhult E, Virhammar J, Alcolea D, et al
    Different Inflammatory Signatures in Alzheimer's Disease and Frontotemporal Dementia Cerebrospinal Fluid.
    J Alzheimers Dis. 2021 Apr 1. pii: JAD201565. doi: 10.3233/JAD-201565.
    PubMed     Abstract available


  765. ZHOU Y, Wang Y, Quan M, Zhao H, et al
    Gut Microbiota Changes and Their Correlation with Cognitive and Neuropsychiatric Symptoms in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Apr 1. pii: JAD201497. doi: 10.3233/JAD-201497.
    PubMed     Abstract available


  766. ZHENG YM, Zhao YY, Zhang T, Hou XH, et al
    Left Ventricular Ejection Fraction and Cerebrospinal Fluid Biomarkers of Alzheimer's Disease Pathology in Cognitively Normal Older Adults: The CABLE Study.
    J Alzheimers Dis. 2021 Apr 1. pii: JAD201222. doi: 10.3233/JAD-201222.
    PubMed     Abstract available


  767. AITKEN WW, Lombard J, Wang K, Toro M, et al
    Relationship of Neighborhood Greenness to Alzheimer's Disease and Non-Alzheimer's Dementia Among 249,405 U.S. Medicare Beneficiaries.
    J Alzheimers Dis. 2021 Apr 1. pii: JAD201179. doi: 10.3233/JAD-201179.
    PubMed     Abstract available


    March 2021
  768. QIU H, Zhao R, Fei G, Pan X, et al
    Dynamic Change of Intracellular Metabolism of Microglia Evaluated by Transcriptomics in an Alzheimer's Mouse Model.
    J Alzheimers Dis. 2021 Mar 30. pii: JAD210213. doi: 10.3233/JAD-210213.
    PubMed     Abstract available


  769. PILLAI JA, Bena J, Bekris LM, Foldvary-Schaefer N, et al
    Unique Sleep and Circadian Rhythm Dysfunction Neuroinflammatory and Immune Profiles in Alzheimer's Disease with Mild Cognitive Impairment.
    J Alzheimers Dis. 2021 Mar 30. pii: JAD201573. doi: 10.3233/JAD-201573.
    PubMed     Abstract available


  770. LI LL, Ma YH, Bi YL, Sun FR, et al
    Serum Uric Acid May Aggravate Alzheimer's Disease Risk by Affecting Amyloidosis in Cognitively Intact Older Adults: The CABLE Study.
    J Alzheimers Dis. 2021 Mar 30. pii: JAD201192. doi: 10.3233/JAD-201192.
    PubMed     Abstract available


  771. FENG LIU Q, Kanmani S, Lee J, Kim GW, et al
    Neoline Improves Memory Impairment and Reduces Amyloid-beta Level and Tau Phosphorylation Through AMPK Activation in the Mouse Alzheimer's Disease Model.
    J Alzheimers Dis. 2021 Mar 26. pii: JAD201614. doi: 10.3233/JAD-201614.
    PubMed     Abstract available


  772. TEITSDOTTIR UD, Halldorsson S, Rolfsson O, Lund SH, et al
    Cerebrospinal Fluid C18 Ceramide Associates with Markers of Alzheimer's Disease and Inflammation at the Pre- and Early Stages of Dementia.
    J Alzheimers Dis. 2021 Mar 25. pii: JAD200964. doi: 10.3233/JAD-200964.
    PubMed     Abstract available


  773. IKEDA S, Mimura M, Ikeda M, Wada-Isoe K, et al
    Economic Burden of Alzheimer's Disease Dementia in Japan.
    J Alzheimers Dis. 2021 Mar 23. pii: JAD210075. doi: 10.3233/JAD-210075.
    PubMed     Abstract available


  774. MORRIS R, Luboff H, Jose RP, Eckhoff K, et al
    Bradycardia Due to Donepezil in Adults: Systematic Analysis of FDA Adverse Event Reporting System.
    J Alzheimers Dis. 2021 Mar 23. pii: JAD201551. doi: 10.3233/JAD-201551.
    PubMed     Abstract available


  775. DOUROS A, Santella C, Dell'Aniello S, Azoulay L, et al
    Infectious Disease Burden and the Risk of Alzheimer's Disease: A Population-Based Study.
    J Alzheimers Dis. 2021 Mar 23. pii: JAD201534. doi: 10.3233/JAD-201534.
    PubMed     Abstract available


  776. ASHIZAWA T, Igarashi A, Sakata Y, Azuma M, et al
    Impact of the Severity of Alzheimer's Disease on the Quality of Life, Activities of Daily Living, and Caregiving Costs for Institutionalized Patients on Anti-Alzheimer Medications in Japan.
    J Alzheimers Dis. 2021 Mar 23. pii: JAD201514. doi: 10.3233/JAD-201514.
    PubMed     Abstract available


  777. KLEIMAN MJ, Barenholtz E, Galvin JE
    Screening for Early-Stage Alzheimer's Disease Using Optimized Feature Sets and Machine Learning.
    J Alzheimers Dis. 2021 Mar 23. pii: JAD201377. doi: 10.3233/JAD-201377.
    PubMed     Abstract available


  778. WONG D, Broberg DN, Doad J, Umoh JU, et al
    Effect of Memantine Treatment and Combination with Vitamin D Supplementation on Body Composition in the APP/PS1 Mouse Model of Alzheimer's Disease Following Chronic Vitamin D Deficiency.
    J Alzheimers Dis. 2021 Mar 22. pii: JAD201137. doi: 10.3233/JAD-201137.
    PubMed     Abstract available


  779. ASTROM DO, Adolfsson R, Segersson D, Forsberg B, et al
    Local Contrasts in Concentration of Ambient Particulate Air Pollution (PM2.5) and Incidence of Alzheimer's Disease and Dementia: Results from the Betula Cohort in Northern Sweden.
    J Alzheimers Dis. 2021 Mar 18. pii: JAD201538. doi: 10.3233/JAD-201538.
    PubMed     Abstract available



  780. Quantifying and Describing the Natural History and Costs of Alzheimer's Disease and Effects of Hypothetical Interventions.
    J Alzheimers Dis. 2021 Mar 16. pii: JAD219002. doi: 10.3233/JAD-219002.
    PubMed    


  781. NI R, Rojdner J, Voytenko L, Dyrks T, et al
    In vitro Characterization of the Regional Binding Distribution of Amyloid PET Tracer Florbetaben and the Glia Tracers Deprenyl and PK1195 in Autopsy Alzheimer's Brain Tissue.
    J Alzheimers Dis. 2021 Mar 16. pii: JAD201344. doi: 10.3233/JAD-201344.
    PubMed     Abstract available


  782. FONSECA LM, Mattar GP, Haddad GG, Ekaterina B, et al
    Neuropsychiatric Symptoms of Alzheimer's Disease in Down Syndrome and Its Impact on Caregiver Distress.
    J Alzheimers Dis. 2021 Mar 16. pii: JAD201009. doi: 10.3233/JAD-201009.
    PubMed     Abstract available


  783. GAUDREAULT R, Herve V, van de Ven TGM, Mousseau N, et al
    Polyphenol-Peptide Interactions in Mitigation of Alzheimer's Disease: Role of Biosurface-Induced Aggregation.
    J Alzheimers Dis. 2021 Mar 15. pii: JAD201549. doi: 10.3233/JAD-201549.
    PubMed     Abstract available


  784. MA YH, Wang YY, Tan L, Xu W, et al
    Social Networks and Cerebrospinal Fluid Biomarkers of Alzheimer's Disease Pathology in Cognitively Intact Older Adults: The CABLE Study.
    J Alzheimers Dis. 2021 Mar 15. pii: JAD201426. doi: 10.3233/JAD-201426.
    PubMed     Abstract available


  785. ARAYA J, Bello F, Shivashankar G, Neira D, et al
    Retinal Ganglion Cells Functional Changes in a Mouse Model of Alzheimer's Disease Are Linked with Neurotransmitter Alterations.
    J Alzheimers Dis. 2021 Mar 13. pii: JAD201195. doi: 10.3233/JAD-201195.
    PubMed     Abstract available


  786. YANG J, Jia L, Li Y, Qiu Q, et al
    Fluid Biomarkers in Clinical Trials for Alzheimer's Disease: Current and Future Application.
    J Alzheimers Dis. 2021 Mar 13. pii: JAD201068. doi: 10.3233/JAD-201068.
    PubMed     Abstract available


  787. MIRANDA A, Montiel E, Ulrich H, Paz C, et al
    Selective Secretase Targeting for Alzheimer's Disease Therapy.
    J Alzheimers Dis. 2021 Mar 13. pii: JAD201027. doi: 10.3233/JAD-201027.
    PubMed     Abstract available


  788. DIAS IHK, Griffiths HR
    Current and Future Directions for Targeting Lipoxin A4 in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Mar 11. pii: JAD210121. doi: 10.3233/JAD-210121.
    PubMed     Abstract available


  789. TONG Q, Chen L
    Associations of Alzheimer's Disease Neuropathologic Changes with Clinical Presentations of Parkinson's Disease.
    J Alzheimers Dis. 2021 Mar 11. pii: JAD210114. doi: 10.3233/JAD-210114.
    PubMed     Abstract available


  790. VALOTASSIOU V, Sifakis N, Tzavara C, Lykou E, et al
    Eating Disorders in Frontotemporal Dementia and Alzheimer's Disease: Evaluation of Brain Perfusion Correlates Using 99mTc-HMPAO SPECT with Brodmann Areas Analysis.
    J Alzheimers Dis. 2021 Mar 10. pii: JAD201434. doi: 10.3233/JAD-201434.
    PubMed     Abstract available


  791. DRAKE JD, Chambers AB, Ott BR, Daiello LA, et al
    Peripheral Markers of Vascular Endothelial Dysfunction Show Independent but Additive Relationships with Brain-Based Biomarkers in Association with Functional Impairment in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Mar 10. pii: JAD200759. doi: 10.3233/JAD-200759.
    PubMed     Abstract available


  792. TASLIMA F, Jung CG, Zhou C, Abdelhamid M, et al
    Tooth Loss Induces Memory Impairment and Gliosis in App Knock-In Mouse Models of Alzheimer's Disease.
    J Alzheimers Dis. 2021 Mar 9. pii: JAD201055. doi: 10.3233/JAD-201055.
    PubMed     Abstract available


  793. GUPTA HV, Beach TG, Mehta SH, Shill HA, et al
    Clinicopathological Correlation: Dopamine and Amyloid PET Imaging with Neuropathology in Three Subjects Clinically Diagnosed with Alzheimer's Disease or Dementia with Lewy Bodies.
    J Alzheimers Dis. 2021 Mar 9. pii: JAD200323. doi: 10.3233/JAD-200323.
    PubMed     Abstract available


  794. MOUSSAVI NIK SH, Porter T, Newman M, Bartlett B, et al
    Relevance of a Truncated PRESENILIN 2 Transcript to Alzheimer's Disease and Neurodegeneration.
    J Alzheimers Dis. 2021 Mar 7. pii: JAD201133. doi: 10.3233/JAD-201133.
    PubMed     Abstract available


  795. ELVERMAN KH, Paitel ER, Figueroa CM, McKindles RJ, et al
    Event-Related Potentials, Inhibition, and Risk for Alzheimer's Disease Among Cognitively Intact Elders.
    J Alzheimers Dis. 2021 Mar 5. pii: JAD201559. doi: 10.3233/JAD-201559.
    PubMed     Abstract available


  796. PEREZ-VALERO E, Lopez-Gordo MA, Morillas C, Pelayo F, et al
    A Review of Automated Techniques for Assisting the Early Detection of Alzheimer's Disease with a Focus on EEG.
    J Alzheimers Dis. 2021 Mar 5. pii: JAD201455. doi: 10.3233/JAD-201455.
    PubMed     Abstract available


  797. JOUINI N, Saied Z, Ben Sassi S, Nebli F, et al
    Impacts of Iron Metabolism Dysregulation on Alzheimer's Disease.
    J Alzheimers Dis. 2021 Mar 5. pii: JAD201250. doi: 10.3233/JAD-201250.
    PubMed     Abstract available


  798. DODICH A, Crespi C, Chiara Santi G, Luzzi S, et al
    Diagnostic Accuracy of Affective Social Tasks in the Clinical Classification Between the Behavioral Variant of Frontotemporal Dementia and Other Neurodegenerative Disease.
    J Alzheimers Dis. 2021 Mar 5. pii: JAD201210. doi: 10.3233/JAD-201210.
    PubMed     Abstract available


  799. WHITE B, Lyketsos CG, Rosenberg PB, Oh ES, et al
    Multiple Neurodegenerative Pathologies in an Alzheimer's Disease Patient Treated with Fornical Deep Brain Stimulation.
    J Alzheimers Dis. 2021 Mar 4. pii: JAD201415. doi: 10.3233/JAD-201415.
    PubMed     Abstract available


  800. VINUELA F, Barro A
    Assessment of a Potential Synergistic Effect of Souvenaid (R) in Mild Alzheimer's Disease Patients on Treatment with Acetylcholinesterase Inhibitors: An Observational, Non-Interventional Study.
    J Alzheimers Dis. 2021 Mar 4. pii: JAD201357. doi: 10.3233/JAD-201357.
    PubMed     Abstract available


  801. ZHANG B, Lin L, Wu S
    A Review of Brain Atrophy Subtypes Definition and Analysis for Alzheimer's Disease Heterogeneity Studies.
    J Alzheimers Dis. 2021 Mar 3. pii: JAD201274. doi: 10.3233/JAD-201274.
    PubMed     Abstract available


  802. DEVOUS MD, Fleisher AS, Pontecorvo MJ, Lu M, et al
    Relationships Between Cognition and Neuropathological Tau in Alzheimer's Disease Assessed by 18F Flortaucipir PET.
    J Alzheimers Dis. 2021 Mar 3. pii: JAD200808. doi: 10.3233/JAD-200808.
    PubMed     Abstract available


    February 2021
  803. AN N, Fu Y, Shi J, Guo HN, et al
    Synergistic Effects of APOE and CLU May Increase the Risk of Alzheimer's Disease: Acceleration of Atrophy in the Volumes and Shapes of the Hippocampus and Amygdala.
    J Alzheimers Dis. 2021 Feb 26. pii: JAD201162. doi: 10.3233/JAD-201162.
    PubMed     Abstract available


  804. HINTEREGGER B, Loeffler T, Flunkert S, Neddens J, et al
    Metabolic, Phenotypic, and Neuropathological Characterization of the Tg4-42 Mouse Model for Alzheimer's Disease.
    J Alzheimers Dis. 2021 Feb 25. pii: JAD201204. doi: 10.3233/JAD-201204.
    PubMed     Abstract available


  805. RYMAN SG, Yutsis M, Tian L, Henderson VW, et al
    Cognition at Each Stage of Lewy Body Disease with Co-occurring Alzheimer's Disease Pathology.
    J Alzheimers Dis. 2021 Feb 25. pii: JAD201187. doi: 10.3233/JAD-201187.
    PubMed     Abstract available


  806. LOPIS D, Pape TL, Manetta C, Conty L, et al
    Sensory Cueing of Autobiographical Memories in Normal Aging and Alzheimer's Disease: A Comparison Between Visual, Auditory, and Olfactory Information.
    J Alzheimers Dis. 2021 Feb 25. pii: JAD200841. doi: 10.3233/JAD-200841.
    PubMed     Abstract available


  807. KIM S, Kim K, Nho K, Myung W, et al
    Shared Genetic Background Between Cerebrospinal Fluid Biomarkers and Risk for Alzheimer's Disease: A Two-Sample Mendelian Randomization Study.
    J Alzheimers Dis. 2021 Feb 25. pii: JAD200671. doi: 10.3233/JAD-200671.
    PubMed     Abstract available


  808. LIU X, Chen X, Zhou X, Shang Y, et al
    Validity of the MemTrax Memory Test Compared to the Montreal Cognitive Assessment in the Detection of Mild Cognitive Impairment and Dementia due to Alzheimer's Disease in a Chinese Cohort.
    J Alzheimers Dis. 2021 Feb 24. pii: JAD200936. doi: 10.3233/JAD-200936.
    PubMed     Abstract available


  809. MERIGHI S, Battistello E, Casetta I, Gragnaniello D, et al
    Upregulation of Cortical A2A Adenosine Receptors is Reflected in Platelets of Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2021 Feb 23. pii: JAD201437. doi: 10.3233/JAD-201437.
    PubMed     Abstract available


  810. CUTTLER JM, Abdellah E, Goldberg Y, Al-Shamaa S, et al
    Low Doses of Ionizing Radiation as a Treatment for Alzheimer's Disease: A Pilot Study.
    J Alzheimers Dis. 2021 Feb 23. pii: JAD200620. doi: 10.3233/JAD-200620.
    PubMed     Abstract available


  811. MONLLOR P, Giraldo E, Badia MC, de la Asuncion JG, et al
    Serum Levels of Clusterin, PKR, and RAGE Correlate with Amyloid Burden in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Feb 20. pii: JAD201443. doi: 10.3233/JAD-201443.
    PubMed     Abstract available


  812. NAGARAJ S, Duong TQ
    Deep Learning and Risk Score Classification of Mild Cognitive Impairment and Alzheimer's Disease.
    J Alzheimers Dis. 2021 Feb 20. pii: JAD201438. doi: 10.3233/JAD-201438.
    PubMed     Abstract available


  813. KLEIN J, Yan X, Johnson A, Tomljanovic Z, et al
    Olfactory Impairment is Related to Tau Pathology and Neuroinflammation in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Feb 20. pii: JAD201149. doi: 10.3233/JAD-201149.
    PubMed     Abstract available


  814. CHUNG M, Chung WK
    Clinical Approach of Low-Dose Whole-Brain Ionizing Radiation Treatment in Alzheimer's Disease Dementia Patients.
    J Alzheimers Dis. 2021 Feb 19. pii: JAD210042. doi: 10.3233/JAD-210042.
    PubMed     Abstract available


  815. CIERI F, Yang Z, Cordes D, Jessica Caldwell ZK, et al
    Sex Differences of Brain Functional Topography Revealed in Normal Aging and Alzheimer's Disease Cohort.
    J Alzheimers Dis. 2021 Feb 19. pii: JAD201596. doi: 10.3233/JAD-201596.
    PubMed     Abstract available


  816. JIN H, Wang R
    Alzheimer-Associated Neuronal Thread Protein: Research Course and Prospects for the Future.
    J Alzheimers Dis. 2021 Feb 19. pii: JAD201273. doi: 10.3233/JAD-201273.
    PubMed     Abstract available


  817. LEYTON E, Matus D, Espinoza S, Benitez JM, et al
    DEF8 and Autophagy-Associated Genes are Altered in Mild Cognitive Impairment, Probable Alzheimer's Disease Patients and a Transgenic Model of the Disease.
    J Alzheimers Dis. 2021 Feb 19. pii: JAD201264. doi: 10.3233/JAD-201264.
    PubMed     Abstract available


  818. ZHANG G, Zhang Y, Shen Y, Wang Y, et al
    The Potential Role of Ferroptosis in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Feb 19. pii: JAD201369. doi: 10.3233/JAD-201369.
    PubMed     Abstract available


  819. KHODADADI H, Lopes Salles E, Jarrahi A, Costigliola V, et al
    Cannabidiol Ameliorates Cognitive Function via Regulation of IL-33 and TREM2 Upregulation in a Murine Model of Alzheimer's Disease.
    J Alzheimers Dis. 2021 Feb 17. pii: JAD210026. doi: 10.3233/JAD-210026.
    PubMed     Abstract available


  820. WANG YY, Huang ZT, Yuan MH, Jing F, et al
    Role of Hypoxia Inducible Factor-1alpha in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Feb 17. pii: JAD201448. doi: 10.3233/JAD-201448.
    PubMed     Abstract available


  821. INDOREWALLA KK, O'Connor MK, Budson AE, Guess DiTerlizzi C, et al
    Modifiable Barriers for Recruitment and Retention of Oldeult Participants from Underrepresented Minorities in Alzheimer's Disease Research.
    J Alzheimers Dis. 2021 Feb 17. pii: JAD201081. doi: 10.3233/JAD-201081.
    PubMed     Abstract available


  822. SHOUP TM, Griciuc A, Normandin MD, Quinti L, et al
    Evaluation of Fluorinated Cromolyn Derivatives as Potential Therapeutics for Alzheimer's Disease.
    J Alzheimers Dis. 2021 Feb 12. pii: JAD201419. doi: 10.3233/JAD-201419.
    PubMed     Abstract available


  823. WANG YZ, Meng L, Zhuang QS, Shen L, et al
    Screening Traditional Chinese Medicine Combination for Cotreatment of Alzheimer's Disease and Type 2 Diabetes Mellitus by Network Pharmacology.
    J Alzheimers Dis. 2021 Feb 12. pii: JAD201336. doi: 10.3233/JAD-201336.
    PubMed     Abstract available


  824. LLADO A, Froelich L, Khandker RK, Roset M, et al
    Assessing the Progression of Alzheimer's Disease in Real-World Settings in Three European Countries.
    J Alzheimers Dis. 2021 Feb 12. pii: JAD201172. doi: 10.3233/JAD-201172.
    PubMed     Abstract available


  825. SOOD A, Pavlik V, Darby E, Chan W, et al
    Different Cognitive Profiles Are Associated with Progression Rate and Age at Death in Probable Alzheimer's Disease.
    J Alzheimers Dis. 2021 Feb 12. pii: JAD201124. doi: 10.3233/JAD-201124.
    PubMed     Abstract available


  826. LIBARD S, Walter J, Alafuzoff I
    In vivo Characterization of Biochemical Variants of Amyloid-beta in Subjects with Idiopathic Normal Pressure Hydrocephalus and Alzheimer's Disease Neuropathological Change.
    J Alzheimers Dis. 2021 Feb 12. pii: JAD201469. doi: 10.3233/JAD-201469.
    PubMed     Abstract available


  827. MA D, Yee E, Stocks JK, Jenkins LM, et al
    Blinded Clinical Evaluation for Dementia of Alzheimer's Type Classification Using FDG-PET: A Comparison Between Feature-Engineered and Non-Feature-Engineered Machine Learning Methods.
    J Alzheimers Dis. 2021 Feb 11. pii: JAD201591. doi: 10.3233/JAD-201591.
    PubMed     Abstract available


  828. DANIELE S, Baldacci F, Piccarducci R, Palermo G, et al
    alpha-Synuclein Heteromers in Red Blood Cells of Alzheimer's Disease and Lewy Body Dementia Patients.
    J Alzheimers Dis. 2021 Feb 11. pii: JAD201038. doi: 10.3233/JAD-201038.
    PubMed     Abstract available


  829. SHEN LX, Yang YX, Kuo K, Li HQ, et al
    Social Isolation, Social Interaction, and Alzheimer's Disease: A Mendelian Randomization Study.
    J Alzheimers Dis. 2021 Feb 9. pii: JAD201442. doi: 10.3233/JAD-201442.
    PubMed     Abstract available


  830. FUTAMURA A, Hieda S, Mori Y, Kasuga K, et al
    Toxic Amyloid-beta42 Conformer May Accelerate the Onset of Alzheimer's Disease in the Preclinical Stage.
    J Alzheimers Dis. 2021 Feb 9. pii: JAD201407. doi: 10.3233/JAD-201407.
    PubMed     Abstract available


  831. WANG J, Guo X, Lu W, Liu J, et al
    Donepezil Combined with DL-3-n-Butylphthalide Delays Cognitive Decline in Patients with Mild to Moderate Alzheimer's Disease: A Multicenter, Prospective Cohort Study.
    J Alzheimers Dis. 2021 Feb 9. pii: JAD201381. doi: 10.3233/JAD-201381.
    PubMed     Abstract available


  832. YAO W, Chen H, Luo C, Sheng X, et al
    Hyperconnectivity of Self-Referential Network as a Predictive Biomarker of the Progression of Alzheimer's Disease.
    J Alzheimers Dis. 2021 Feb 6. pii: JAD201376. doi: 10.3233/JAD-201376.
    PubMed     Abstract available


  833. YU E, Liao Z, Fan W, Hu W, et al
    The Economic Burden of Alzheimer's Disease in Zhejiang Province.
    J Alzheimers Dis. 2021 Feb 6. pii: JAD201285. doi: 10.3233/JAD-201285.
    PubMed     Abstract available


  834. ROSTAMZADEH A, Schwegler C, Gil-Navarro S, Rosende-Roca M, et al
    Biomarker-Based Risk Prediction of Alzheimer's Disease Dementia in Mild Cognitive Impairment: Psychosocial, Ethical, and Legal Aspects. Study Protocol of the PreDADQoL Project.
    J Alzheimers Dis. 2021 Feb 4. pii: JAD200484. doi: 10.3233/JAD-200484.
    PubMed     Abstract available


  835. CHALKIAS E, Topouzis F, Tegos T, Tsolaki M, et al
    The Contribution of Ocular Biomarkers in the Differential Diagnosis of Alzheimer's Disease versus Other Types of Dementia and Future Prospects.
    J Alzheimers Dis. 2021 Feb 1. pii: JAD201516. doi: 10.3233/JAD-201516.
    PubMed     Abstract available


  836. KHALSA DS, Newberg A
    Spiritual Fitness: A New Dimension in Alzheimer's Disease Prevention.
    J Alzheimers Dis. 2021 Feb 1. pii: JAD201433. doi: 10.3233/JAD-201433.
    PubMed     Abstract available


  837. RIPHAGEN JM, Van Egroo M, Jacobs HIL
    Elevated Norepinephrine Metabolism Gauges Alzheimer's Disease-Related Pathology and Memory Decline.
    J Alzheimers Dis. 2021 Feb 1. pii: JAD201411. doi: 10.3233/JAD-201411.
    PubMed     Abstract available


  838. KHATAMI SG, Domingo-Fernandez D, Mubeen S, Hoyt CT, et al
    A Systems Biology Approach for Hypothesizing the Effect of Genetic Variants on Neuroimaging Features in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Feb 1. pii: JAD201397. doi: 10.3233/JAD-201397.
    PubMed     Abstract available


  839. PIUBELLI L, Murtas G, Rabattoni V, Pollegioni L, et al
    The Role of D-Amino Acids in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Feb 1. pii: JAD201217. doi: 10.3233/JAD-201217.
    PubMed     Abstract available


    January 2021
  840. RIGBY T, Johnson DK, Taylor A, Galvin JE, et al
    Comparison of the Caregiving Experience of Grief, Burden, and Quality of Life in Dementia with Lewy Bodies, Alzheimer's Disease, and Parkinson's Disease Dementia.
    J Alzheimers Dis. 2021 Jan 30. pii: JAD201326. doi: 10.3233/JAD-201326.
    PubMed     Abstract available


  841. LI M, Li R, Lyu JH, Chen JH, et al
    Relationship Between Alzheimer's Disease and Retinal Choroidal Thickness: A Cross-Sectional Study.
    J Alzheimers Dis. 2021 Jan 30. pii: JAD201142. doi: 10.3233/JAD-201142.
    PubMed     Abstract available


  842. CHUANG YC, Chiu MJ, Chen TF, Chang YL, et al
    An Exploration of the Own-Age Effect on Facial Emotion Recognition in Normal Elderly People and Individuals with the Preclinical and Demented Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jan 27. pii: JAD200916. doi: 10.3233/JAD-200916.
    PubMed     Abstract available


  843. YU F, Vock DM, Zhang L, Salisbury D, et al
    Cognitive Effects of Aerobic Exercise in Alzheimer's Disease: A Pilot Randomized Controlled Trial.
    J Alzheimers Dis. 2021 Jan 26. pii: JAD201100. doi: 10.3233/JAD-201100.
    PubMed     Abstract available


  844. GUO M, Peng J, Huang X, Xiao L, et al
    Gut Microbiome Features of Chinese Patients Newly Diagnosed with Alzheimer's Disease or Mild Cognitive Impairment.
    J Alzheimers Dis. 2021 Jan 26. pii: JAD201040. doi: 10.3233/JAD-201040.
    PubMed     Abstract available


  845. MACEDO A, Gomez C, Rebelo MA, Poza J, et al
    Risk Variants in Three Alzheimer's Disease Genes Show Association with EEG Endophenotypes.
    J Alzheimers Dis. 2021 Jan 26. pii: JAD200963. doi: 10.3233/JAD-200963.
    PubMed     Abstract available


  846. LLANO DA, Devanarayan V
    Serum Phosphatidylethanolamine and Lysophosphatidylethanolamine Levels Differentiate Alzheimer's Disease from Controls and Predict Progression from Mild Cognitive Impairment.
    J Alzheimers Dis. 2021 Jan 25. pii: JAD201420. doi: 10.3233/JAD-201420.
    PubMed     Abstract available


  847. ZHUANG QS, Meng L, Wang Z, Shen L, et al
    Associations Between Obesity and Alzheimer's Disease: Multiple Bioinformatic Analyses.
    J Alzheimers Dis. 2021 Jan 25. pii: JAD201235. doi: 10.3233/JAD-201235.
    PubMed     Abstract available


  848. JORGE L, Martins R, Canario N, Xavier C, et al
    Investigating the Spatial Associations Between Amyloid-beta Deposition, Grey Matter Volume, and Neuroinflammation in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jan 23. pii: JAD200840. doi: 10.3233/JAD-200840.
    PubMed     Abstract available


  849. CHEN F, Zhang Y, Wang L, Wang T, et al
    PLCG2 rs72824905 Variant Reduces the Risk of Alzheimer's Disease and Multiple Sclerosis.
    J Alzheimers Dis. 2021 Jan 23. pii: JAD201140. doi: 10.3233/JAD-201140.
    PubMed     Abstract available


  850. GUZMAN-MARTINEZ L, Calfio C, Farias GA, Vilches C, et al
    New Frontiers in the Prevention, Diagnosis, and Treatment of Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jan 23. pii: JAD201059. doi: 10.3233/JAD-201059.
    PubMed     Abstract available


  851. CUERVO-ZANATTA D, Garcia-Mena J, Perez-Cruz C
    Gut Microbiota Alterations and Cognitive Impairment Are Sexually Dissociated in a Transgenic Mice Model of Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jan 21. pii: JAD201367. doi: 10.3233/JAD-201367.
    PubMed     Abstract available


  852. GROBER E, Qi Q, Kuo L, Hassenstab J, et al
    Stages of Objective Memory Impairment Predict Alzheimer's Disease Neuropathology: Comparison with the Clinical Dementia Rating Scale-Sum of Boxes.
    J Alzheimers Dis. 2021 Jan 21. pii: JAD200946. doi: 10.3233/JAD-200946.
    PubMed     Abstract available


  853. ZHANG F, Petersen M, Johnson L, Hall J, et al
    Recursive Support Vector Machine Biomarker Selection for Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jan 18. pii: JAD201254. doi: 10.3233/JAD-201254.
    PubMed     Abstract available


  854. MEHDER RH, Bennett BM, Andrew RD
    Age-Related Neuronal Deterioration Specifically Within the Dorsal CA1 Region of the Hippocampus in a Mouse Model of Late Onset Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jan 15. pii: JAD201024. doi: 10.3233/JAD-201024.
    PubMed     Abstract available


  855. HAYASHI T, Shimonaka S, Elahi M, Matsumoto SE, et al
    Learning Deficits Accompanied by Microglial Proliferation After the Long-Term Post-Injection of Alzheimer's Disease Brain Extract in Mouse Brains.
    J Alzheimers Dis. 2021 Jan 15. pii: JAD201002. doi: 10.3233/JAD-201002.
    PubMed     Abstract available


  856. LEHINGUE E, Gueniat J, Jourdaa S, Hardouin JB, et al
    Improving the Diagnosis of the Frontal Variant of Alzheimer's Disease with the DAPHNE Scale.
    J Alzheimers Dis. 2021 Jan 15. pii: JAD201088. doi: 10.3233/JAD-201088.
    PubMed     Abstract available


  857. QIAN X, Zhang S, Duan L, Yang F, et al
    Periodontitis Deteriorates Cognitive Function and Impairs Neurons and Glia in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jan 13. pii: JAD201007. doi: 10.3233/JAD-201007.
    PubMed     Abstract available


  858. SHAFFER RM, Li G, Adar SD, Dirk Keene C, et al
    Fine Particulate Matter and Markers of Alzheimer's Disease Neuropathology at Autopsy in a Community-Based Cohort.
    J Alzheimers Dis. 2021 Jan 13. pii: JAD201005. doi: 10.3233/JAD-201005.
    PubMed     Abstract available


  859. LAO K, Zhang R, Luan J, Zhang Y, et al
    Therapeutic Strategies Targeting Amyloid-beta Receptors and Transporters in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jan 13. pii: JAD200851. doi: 10.3233/JAD-200851.
    PubMed     Abstract available


  860. LY M, Raji CA, Yu GZ, Wang Q, et al
    Obesity and White Matter Neuroinflammation Related Edema in Alzheimer Disease Dementia Biomarker Negative Cognitively Normal Individuals.
    J Alzheimers Dis. 2021 Jan 13. pii: JAD201242. doi: 10.3233/JAD-201242.
    PubMed     Abstract available


  861. LOEFFLER DA
    Modifiable, Non-Modifiable, and Clinical Factors Associated with Progression of Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jan 13. pii: JAD201182. doi: 10.3233/JAD-201182.
    PubMed     Abstract available


  862. MERCERON-MARTINEZ D, Ibaceta-Gonzalez C, Salazar C, Almaguer-Melian W, et al
    Alzheimer's Disease, Neural Plasticity, and Functional Recovery.
    J Alzheimers Dis. 2021 Jan 13. pii: JAD201178. doi: 10.3233/JAD-201178.
    PubMed     Abstract available


  863. FERINI-STRAMBI L, Hensley M, Salsone M
    Decoding Causal Links Between Sleep Apnea and Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jan 13. pii: JAD201066. doi: 10.3233/JAD-201066.
    PubMed     Abstract available


  864. CHEN YS, Shu K, Kang HC
    Deep Brain Stimulation in Alzheimer's Disease: Targeting the Nucleus Basalis of Meynert.
    J Alzheimers Dis. 2021 Jan 13. pii: JAD201141. doi: 10.3233/JAD-201141.
    PubMed     Abstract available


  865. PRAKASH M, Abdelaziz M, Zhang L, Strange BA, et al
    Quantitative Longitudinal Predictions of Alzheimer's Disease by Multi-Modal Predictive Learning.
    J Alzheimers Dis. 2021 Jan 12. pii: JAD200906. doi: 10.3233/JAD-200906.
    PubMed     Abstract available


  866. BARIL AA, Beiser AS, Redline S, McGrath ER, et al
    Interleukin-6 Interacts with Sleep Apnea Severity when Predicting Incident Alzheimer's Disease Dementia.
    J Alzheimers Dis. 2021 Jan 11. pii: JAD200545. doi: 10.3233/JAD-200545.
    PubMed     Abstract available


  867. MAI Y, Yu Q, Zhu F, Luo Y, et al
    AD Resemblance Atrophy Index as a Diagnostic Biomarker for Alzheimer's Disease: A Retrospective Clinical and Biological Validation.
    J Alzheimers Dis. 2021 Jan 11. pii: JAD201033. doi: 10.3233/JAD-201033.
    PubMed     Abstract available


  868. DELIC V, Ratliff WA, Citron BA
    Sleep Deprivation, a Link Between Post-Traumatic Stress Disorder and Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jan 11. pii: JAD201378. doi: 10.3233/JAD-201378.
    PubMed     Abstract available


  869. CASTAGNA A, Fabbo A, Manzo C, Lacava R, et al
    A Retrospective Study on the Benefits of Combined Citicoline, Memantine, and Acetylcholinesterase Inhibitor Treatments in Older Patients Affected with Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jan 11. pii: JAD201211. doi: 10.3233/JAD-201211.
    PubMed     Abstract available


  870. DE LA TORRE JC
    Deciphering Alzheimer's Disease Pathogenic Pathway: Role of Chronic Brain Hypoperfusion on p-Tau and mTOR.
    J Alzheimers Dis. 2021 Jan 11. pii: JAD201165. doi: 10.3233/JAD-201165.
    PubMed     Abstract available


  871. DARST BF, Huo Z, Jonaitis EM, Koscik RL, et al
    Metabolites Associated with Early Cognitive Changes Implicated in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jan 8. pii: JAD200176. doi: 10.3233/JAD-200176.
    PubMed    


  872. PARK JH, Ah Lee S
    The Fragility of Temporal Memory in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jan 8. pii: JAD200892. doi: 10.3233/JAD-200892.
    PubMed     Abstract available


  873. WU R, Gu J, Zhou D, Tung YC, et al
    Seeding-Competent Tau in Gray Matter Versus White Matter of Alzheimer's Disease Brain.
    J Alzheimers Dis. 2021 Jan 8. pii: JAD201290. doi: 10.3233/JAD-201290.
    PubMed     Abstract available


  874. HYUN LEE Y, Jeon S, Soo Yoo H, Jong Chung S, et al
    Effect of Alzheimer's Disease and Lewy Body Disease on Metabolic Changes.
    J Alzheimers Dis. 2021 Jan 8. pii: JAD201094. doi: 10.3233/JAD-201094.
    PubMed     Abstract available


  875. JING J, Zhang F, Zhao L, Xie J, et al
    Correlation Between Brain 18F-AV45 and 18F-FDG PET Distribution Characteristics and Cognitive Function in Patients with Mild and Moderate Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jan 5. pii: JAD201335. doi: 10.3233/JAD-201335.
    PubMed     Abstract available


  876. KHAN MJ, Desaire H, Lopez OL, Kamboh MI, et al
    Why Inclusion Matters for Alzheimer's Disease Biomarker Discovery in Plasma.
    J Alzheimers Dis. 2021 Jan 5. pii: JAD201318. doi: 10.3233/JAD-201318.
    PubMed     Abstract available


  877. YAN Y, Wu X, Wang X, Geng Z, et al
    The Retinal Vessel Density Can Reflect Cognitive Function in Patients with Alzheimer's Disease: Evidence from Optical Coherence Tomography Angiography.
    J Alzheimers Dis. 2021 Jan 5. pii: JAD200971. doi: 10.3233/JAD-200971.
    PubMed     Abstract available


  878. SOHRABI M, Pecoraro HL, Combs CK
    Gut Inflammation Induced by Dextran Sulfate Sodium Exacerbates Amyloid-beta Plaque Deposition in the AppNL - G - F Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jan 3. pii: JAD201099. doi: 10.3233/JAD-201099.
    PubMed     Abstract available


  879. RADHAKRISHNAN NS, Mufti M, Ortiz D, Maye ST, et al
    Implementing Delirium Prevention in the Era of COVID-19.
    J Alzheimers Dis. 2021;79:31-36.
    PubMed     Abstract available


  880. CLARK IA, Vissel B
    Broader Insights into Understanding Tumor Necrosis Factor and Neurodegenerative Disease Pathogenesis Infer New Therapeutic Approaches.
    J Alzheimers Dis. 2021;79:931-948.
    PubMed     Abstract available


  881. CARCAVILLA N, Pozo AS, Gonzalez B, Moral-Cuesta D, et al
    Needs of Dementia Family Caregivers in Spain During the COVID-19 Pandemic.
    J Alzheimers Dis. 2021;80:533-537.
    PubMed     Abstract available


  882. TAM MT, Dosso JA, Robillard JM
    The Impact of a Global Pandemic on People Living with Dementia and Their Care Partners: Analysis of 417 Lived Experience Reports.
    J Alzheimers Dis. 2021;80:865-875.
    PubMed     Abstract available



  883. Clinical Approach of Low-Dose Whole-Brain Ionizing Radiation Treatment in Alzheimer's Disease Dementia Patients.
    J Alzheimers Dis. 2021;81:1343.
    PubMed    


  884. DAVOUDI A, Dion C, Amini S, Tighe PJ, et al
    Classifying Non-Dementia and Alzheimer's Disease/Vascular Dementia Patients Using Kinematic, Time-Based, and Visuospatial Parameters: The Digital Clock Drawing Test.
    J Alzheimers Dis. 2021;82:47-57.
    PubMed     Abstract available


  885. TONIOLO S, Scarioni M, Di Lorenzo F, Hort J, et al
    Dementia and COVID-19, a Bidirectional Liaison: Risk Factors, Biomarkers, and Optimal Health Care.
    J Alzheimers Dis. 2021;82:883-898.
    PubMed     Abstract available


  886. SUH SW, Kim YJ, Kwak KP, Kim K, et al
    A 9-Year Comparison of Dementia Prevalence in Korea: Results of NaSDEK 2008 and 2017.
    J Alzheimers Dis. 2021;81:821-831.
    PubMed     Abstract available


  887. LIU X, Chen KL, Wang Y, Huang YY, et al
    A Novel ITM2B Mutation Associated with Familial Chinese Dementia.
    J Alzheimers Dis. 2021;81:499-505.
    PubMed     Abstract available


  888. SCHMIDT SL, Boechat YEM, Schmidt GJ, Nicaretta D, et al
    Clinical Utility of a Reaction-Time Attention Task in the Evaluation of Cognitive Impairment in Elderly with High Educational Disparity.
    J Alzheimers Dis. 2021;81:691-697.
    PubMed     Abstract available


  889. MARTINEZ-FLOREZ JF, Osorio JD, Cediel JC, Rivas JC, et al
    Short-Term Memory Binding Distinguishing Amnestic Mild Cognitive Impairment from Healthy Aging: A Machine Learning Study.
    J Alzheimers Dis. 2021;81:729-742.
    PubMed     Abstract available


  890. KANATOME A, Ano Y, Shinagawa K, Ide Y, et al
    beta-Lactolin Enhances Neural Activity, Indicated by Event-Related P300 Amplitude, in Healthy Adults: A Randomized Controlled Trial.
    J Alzheimers Dis. 2021;81:787-796.
    PubMed     Abstract available


  891. WANG X, Bui H, Vemuri P, Graff-Radford J, et al
    Lipidomic Network of Mild Cognitive Impairment from the Mayo Clinic Study of Aging.
    J Alzheimers Dis. 2021;81:533-543.
    PubMed     Abstract available


  892. HALAAS NB, Zetterberg H, Idland AV, Knapskog AB, et al
    Cerebrospinal Fluid Concentration of Neurogranin in Hip Fracture Patients with Delirium.
    J Alzheimers Dis. 2021;81:667-677.
    PubMed     Abstract available


  893. HIRAO K, Yamashita F, Tsugawa A, Haime R, et al
    Association of White Matter Hyperintensity Progression with Cognitive Decline in Patients with Amnestic Mild Cognitive Impairment.
    J Alzheimers Dis. 2021;80:877-883.
    PubMed     Abstract available


  894. QUINT WH, Matecko-Burmann I, Schilcher I, Loffler T, et al
    Bispecific Tau Antibodies with Additional Binding to C1q or Alpha-Synuclein.
    J Alzheimers Dis. 2021;80:813-829.
    PubMed     Abstract available


  895. YUAN L, Zhang J, Guo JH, Holscher C, et al
    DAla2-GIP-GLU-PAL Protects Against Cognitive Deficits and Pathology in APP/PS1 Mice by Inhibiting Neuroinflammation and Upregulating cAMP/PKA/CREB Signaling Pathways.
    J Alzheimers Dis. 2021;80:695-713.
    PubMed     Abstract available


  896. SAHU B, Mackos AR, Floden AM, Wold LE, et al
    Particulate Matter Exposure Exacerbates Amyloid-beta Plaque Deposition and Gliosis in APP/PS1 Mice.
    J Alzheimers Dis. 2021;80:761-774.
    PubMed     Abstract available


  897. SATO K, Mano T, Iwata A, Toda T, et al
    Safety of Memantine in Combination with Potentially Interactive Drugs in the Real World: A Pharmacovigilance Study Using the Japanese Adverse Drug Event Report (JADER) Database.
    J Alzheimers Dis. 2021;82:1333-1344.
    PubMed     Abstract available


  898. UMEGAKI H, Suzuki Y, Komiya H, Watanabe K, et al
    Frequencies and Neuropsychological Characteristics of Errors in the Clock Drawing Test.
    J Alzheimers Dis. 2021;82:1291-1300.
    PubMed     Abstract available


  899. GONZALEZ-ALCAIDE G, Fernandez-Rios M, Redolat R, Serra E, et al
    Research on Emotion Recognition and Dementias: Foundations and Prospects.
    J Alzheimers Dis. 2021;82:939-950.
    PubMed     Abstract available


  900. EDLUND AK, Chen K, Lee W, Protas H, et al
    Plasma Apolipoprotein E3 and Glucose Levels Are Associated in APOE varepsilon3/varepsilon4 Carriers.
    J Alzheimers Dis. 2021;81:339-354.
    PubMed     Abstract available


  901. STONNINGTON CM, Wu J, Zhang J, Shi J, et al
    Improved Prediction of Imminent Progression to Clinically Significant Memory Decline Using Surface Multivariate Morphometry Statistics and Sparse Coding.
    J Alzheimers Dis. 2021;81:209-220.
    PubMed     Abstract available


  902. RHODES E, Insel PS, Butters MA, Morin R, et al
    The Impact of Amyloid Burden and APOE on Rates of Cognitive Impairment in Late Life Depression.
    J Alzheimers Dis. 2021;80:991-1002.
    PubMed     Abstract available


  903. PEIRA E, Grazzini M, Bauckneht M, Sensi F, et al
    Probing the Role of a Regional Quantitative Assessment of Amyloid PET.
    J Alzheimers Dis. 2021;80:383-396.
    PubMed     Abstract available


  904. LI X, Shen M, Jin Y, Jia S, et al
    Validity and Reliability of the New Chinese Version of the Frontal Assessment Battery-Phonemic.
    J Alzheimers Dis. 2021;80:371-381.
    PubMed     Abstract available


  905. COSTA AS, Pinho J, Kucikiene D, Reich A, et al
    Cerebral Amyloid Angiopathy in Amyloid-Positive Patients from a Memory Clinic Cohort.
    J Alzheimers Dis. 2021;79:1661-1672.
    PubMed     Abstract available


  906. GROBER E, Qi Q, Kuo L, Hassenstab J, et al
    The Free and Cued Selective Reminding Test Predicts Braak Stage.
    J Alzheimers Dis. 2021;80:175-183.
    PubMed     Abstract available


  907. DENNISON JL, Ricciardi NR, Lohse I, Volmar CH, et al
    Sexual Dimorphism in the 3xTg-AD Mouse Model and Its Impact on Pre-Clinical Research.
    J Alzheimers Dis. 2021;80:41-52.
    PubMed     Abstract available


  908. GNANAPRAKASH M, Staniszewski A, Zhang H, Pitstick R, et al
    Leucine Carboxyl Methyltransferase 1 Overexpression Protects Against Cognitive and Electrophysiological Impairments in Tg2576 APP Transgenic Mice.
    J Alzheimers Dis. 2021;79:1813-1829.
    PubMed     Abstract available


  909. MARTINEZ-MALDONADO A, Ontiveros-Torres MA, Harrington CR, Montiel-Sosa JF, et al
    Molecular Processing of Tau Protein in Progressive Supranuclear Palsy: Neuronal and Glial Degeneration.
    J Alzheimers Dis. 2021;79:1517-1531.
    PubMed     Abstract available


  910. BASCUNANA P, Brackhan M, Pahnke J
    Machine Learning-Supported Analyses Improve Quantitative Histological Assessments of Amyloid-beta Deposits and Activated Microglia.
    J Alzheimers Dis. 2021;79:597-605.
    PubMed     Abstract available


  911. BERGER M, Cooter M, Roesler AS, Chung S, et al
    APOE4 Copy Number-Dependent Proteomic Changes in the Cerebrospinal Fluid.
    J Alzheimers Dis. 2021;79:511-530.
    PubMed     Abstract available


  912. NIU J, Iqbal K, Liu F, Hu W, et al
    Rats Display Sexual Dimorphism in Phosphorylation of Brain Tau with Age.
    J Alzheimers Dis. 2021;82:855-869.
    PubMed     Abstract available


  913. KORPIOJA A, Kruger J, Koivuluoma S, Pylkas K, et al
    Novel Rare SORL1 Variants in Early-Onset Dementia.
    J Alzheimers Dis. 2021;82:761-770.
    PubMed     Abstract available


  914. SHINOHARA M, Suzuki K, Bu G, Sato N, et al
    Interaction Between APOE Genotype and Diabetes in Longevity.
    J Alzheimers Dis. 2021;82:719-726.
    PubMed     Abstract available


  915. SVENSSON J, Blomqvist M, Kettunen P, Eckerstrom C, et al
    Cerebrospinal Fluid Sulfatide Levels Lack Diagnostic Utility in the Subcortical Small Vessel Type of Dementia.
    J Alzheimers Dis. 2021;82:781-790.
    PubMed     Abstract available


  916. ZILLI EM, O'Donnell A, Salinas J, Aparicio HJ, et al
    Herpes Labialis, Chlamydophila pneumoniae, Helicobacter pylori, and Cytomegalovirus Infections and Risk of Dementia: The Framingham Heart Study.
    J Alzheimers Dis. 2021;82:593-605.
    PubMed     Abstract available


  917. YERSTEIN O, Parand L, Liang LJ, Isaac A, et al
    Benson's Disease or Posterior Cortical Atrophy, Revisited.
    J Alzheimers Dis. 2021;82:493-502.
    PubMed     Abstract available


  918. KARANTH SD, Schmitt FA, Nelson PT, Katsumata Y, et al
    Four Common Late-Life Cognitive Trajectories Patterns Associate with Replicable Underlying Neuropathologies.
    J Alzheimers Dis. 2021;82:647-659.
    PubMed     Abstract available


  919. XIAO T, Wijnant SRA, Licher S, Terzikhan N, et al
    Lung Function Impairment and the Risk of Incident Dementia: The Rotterdam Study.
    J Alzheimers Dis. 2021;82:621-630.
    PubMed     Abstract available


  920. RIEGEROVA P, Brejcha J, Bezdekova D, Chum T, et al
    Expression and Localization of AbetaPP in SH-SY5Y Cells Depends on Differentiation State.
    J Alzheimers Dis. 2021;82:485-491.
    PubMed     Abstract available


  921. CHAPARRO D, Flores-Gaspar A, Ali-Torres J
    Computational Design of Copper Ligands with Controlled Metal Chelating, Pharmacokinetics, and Redox Properties for Alzheimer's Disease.
    J Alzheimers Dis. 2021;82.
    PubMed     Abstract available


  922. SHENG C, Lin L, Lin H, Wang X, et al
    Altered Gut Microbiota in Adults with Subjective Cognitive Decline: The SILCODE Study.
    J Alzheimers Dis. 2021;82:513-526.
    PubMed     Abstract available


  923. WOODWORTH DC, Scambray KA, Corrada MM, Kawas CH, et al
    Neuroimaging in the Oldest-Old: A Review of the Literature.
    J Alzheimers Dis. 2021;82:129-147.
    PubMed     Abstract available


  924. NG KP, Cheng GH, Yatawara C, Rosa-Neto P, et al
    Baseline Neurodegeneration Influences the Longitudinal Effects of Tau on Cognition.
    J Alzheimers Dis. 2021;82:159-167.
    PubMed     Abstract available


  925. ALMKVIST O, Bruggen K, Nordberg A
    Subcortical and Cortical Regions of Amyloid-beta Pathology Measured by 11C-PiB PET Are Differentially Associated with Cognitive Functions and Stages of Disease in Memory Clinic Patients.
    J Alzheimers Dis. 2021;81:1613-1624.
    PubMed     Abstract available


  926. ZHANG H, D'Agostino C, Forman HJ, Cacciottolo M, et al
    Urban Air Pollution Nanoparticles from Los Angeles: Recently Decreased Neurotoxicity.
    J Alzheimers Dis. 2021;82:307-316.
    PubMed     Abstract available


  927. WANG YY, Ge YJ, Tan CC, Cao XP, et al
    The Proportion of APOE4 Carriers Among Non-Demented Individuals: A Pooled Analysis of 389,000 Community-Dwellers.
    J Alzheimers Dis. 2021;81:1331-1339.
    PubMed     Abstract available


  928. SIMONSEN AH, Musaeus CS, Christensen GL, Hasselbalch SG, et al
    Upwards Drift of Cerebrospinal Fluid Amyloid-beta 42 Over Twelve Years in a Consecutive Clinical Cohort.
    J Alzheimers Dis. 2021;81:1369-1373.
    PubMed     Abstract available


  929. PAIS M, Loureiro J, do Vale V, Radanovic M, et al
    Heterogeneity of Cerebrospinal Fluid Biomarkers Profiles in Individuals with Distinct Levels of Cognitive Decline: A Cross-Sectional Study.
    J Alzheimers Dis. 2021;81:949-962.
    PubMed     Abstract available


  930. BEISHON LC, Panerai RB, Budgeon C, Subramaniam H, et al
    The Cognition and Flow Study: A Feasibility Randomized Controlled Trial of the Effects of Cognitive Training on Cerebral Blood Flow.
    J Alzheimers Dis. 2021;80:1567-1581.
    PubMed     Abstract available


  931. LUKKARINEN H, Tesseur I, Pemberton D, Van Der Ark P, et al
    Time Trends of Cerebrospinal Fluid Biomarkers of Neurodegeneration in Idiopathic Normal Pressure Hydrocephalus.
    J Alzheimers Dis. 2021;80:1629-1642.
    PubMed     Abstract available


  932. TANNER JJ, Hanchate S, Price CC, Garvan C, et al
    Relationships Between Chronic Pain Stage, Cognition, Temporal Lobe Cortex, and Sociodemographic Variables.
    J Alzheimers Dis. 2021;80:1539-1551.
    PubMed     Abstract available


  933. DING XL, Tuo QZ, Lei P
    An Introduction to Ultrasensitive Assays for Plasma Tau Detection.
    J Alzheimers Dis. 2021;80:1353-1362.
    PubMed     Abstract available


  934. JARDEL A, Hopes L, Malaplate C, Roch V, et al
    Prognostic Impact of 18-F-Florbetaben Amyloid PET Imaging in Patients with Isolated Increases in Cerebrospinal Fluid Phospho-Tau Biomarkers: A Longitudinal Study.
    J Alzheimers Dis. 2021;80:1389-1394.
    PubMed     Abstract available


  935. CLARK AL, Weigand AJ, Thomas KR, Solders SK, et al
    Elevated Inflammatory Markers and Arterial Stiffening Exacerbate Tau but Not Amyloid Pathology in Older Adults with Mild Cognitive Impairment.
    J Alzheimers Dis. 2021;80:1451-1463.
    PubMed     Abstract available


  936. GJORA L, Strand BH, Bergh S, Borza T, et al
    Current and Future Prevalence Estimates of Mild Cognitive Impairment, Dementia, and Its Subtypes in a Population-Based Sample of People 70 Years and Older in Norway: The HUNT Study.
    J Alzheimers Dis. 2021;79:1213-1226.
    PubMed     Abstract available


  937. GRUTERS AAA, Ramakers IHGB, Stiekema APM, Verhey FRJ, et al
    An Exploratory Study of the Development and Pilot Testing of an Interactive Visual Tool of Neuropsychological Test Results in Memory Clinics.
    J Alzheimers Dis. 2021;79:1157-1170.
    PubMed     Abstract available


  938. KUMON H, Yoshino Y, Funahashi Y, Mori H, et al
    PICALM mRNA Expression in the Blood of Patients with Neurodegenerative Diseases and Geriatric Depression.
    J Alzheimers Dis. 2021;79:1055-1062.
    PubMed     Abstract available


  939. BASTA M, Zaganas I, Simos P, Koutentaki E, et al
    Apolipoprotein E varepsilon4 (APOE varepsilon4) Allele is Associated with Long Sleep Duration Among Elderly with Cognitive Impairment.
    J Alzheimers Dis. 2021;79:763-771.
    PubMed     Abstract available


  940. BALEA-FERNANDEZ FJ, Martinez-Vega B, Ortega S, Fabelo H, et al
    Analysis of Risk Factors in Dementia Through Machine Learning.
    J Alzheimers Dis. 2021;79:845-861.
    PubMed     Abstract available


  941. OVIEDO DC, Perez-Lao AR, Flores-Cuadra JA, Villarreal AE, et al
    Apolipoprotein varepsilon4 Affects Multiple Domains of Neuropsychological Functioning in a Sample of Elderly Hispanics.
    J Alzheimers Dis. 2021;82.
    PubMed     Abstract available


  942. STOJAKOVIC A, Chang SY, Nesbitt J, Pichurin NP, et al
    Partial Inhibition of Mitochondrial Complex I Reduces Tau Pathology and Improves Energy Homeostasis and Synaptic Function in 3xTg-AD Mice.
    J Alzheimers Dis. 2021;79:335-353.
    PubMed     Abstract available


  943. SUN L, Li W, Yue L, Xiao S, et al
    Blood TDP-43 Combined with Demographics Information Predicts Dementia Occurrence in Community Non-Dementia Elderly.
    J Alzheimers Dis. 2021;79:301-309.
    PubMed     Abstract available


  944. SOARES JZ, Pettersen R, Benth JS, Persson K, et al
    Vitamin D Levels, APOE Allele, and MRI Volumetry Assessed by NeuroQuant in Norwegian Adults with Cognitive Symptoms.
    J Alzheimers Dis. 2021;79:311-321.
    PubMed     Abstract available


  945. VITTAL RAO H, Bihaqi SW, Iannucci J, Sen A, et al
    Thrombin Signaling Contributes to High Glucose-Induced Injury of Human Brain Microvascular Endothelial Cells.
    J Alzheimers Dis. 2021;79:211-224.
    PubMed     Abstract available


  946. TUENA C, Mancuso V, Stramba-Badiale C, Pedroli E, et al
    Egocentric and Allocentric Spatial Memory in Mild Cognitive Impairment with Real-World and Virtual Navigation Tasks: A Systematic Review.
    J Alzheimers Dis. 2021;79:95-116.
    PubMed     Abstract available


  947. RODRIGUEZ-SALGADO AM, Llibre-Guerra JJ, Tsoy E, Penalver-Guia AI, et al
    A Brief Digital Cognitive Assessment for Detection of Cognitive Impairment in Cuban Older Adults.
    J Alzheimers Dis. 2021;79:85-94.
    PubMed     Abstract available


  948. TRAN L, Jung J, Carlin C, Lee S, et al
    Use of Direct-Acting Antiviral Agents and Survival Among Medicare Beneficiaries with Dementia and Chronic Hepatitis C.
    J Alzheimers Dis. 2021;79:71-83.
    PubMed     Abstract available


  949. YLA-HERTTUALA S, Hakulinen M, Poutiainen P, Laitinen TM, et al
    Severe Obstructive Sleep Apnea and Increased Cortical Amyloid-beta Deposition.
    J Alzheimers Dis. 2021;79:153-161.
    PubMed     Abstract available


  950. ZHU M, Jia L, Jia J
    Inhibition of miR-96-5p May Reduce Abeta42/Abeta40 Ratio via Regulating ATP-binding cassette transporter A1.
    J Alzheimers Dis. 2021;83:367-377.
    PubMed     Abstract available


  951. TAKAO H, Amemiya S, Abe O
    Reproducibility of Brain Volume Changes in Longitudinal Voxel-Based Morphometry Between Non-Accelerated and Accelerated Magnetic Resonance Imaging.
    J Alzheimers Dis. 2021;83:281-290.
    PubMed     Abstract available


  952. VAN DER LEE SJ, van Steenoven I, van de Beek M, Tesi N, et al
    Genetics Contributes to Concomitant Pathology and Clinical Presentation in Dementia with Lewy Bodies.
    J Alzheimers Dis. 2021;83:269-279.
    PubMed     Abstract available


  953. KAWAMURA K, Miyajima M, Nakajima M, Kanai M, et al
    Cerebrospinal Fluid Amyloid-beta Oligomer Levels in Patients with Idiopathic Normal Pressure Hydrocephalus.
    J Alzheimers Dis. 2021;83:179-190.
    PubMed     Abstract available


  954. IBANEZ A, Fittipaldi S, Trujillo C, Jaramillo T, et al
    Predicting and Characterizing Neurodegenerative Subtypes with Multimodal Neurocognitive Signatures of Social and Cognitive Processes.
    J Alzheimers Dis. 2021;83:227-248.
    PubMed     Abstract available


  955. JONES E, Aigbogun MS, Pike J, Berry M, et al
    Agitation in Dementia: Real-World Impact and Burden on Patients and the Healthcare System.
    J Alzheimers Dis. 2021;83:89-101.
    PubMed     Abstract available


  956. PARK J, Galvin JE
    Pre-Loss Grief in Caregivers of Older Adults with Dementia with Lewy Bodies.
    J Alzheimers Dis. 2021;82:1847-1859.
    PubMed     Abstract available


  957. QUATTRINI G, Marizzoni M, Pizzini FB, Galazzo IB, et al
    Convergent and Discriminant Validity of Default Mode Network and Limbic Network Perfusion in Amnestic Mild Cognitive Impairment Patients.
    J Alzheimers Dis. 2021;82:1797-1808.
    PubMed     Abstract available


  958. MORI H, Funahashi Y, Yoshino Y, Kumon H, et al
    Blood CDKN2A Gene Expression in Aging and Neurodegenerative Diseases.
    J Alzheimers Dis. 2021;82:1737-1744.
    PubMed     Abstract available


  959. WANG WZ, Li MW, Chen Y, Liu LY, et al
    3xTg-AD Mice Overexpressing Phospholipid Transfer Protein Improves Cognition Through Decreasing Amyloid-beta Production and Tau Hyperphosphorylation.
    J Alzheimers Dis. 2021;82:1635-1649.
    PubMed     Abstract available


  960. ELMALEH DR, Downey MA, Kundakovic L, Wilkinson JE, et al
    New Approaches to Profile the Microbiome for Treatment of Neurodegenerative Disease.
    J Alzheimers Dis. 2021;82:1373-1401.
    PubMed     Abstract available


  961. BARRETT T, Stangis KA, Saito T, Saido T, et al
    Neuronal Cell Cycle Re-Entry Enhances Neuropathological Features in AppNLF Knock-In Mice.
    J Alzheimers Dis. 2021;82:1683-1702.
    PubMed     Abstract available


  962. SAKAKIBARA Y, Hirota Y, Ibaraki K, Takei K, et al
    Widespread Reduced Density of Noradrenergic Locus Coeruleus Axons in the App Knock-In Mouse Model of Amyloid-beta Amyloidosis.
    J Alzheimers Dis. 2021;82:1513-1530.
    PubMed     Abstract available


  963. LI W, Wang S, Zhang H, Li B, et al
    Honokiol Restores Microglial Phagocytosis by Reversing Metabolic Reprogramming.
    J Alzheimers Dis. 2021;82:1475-1485.
    PubMed     Abstract available


  964. LAZAROVA MI, Tsekova DS, Tancheva LP, Kirilov KT, et al
    New Galantamine Derivatives with Inhibitory Effect on Acetylcholinesterase Activity.
    J Alzheimers Dis. 2021;83:1211-1220.
    PubMed     Abstract available


  965. SAKURAI K, Kaneda D, Uchida Y, Inui S, et al
    Can Medial Temporal Impairment Be an Imaging Red Flag for Neurodegeneration in Disproportionately Enlarged Subarachnoid Space Hydrocephalus?
    J Alzheimers Dis. 2021;83:1199-1209.
    PubMed     Abstract available


  966. FELISBERTI FM
    Hedonic Preferences to Audio and Visual Stimulation in Seniors with Cognitive Impairments.
    J Alzheimers Dis. 2021;83:1353-1366.
    PubMed     Abstract available


  967. SCHENNING KJ, Holden S, Davis BA, Mulford A, et al
    Gene-Specific DNA Methylation Linked to Postoperative Cognitive Dysfunction in Apolipoprotein E3 and E4 Mice.
    J Alzheimers Dis. 2021;83:1251-1268.
    PubMed     Abstract available


  968. SIERRA-FONSECA JA, Rodriguez M, Themann A, Lira O, et al
    Autophagy Induction and Accumulation of Phosphorylated Tau in the Hippocampus and Prefrontal Cortex of Adult C57BL/6 Mice Subjected to Adolescent Fluoxetine Treatment.
    J Alzheimers Dis. 2021;83:1691-1702.
    PubMed     Abstract available


  969. MORRIS R, Umeukeje G, Bu K, Cheng F, et al
    The Association Between Use of Rivastigmine and Pneumonia: Systematic Analysis of FDA Adverse Event Reporting System.
    J Alzheimers Dis. 2021;83:1061-1071.
    PubMed     Abstract available


  970. JORDA A, Aldasoro M, Aldasoro C, Valles SL, et al
    Inflammatory Chemokines Expression Variations and Their Receptors in APP/PS1 Mice.
    J Alzheimers Dis. 2021;83:1051-1060.
    PubMed     Abstract available


  971. GOUILLY D, Tisserand C, Nogueira L, Saint-Lary L, et al
    Taking the A Train? Limited Consistency of Abeta42 and the Abeta42/40 Ratio in the AT(N) Classification.
    J Alzheimers Dis. 2021;83:1033-1038.
    PubMed     Abstract available


  972. SIQUEIRA LD, Celes APM, Santos HD, Ferreira ST, et al
    A Specialized Nutritional Formulation Prevents Hippocampal Glial Activation and Memory Impairment Induced by Amyloid-beta Oligomers in Mice.
    J Alzheimers Dis. 2021;83:1113-1124.
    PubMed     Abstract available


  973. POPE CA, Wilkins HM, Swerdlow RH, Wolfe MS, et al
    Mutations in the Amyloid-beta Protein Precursor Reduce Mitochondrial Function and Alter Gene Expression Independent of 42-Residue Amyloid-beta Peptide.
    J Alzheimers Dis. 2021;83:1039-1049.
    PubMed     Abstract available


  974. SUBRAMANIAM S, Blake DT, Constantinidis C
    Cholinergic Deep Brain Stimulation for Memory and Cognitive Disorders.
    J Alzheimers Dis. 2021;83:491-503.
    PubMed     Abstract available


  975. DHANA K, James BD, Agarwal P, Aggarwal NT, et al
    MIND Diet, Common Brain Pathologies, and Cognition in Community-Dwelling Older Adults.
    J Alzheimers Dis. 2021;83:683-692.
    PubMed     Abstract available


  976. YANG L, Wu C, Tucker L, Dong Y, et al
    Photobiomodulation Therapy Attenuates Anxious-Depressive-Like Behavior in the TgF344 Rat Model.
    J Alzheimers Dis. 2021;83:1415-1429.
    PubMed     Abstract available


  977. ASO Y, Kimura N, Matsubara E
    Novel Serum Biomarkers of Neurovascular Unit Associated with Cortical Amyloid Deposition.
    J Alzheimers Dis. 2021;84:905-914.
    PubMed     Abstract available


  978. YIN X, Zhou Z, Qiu Y, Fan X, et al
    SIRT1 Regulates Tau Expression and Tau Synaptic Pathology.
    J Alzheimers Dis. 2021;84:895-904.
    PubMed     Abstract available


  979. DAI S, Zhou F, Sun J, Li Y, et al
    NPD1 Enhances Autophagy and Reduces Hyperphosphorylated Tau and Amyloid-beta42 by Inhibiting GSK3beta Activation in N2a/APP695swe Cells.
    J Alzheimers Dis. 2021;84:869-881.
    PubMed     Abstract available


  980. FINK A, Doblhammer G, Tamguney G
    Recurring Gastrointestinal Infections Increase the Risk of Dementia.
    J Alzheimers Dis. 2021;84:797-806.
    PubMed     Abstract available


  981. LAZAROVA M, Tancheva L, Alexandrova A, Tsvetanova E, et al
    Effects of New Galantamine Derivatives in a Scopolamine Model of Dementia in Mice.
    J Alzheimers Dis. 2021;84:671-690.
    PubMed     Abstract available


  982. KITANI-MORII F, Friedland RP, Yoshida H, Mizuno T, et al
    Drosophila as a Model for Microbiota Studies of Neurodegeneration.
    J Alzheimers Dis. 2021;84:479-490.
    PubMed     Abstract available


  983. LAZRIS D, Perkins MM, Bay AA, Hackney ME, et al
    Qualitative Evaluation Informs Understanding of Motor Cognition and Therapies in Older Adults with Mild Cognitive Impairment.
    J Alzheimers Dis. 2021;84:691-703.
    PubMed     Abstract available


  984. WEI S, Shang S, Dang L, Gao F, et al
    Blood Triglyceride and High-Density Lipoprotein Levels Are Associated with Plasma Amyloid-beta Transport: A Population-Based Cross-Sectional Study.
    J Alzheimers Dis. 2021;84:303-314.
    PubMed     Abstract available


  985. XIA L, Pang Y, Li J, Wu B, et al
    Dihydroartemisinin Induces O-GlcNAcylation and Improves Cognitive Function in a Mouse Model of Tauopathy.
    J Alzheimers Dis. 2021;84:239-248.
    PubMed     Abstract available


  986. DEFEIS B, Ying G, Kurasz AM, De Wit L, et al
    Latent Factor Structure of Outcome Measures Used in the HABIT(R) Mild Cognitive Impairment Intervention Programs.
    J Alzheimers Dis. 2021;84:193-205.
    PubMed     Abstract available


  987. GAN J, Liu S, Wang XD, Hu W, et al
    The Association Between Hyperhidrosis and Dementia: A Community-Based Research.
    J Alzheimers Dis. 2021;84:1657-1667.
    PubMed     Abstract available


  988. UPITE J, Bruning T, Mohle L, Brackhan M, et al
    A New Tool for the Analysis of the Effect of Intracerebrally Injected Anti-Amyloid-beta Compounds.
    J Alzheimers Dis. 2021;84:1677-1690.
    PubMed     Abstract available


  989. GALVIN JE, Chrisphonte S, Chang LC
    Medical and Social Determinants of Brain Health and Dementia in a Multicultural Community Cohort of Older Adults.
    J Alzheimers Dis. 2021;84:1563-1576.
    PubMed     Abstract available


  990. FOUCARD C, Palisson J, Belin C, Bereaux C, et al
    The Diagnostic Value of a Short Memory Test: The TNI-93.
    J Alzheimers Dis. 2021;84:1461-1471.
    PubMed     Abstract available


  991. HOILUND-CARLSEN PF, Alavi A
    Aducanumab (Marketed as Aduhelm) Approval Is Likely Based on Misinterpretation of PET Imaging Data.
    J Alzheimers Dis. 2021;84:1457-1460.
    PubMed     Abstract available


  992. NAKAHATA N, Nakamura T, Kawarabayashi T, Seino Y, et al
    Age-Related Cognitive Decline and Prevalence of Mild Cognitive Impairment in the Iwaki Health Promotion Project.
    J Alzheimers Dis. 2021;84:1233-1245.
    PubMed     Abstract available


  993. TIAN T, Qin X, Wang Y, Shi Y, et al
    40 Hz Light Flicker Promotes Learning and Memory via Long Term Depression in Wild-Type Mice.
    J Alzheimers Dis. 2021;84:983-993.
    PubMed     Abstract available


  994. FILIPPONE A, Li JG, Pratico D
    VPS35 Downregulation Alters Degradation Pathways in Neuronal Cells.
    J Alzheimers Dis. 2021;84:1079-1089.
    PubMed     Abstract available


    December 2020
  995. SOLDEVILA-DOMENECH N, Forcano L, Boronat A, Lorenzo T, et al
    Effects of COVID-19 Home Confinement on Mental Health in Individuals with Increased Risk of Alzheimer's Disease.
    J Alzheimers Dis. 2020 Dec 31. pii: JAD201408. doi: 10.3233/JAD-201408.
    PubMed     Abstract available


  996. GONZALEZ C, Tommasi NS, Briggs D, Properzi MJ, et al
    Financial Capacity and Regional Cerebral Tau in Cognitively Normal Older Adults, Mild Cognitive Impairment, and Alzheimer's Disease Dementia.
    J Alzheimers Dis. 2020 Dec 29. pii: JAD201122. doi: 10.3233/JAD-201122.
    PubMed     Abstract available


  997. FU Z, Zhao M, Wang X, He Y, et al
    Altered Neuroanatomical Asymmetries of Subcortical Structures in Subjective Cognitive Decline, Amnestic Mild Cognitive Impairment, and Alzheimer's Disease.
    J Alzheimers Dis. 2020 Dec 29. pii: JAD201116. doi: 10.3233/JAD-201116.
    PubMed    


  998. BARTHELSON K, Pederson SM, Newman M, Lardelli M, et al
    Brain Transcriptome Analysis of a Protein-Truncating Mutation in Sortilin-Related Receptor 1 Associated With Early-Onset Familial Alzheimer's Disease Indicates Early Effects on Mitochondrial and Ribosome Function.
    J Alzheimers Dis. 2020 Dec 26. pii: JAD201383. doi: 10.3233/JAD-201383.
    PubMed     Abstract available


  999. TRUMBORE CN
    Shear-Induced Amyloid Aggregation in the Brain: V. Are Alzheimer's and Other Amyloid Diseases Initiated in the Lower Brain and Brainstem by Cerebrospinal Fluid Flow Stresses?
    J Alzheimers Dis. 2020 Dec 26. pii: JAD201025. doi: 10.3233/JAD-201025.
    PubMed     Abstract available


  1000. RYAN M, Tan VTY, Thompson N, Guevremont D, et al
    Lentivirus-Mediated Expression of Human Secreted Amyloid Precursor Protein-Alpha Promotes Long-Term Induction of Neuroprotective Genes and Pathways in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2020 Dec 26. pii: JAD200757. doi: 10.3233/JAD-200757.
    PubMed     Abstract available


  1001. BABULAL GM, Johnson A, Fagan AM, Morris JC, et al
    Identifying Preclinical Alzheimer's Disease Using Everyday Driving Behavior: Proof of Concept.
    J Alzheimers Dis. 2020 Dec 23. pii: JAD201294. doi: 10.3233/JAD-201294.
    PubMed     Abstract available


  1002. STREIT WJ, Khoshbouei H, Bechmann I
    The Role of Microglia in Sporadic Alzheimer's Disease.
    J Alzheimers Dis. 2020 Dec 23. pii: JAD201248. doi: 10.3233/JAD-201248.
    PubMed     Abstract available


  1003. FUTAMURA A, Hieda S, Mori Y, Sugimoto A, et al
    Cingulate Island Sign in Single Photon Emission Computed Tomography: Clinical Biomarker Correlations in Lewy Body Disease and Alzheimer's Disease.
    J Alzheimers Dis. 2020 Dec 23. pii: JAD201145. doi: 10.3233/JAD-201145.
    PubMed     Abstract available


  1004. HOANG MT, Kareholt I, von Euler M, von Koch L, et al
    Satisfaction with Stroke Care Among Patients with Alzheimer's and Other Dementias: A Swedish Register-Based Study.
    J Alzheimers Dis. 2020 Dec 23. pii: JAD200976. doi: 10.3233/JAD-200976.
    PubMed     Abstract available


  1005. BAO YW, Chau ACM, Chiu PK, Shea YF, et al
    Heterogeneity of Amyloid Binding in Cognitively Impaired Patients Consecutively Recruited from a Memory Clinic: Evaluating the Utility of Quantitative 18F-Flutemetamol PET-CT in Discrimination of Mild Cognitive Impairment from Alzheimer's Disease and
    J Alzheimers Dis. 2020 Dec 23. pii: JAD200890. doi: 10.3233/JAD-200890.
    PubMed     Abstract available


  1006. TROMP K, Smedinga M, Richard E, Perry M, et al
    Views on Early Diagnosis of Alzheimer's Disease Among Dutch Physicians: A Qualitative Interview Study.
    J Alzheimers Dis. 2020 Dec 23. pii: JAD200884. doi: 10.3233/JAD-200884.
    PubMed     Abstract available


  1007. YUAN J, Maserejian N, Liu Y, Devine S, et al
    Severity Distribution of Alzheimer's Disease Dementia and Mild Cognitive Impairment in the Framingham Heart Study.
    J Alzheimers Dis. 2020 Dec 20. pii: JAD200786. doi: 10.3233/JAD-200786.
    PubMed     Abstract available


  1008. MINTA K, Brinkmalm G, Portelius E, Johansson P, et al
    Brevican and Neurocan Peptides as Potential Cerebrospinal Fluid Biomarkers for Differentiation Between Vascular Dementia and Alzheimer's Disease.
    J Alzheimers Dis. 2020 Dec 17. pii: JAD201039. doi: 10.3233/JAD-201039.
    PubMed     Abstract available


  1009. WU W, Lee I, Spratt H, Fang X, et al
    tRNA-Derived Fragments in Alzheimer's Disease: Implications for New Disease Biomarkers and Neuropathological Mechanisms.
    J Alzheimers Dis. 2020 Dec 17. pii: JAD200917. doi: 10.3233/JAD-200917.
    PubMed     Abstract available


  1010. PETERSEN ME, Rafii MS, Zhang F, Hall J, et al
    Plasma Total-Tau and Neurofilament Light Chain as Diagnostic Biomarkers of Alzheimer's Disease Dementia and Mild Cognitive Impairment in Adults with Down Syndrome.
    J Alzheimers Dis. 2020 Dec 16. pii: JAD201167. doi: 10.3233/JAD-201167.
    PubMed     Abstract available


  1011. ORJUELA A, Lakey-Beitia J, Mojica-Flores R, Hegde ML, et al
    Computational Evaluation of Interaction Between Curcumin Derivatives and Amyloid-beta Monomers and Fibrils: Relevance to Alzheimer's Disease.
    J Alzheimers Dis. 2020 Dec 16. pii: JAD200941. doi: 10.3233/JAD-200941.
    PubMed     Abstract available


  1012. MOZERSKY J, Hartz S, Linnenbringer E, Levin L, et al
    Communicating 5-Year Risk of Alzheimer's Disease Dementia: Development and Evaluation of Materials that Incorporate Multiple Genetic and Biomarker Research Results.
    J Alzheimers Dis. 2020 Dec 15. pii: JAD200993. doi: 10.3233/JAD-200993.
    PubMed     Abstract available


  1013. FANET H, Tournissac M, Leclerc M, Caron V, et al
    Tetrahydrobiopterin Improves Recognition Memory in the Triple-Transgenic Mouse Model of Alzheimer's Disease, Without Altering Amyloid-beta and Tau Pathologies.
    J Alzheimers Dis. 2020 Dec 15. pii: JAD200637. doi: 10.3233/JAD-200637.
    PubMed     Abstract available


  1014. MURCHISON CF, Kennedy RE, McConathy JE, Roberson ED, et al
    Racial Differences in Alzheimer's Disease Specialist Encounters are Associated with Usage of Molecular Imaging and Dementia Medications: An Enterprise-Wide Analysis Using i2b2.
    J Alzheimers Dis. 2020 Dec 14. pii: JAD200796. doi: 10.3233/JAD-200796.
    PubMed     Abstract available


  1015. ROMANO RR, Carter MA, Dietrich MS, Cowan RL, et al
    Could Altered Evoked Pain Responsiveness Be a Phenotypic Biomarker for Alzheimer's Disease Risk? A Cross-Sectional Analysis of Cognitively Healthy Individuals.
    J Alzheimers Dis. 2020 Dec 13. pii: JAD201293. doi: 10.3233/JAD-201293.
    PubMed     Abstract available


  1016. TEIPEL SJ, Marie Temp AG, Levin F, Dyrba M, et al
    Association of TDP-43 Pathology with Global and Regional 18F-Florbetapir PET Signal in the Alzheimer's Disease Spectrum.
    J Alzheimers Dis. 2020 Dec 13. pii: JAD201032. doi: 10.3233/JAD-201032.
    PubMed     Abstract available


  1017. IBI D, Hirashima K, Kojima Y, Sumiya K, et al
    Preventive Effects of Continuous Betaine Intake on Cognitive Impairment and Aberrant Gene Expression in Hippocampus of 3xTg Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2020 Dec 13. pii: JAD200972. doi: 10.3233/JAD-200972.
    PubMed     Abstract available


  1018. WANG Q, Chen B, Zhong X, Zhou H, et al
    Olfactory Dysfunction Is Already Present with Subjective Cognitive Decline and Deepens with Disease Severity in the Alzheimer's Disease Spectrum.
    J Alzheimers Dis. 2020 Dec 13. pii: JAD201168. doi: 10.3233/JAD-201168.
    PubMed     Abstract available


  1019. ETTCHETO M, Busquets O, Cano A, Sanchez-Lopez E, et al
    Pharmacological Strategies to Improve Dendritic Spines in Alzheimer's Disease.
    J Alzheimers Dis. 2020 Dec 2. pii: JAD201106. doi: 10.3233/JAD-201106.
    PubMed     Abstract available


  1020. BEACH TG, Malek-Ahmadi M
    Alzheimer's Disease Neuropathological Comorbidities are Common in the Younger-Old.
    J Alzheimers Dis. 2020 Dec 1. pii: JAD201213. doi: 10.3233/JAD-201213.
    PubMed     Abstract available


  1021. FLAX J, Wilkins HM, Miller R, Griffith S, et al
    OGA Inhibition Alters Energetics and Nutrient Sensing in Alzheimer's Disease Cytoplasmic Hybrids.
    J Alzheimers Dis. 2020 Dec 1. pii: JAD200996. doi: 10.3233/JAD-200996.
    PubMed     Abstract available


  1022. BIRKENBIHL C, Westwood S, Shi L, Nevado-Holgado A, et al
    ANMerge: A Comprehensive and Accessible Alzheimer's Disease Patient-Level Dataset.
    J Alzheimers Dis. 2020 Dec 1. pii: JAD200948. doi: 10.3233/JAD-200948.
    PubMed     Abstract available


  1023. JAYATUNGA DPW, Hone E, Bharadwaj P, Garg M, et al
    Targeting Mitophagy in Alzheimer's Disease.
    J Alzheimers Dis. 2020 Dec 1. pii: JAD191258. doi: 10.3233/JAD-191258.
    PubMed     Abstract available


    November 2020
  1024. DENIZ K, Ho CCG, Malphrus KG, Reddy JS, et al
    Plasma Biomarkers of Alzheimer's Disease in African Americans.
    J Alzheimers Dis. 2020 Nov 27. pii: JAD200828. doi: 10.3233/JAD-200828.
    PubMed     Abstract available


  1025. BASTRUP J, Hansen KH, Poulsen TBG, Kastaniegaard K, et al
    Anti-Abeta Antibody Aducanumab Regulates the Proteome of Senile Plaques and Closely Surrounding Tissue in a Transgenic Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2020 Nov 27. pii: JAD200715. doi: 10.3233/JAD-200715.
    PubMed     Abstract available


  1026. KOYCHEV I, Jansen K, Dette A, Shi L, et al
    Blood-Based ATN Biomarkers of Alzheimer's Disease: A Meta-Analysis.
    J Alzheimers Dis. 2020 Nov 24. pii: JAD200900. doi: 10.3233/JAD-200900.
    PubMed     Abstract available


  1027. SOTO-MERCADO V, Mendivil-Perez M, Jimenez-Del-Rio M, Velez-Pardo C, et al
    Multi-Target Effects of the Cannabinoid CP55940 on Familial Alzheimer's Disease PSEN1 E280A Cholinergic-Like Neurons: Role of CB1 Receptor.
    J Alzheimers Dis. 2020 Nov 23. pii: JAD201045. doi: 10.3233/JAD-201045.
    PubMed     Abstract available


  1028. GIL R, Arroyo-Anllo EM
    Alzheimer's Disease and Face Masks in Times of COVID-19.
    J Alzheimers Dis. 2020 Nov 22. pii: JAD201233. doi: 10.3233/JAD-201233.
    PubMed     Abstract available


  1029. YEE E, Ma D, Popuri K, Wang L, et al
    Construction of MRI-Based Alzheimer's Disease Score Based on Efficient 3D Convolutional Neural Network: Comprehensive Validation on 7,902 Images from a Multi-Center Dataset.
    J Alzheimers Dis. 2020 Nov 21. pii: JAD200830. doi: 10.3233/JAD-200830.
    PubMed     Abstract available


  1030. SERGOTT RC, Raji A, Kost J, Sur C, et al
    Retinal Optical Coherence Tomography Metrics are Unchanged in Verubecestat Alzheimer's Disease Clinical Trial but Correlate with Baseline Regional Brain Atrophy.
    J Alzheimers Dis. 2020 Nov 21. pii: JAD200735. doi: 10.3233/JAD-200735.
    PubMed     Abstract available


  1031. VAN WAALWIJK VAN DOORN LJC, Ghafoorian M, van Leijsen EMC, Claassen JAHR, et al
    White Matter Hyperintensities are No Major Confounder for Alzheimer's Disease Cerebrospinal Fluid Biomarkers.
    J Alzheimers Dis. 2020 Nov 21. pii: JAD200496. doi: 10.3233/JAD-200496.
    PubMed     Abstract available


  1032. FLORES-CUADRA JA, Madrid A, Fernandez PL, Perez-Lao AR, et al
    Critical Review of the Alzheimer's Disease Non-Transgenic Models: Can They Contribute to Disease Treatment?
    J Alzheimers Dis. 2020 Nov 20. pii: JAD200870. doi: 10.3233/JAD-200870.
    PubMed     Abstract available


  1033. BUSQUETS O, Parcerisas A, Verdaguer E, Ettcheto M, et al
    c-Jun N-Terminal Kinases in Alzheimer's Disease: A Possible Target for the Modulation of the Earliest Alterations.
    J Alzheimers Dis. 2020 Nov 18. pii: JAD201053. doi: 10.3233/JAD-201053.
    PubMed     Abstract available


  1034. RADESTIG MA, Skoog J, Zetterberg H, Kern J, et al
    Cognitive Performance and Cerebrospinal Fluid Markers in Preclinical Alzheimer's Disease: Results from the Gothenburg H70 Birth Cohort Studies.
    J Alzheimers Dis. 2020 Nov 17. pii: JAD200751. doi: 10.3233/JAD-200751.
    PubMed     Abstract available


  1035. YANG B, Yang S, Zhang Y, Liu W, et al
    Stressor-Oriented MUlticomponent Intervention and the WeLl-Being of Patients with Alzheimer's Disease: A Randomized Controlled Trial (SOUL-P).
    J Alzheimers Dis. 2020 Nov 17. pii: JAD200652. doi: 10.3233/JAD-200652.
    PubMed     Abstract available


  1036. FEMMINELLA GD, Harold D, Scott J, Williams J, et al
    The Differential Influence of Immune, Endocytotic, and Lipid Metabolism Genes on Amyloid Deposition and Neurodegeneration in Subjects at Risk of Alzheimer's Disease.
    J Alzheimers Dis. 2020 Nov 17. pii: JAD200578. doi: 10.3233/JAD-200578.
    PubMed     Abstract available


  1037. BECKER S, Boettinger O, Sulzer P, Hobert MA, et al
    Everyday Function in Alzheimer's and Parkinson's Patients with Mild Cognitive Impairment.
    J Alzheimers Dis. 2020 Nov 17. pii: JAD200256. doi: 10.3233/JAD-200256.
    PubMed     Abstract available


  1038. MADERNA E, Visona S, Bolcato V, Redaelli V, et al
    Neuropathological Alzheimer's Disease Lesions in Nasu-Hakola Disease with TREM2 Mutation: Atypical Distribution of Neurofibrillary Changes.
    J Alzheimers Dis. 2020 Nov 13. pii: JAD201085. doi: 10.3233/JAD-201085.
    PubMed     Abstract available


  1039. BARKER W, Quinonez C, Greig MT, Behar R, et al
    Utility of Plasma Neurofilament Light in the 1Florida Alzheimer's Disease Research Center (ADRC).
    J Alzheimers Dis. 2020 Nov 13. pii: JAD200901. doi: 10.3233/JAD-200901.
    PubMed     Abstract available


  1040. GUARNIERI B, Maestri M, Cucchiara F, Lo Gerfo A, et al
    Multicenter Study on Sleep and Circadian Alterations as Objective Markers of Mild Cognitive Impairment and Alzheimer's Disease Reveals Sex Differences.
    J Alzheimers Dis. 2020 Nov 11. pii: JAD200632. doi: 10.3233/JAD-200632.
    PubMed     Abstract available


  1041. SINGH A, Allen D, Fracassi A, Tumurbaatar B, et al
    Functional Integrity of Synapses in the Central Nervous System of Cognitively Intact Individuals with High Alzheimer's Disease Neuropathology is Associated with Absence of Synaptic Tau Oligomers.
    J Alzheimers Dis. 2020 Nov 7. pii: JAD200716. doi: 10.3233/JAD-200716.
    PubMed     Abstract available


  1042. WALKER JD, Spiro G, Loewen K, Jacklin K, et al
    Alzheimer's Disease and Related Dementia in Indigenous Populations: A Systematic Review of Risk Factors.
    J Alzheimers Dis. 2020 Nov 7. pii: JAD200704. doi: 10.3233/JAD-200704.
    PubMed     Abstract available


  1043. HONG T, Hirano S, Sakurai T, Nakano Y, et al
    The Neuropsychological Correlates of Brain Perfusion and Gray Matter Volume in Alzheimer's Disease.
    J Alzheimers Dis. 2020 Nov 7. pii: JAD200676. doi: 10.3233/JAD-200676.
    PubMed     Abstract available


  1044. LI X, Xuan W, Chen D, Gao H, et al
    Research Progress of Alzheimer's Disease Therapeutic Drugs: Based on Renin-Angiotensin System Axis.
    J Alzheimers Dis. 2020 Nov 6. pii: JAD200770. doi: 10.3233/JAD-200770.
    PubMed     Abstract available


  1045. DE LA FUENTE GARCIA S, Ritchie C, Luz S
    Artificial Intelligence, Speech, and Language Processing Approaches to Monitoring Alzheimer's Disease: A Systematic Review.
    J Alzheimers Dis. 2020 Nov 6. pii: JAD200888. doi: 10.3233/JAD-200888.
    PubMed     Abstract available


  1046. YANG YX, Ku K, Li HQ, Shen XN, et al
    Investigating Causal Relations Between Risk Tolerance, Risky Behaviors, and Alzheimer's Disease: A Bidirectional Two-Sample Mendelian Randomization Study.
    J Alzheimers Dis. 2020 Nov 6. pii: JAD200773. doi: 10.3233/JAD-200773.
    PubMed     Abstract available


  1047. ARMSTRONG TD, Suwannasual U, Kennedy CL, Thasma A, et al
    Exposure to Traffic-Generated Pollutants Exacerbates the Expression of Factors Associated with the Pathophysiology of Alzheimer's Disease in Aged C57BL/6 Wild-Type Mice.
    J Alzheimers Dis. 2020 Nov 4. pii: JAD200929. doi: 10.3233/JAD-200929.
    PubMed     Abstract available


  1048. RICHTER N, Bischof G, Dronse J, Nellessen N, et al
    Entorhinal Tau Predicts Hippocampal Activation and Memory Deficits in Alzheimer's Disease.
    J Alzheimers Dis. 2020 Nov 4. pii: JAD200835. doi: 10.3233/JAD-200835.
    PubMed     Abstract available


    October 2020
  1049. POPLE CB, Meng Y, Li DZ, Bigioni L, et al
    Neuromodulation in the Treatment of Alzheimer's Disease: Current and Emerging Approaches.
    J Alzheimers Dis. 2020 Oct 29. pii: JAD200913. doi: 10.3233/JAD-200913.
    PubMed     Abstract available


  1050. YILMAZ A, Ustun I, Ugur Z, Akyol S, et al
    A Community-Based Study Identifying Metabolic Biomarkers of Mild Cognitive Impairment and Alzheimer's Disease Using Artificial Intelligence and Machine Learning.
    J Alzheimers Dis. 2020 Oct 29. pii: JAD200305. doi: 10.3233/JAD-200305.
    PubMed     Abstract available


  1051. BARTELS C, Kogel A, Schweda M, Wiltfang J, et al
    Use of Cerebrospinal Fluid Biomarkers of Alzheimer's Disease Risk in Mild Cognitive Impairment and Subjective Cognitive Decline in Routine Clinical Care in Germany.
    J Alzheimers Dis. 2020 Oct 20. pii: JAD200794. doi: 10.3233/JAD-200794.
    PubMed     Abstract available


  1052. LIU KY, Costello H, Reeves S, Howard R, et al
    The Relationship Between Anxiety and Incident Agitation in Alzheimer's Disease.
    J Alzheimers Dis. 2020 Oct 20. pii: JAD200516. doi: 10.3233/JAD-200516.
    PubMed     Abstract available


  1053. FIELDS TN, Mueller KD, Koscik RL, Johnson SC, et al
    Self-Reported Hearing Loss and Longitudinal Cognitive Function in a Cohort Enriched with Risk for Alzheimer's Disease.
    J Alzheimers Dis. 2020 Oct 17. pii: JAD200701. doi: 10.3233/JAD-200701.
    PubMed     Abstract available


  1054. GIBSON GE, Luchsinger JA, Cirio R, Chen H, et al
    Benfotiamine and Cognitive Decline in Alzheimer's Disease: Results of a Randomized Placebo-Controlled Phase IIa Clinical Trial.
    J Alzheimers Dis. 2020 Oct 16. pii: JAD200896. doi: 10.3233/JAD-200896.
    PubMed     Abstract available


  1055. RESCHKE-HERNANDEZ AE, Belfi AM, Guzman-Velez E, Tranel D, et al
    Hooked on a Feeling: Influence of Brief Exposure to Familiar Music on Feelings of Emotion in Individuals with Alzheimer's Disease.
    J Alzheimers Dis. 2020 Oct 16. pii: JAD200889. doi: 10.3233/JAD-200889.
    PubMed     Abstract available


  1056. CROCCO E, Curiel-Cid RE, Kitaigorodsky M, Gonzalez-Jimenez CJ, et al
    A Brief Version of the LASSI-L Detects Prodromal Alzheimer's Disease States.
    J Alzheimers Dis. 2020 Oct 16. pii: JAD200790. doi: 10.3233/JAD-200790.
    PubMed     Abstract available


  1057. MENNE F, Schipke CG, Klostermann A, Fuentes-Casan M, et al
    Value of Neuropsychological Tests to Identify Patients with Depressive Symptoms on the Alzheimer's Disease Continuum.
    J Alzheimers Dis. 2020 Oct 16. pii: JAD200710. doi: 10.3233/JAD-200710.
    PubMed     Abstract available


  1058. KRITIKOS M, Gandy S, Meliker JR, Luft BJ, et al
    Acute versus Chronic Exposures to Inhaled Particulate Matter and Neurocognitive Dysfunction: Pathways to Alzheimer's Disease or a Related Dementia.
    J Alzheimers Dis. 2020 Oct 16. pii: JAD200679. doi: 10.3233/JAD-200679.
    PubMed     Abstract available


  1059. MARIZZONI M, Cattaneo A, Mirabelli P, Festari C, et al
    Short-Chain Fatty Acids and Lipopolysaccharide as Mediators Between Gut Dysbiosis and Amyloid Pathology in Alzheimer's Disease.
    J Alzheimers Dis. 2020 Oct 14. pii: JAD200306. doi: 10.3233/JAD-200306.
    PubMed     Abstract available


  1060. KHALSA DS
    The End of Alzheimer's Protocol: The First Protocol to Enhance Cognition and Reverse Decline at Any Age by Dale Bredesen, Avery, 2020, 352 pp.
    J Alzheimers Dis. 2020 Oct 13. pii: JAD201157. doi: 10.3233/JAD-201157.
    PubMed    


  1061. ITZHAKI RF
    Antivirals Against SARS-CoV2: Relevance to the Treatment of Alzheimer's Disease.
    J Alzheimers Dis. 2020 Oct 13. pii: JAD200986. doi: 10.3233/JAD-200986.
    PubMed     Abstract available


  1062. MATIAS-GUIU JA, Pytel V, Matias-Guiu J
    Death Rate Due to COVID-19 in Alzheimer's Disease and Frontotemporal Dementia.
    J Alzheimers Dis. 2020 Oct 13. pii: JAD200940. doi: 10.3233/JAD-200940.
    PubMed     Abstract available


  1063. DUGGAN MR, Torkzaban B, Ahooyi TM, Khalili K, et al
    Potential Role for Herpesviruses in Alzheimer's Disease.
    J Alzheimers Dis. 2020 Oct 13. pii: JAD200814. doi: 10.3233/JAD-200814.
    PubMed     Abstract available


  1064. GABERE M, Thu Pham NT, Graff-Radford J, Machulda MM, et al
    Automated Hippocampal Subfield Volumetric Analyses in Atypical Alzheimer's Disease.
    J Alzheimers Dis. 2020 Oct 13. pii: JAD200625. doi: 10.3233/JAD-200625.
    PubMed     Abstract available


  1065. LOUPY KM, Lee T, Zambrano CA, Elsayed AI, et al
    Alzheimer's Disease: Protective Effects of Mycobacterium vaccae, a Soil-Derived Mycobacterium with Anti-Inflammatory and Anti-Tubercular Properties, on the Proteomic Profiles of Plasma and Cerebrospinal Fluid in Rats.
    J Alzheimers Dis. 2020 Oct 13. pii: JAD200568. doi: 10.3233/JAD-200568.
    PubMed     Abstract available


  1066. ZHANG T, Han X, Zhang X, Chen Z, et al
    Dietary Fatty Acid Factors in Alzheimer's Disease: A Mini-Review.
    J Alzheimers Dis. 2020 Oct 13. pii: JAD200558. doi: 10.3233/JAD-200558.
    PubMed     Abstract available


  1067. RUITER M, Herstel LJ, Wierenga CJ
    Reduction of Dendritic Inhibition in CA1 Pyramidal Neurons in Amyloidosis Models of Early Alzheimer's Disease.
    J Alzheimers Dis. 2020 Oct 13. pii: JAD200527. doi: 10.3233/JAD-200527.
    PubMed     Abstract available


  1068. ROSIN ER, Blasco D, Pilozzi AR, Yang LH, et al
    A Narrative Review of Alzheimer's Disease Stigma.
    J Alzheimers Dis. 2020 Oct 9. pii: JAD200932. doi: 10.3233/JAD-200932.
    PubMed     Abstract available


  1069. HUTTENRAUCH M, Lopez-Noguerola JS, Castro-Obregon S
    Connecting Mind-Body Therapy-Mediated Effects to Pathological Features of Alzheimer's Disease.
    J Alzheimers Dis. 2020 Oct 9. pii: JAD200743. doi: 10.3233/JAD-200743.
    PubMed     Abstract available


  1070. RAVONA-SPRINGER R, Sharvit-Ginon I, Ganmore I, Greenbaum L, et al
    The Israel Registry for Alzheimer's Prevention (IRAP) Study: Design and Baseline Characteristics.
    J Alzheimers Dis. 2020 Oct 2. pii: JAD200623. doi: 10.3233/JAD-200623.
    PubMed     Abstract available


  1071. CHANG KH, Huang CC, Chen CM, Wu HC, et al
    Differences in Clinical Presentation of Behavioral and Psychological Symptoms of Dementia in Alzheimer's Disease According to Sex and Education Level.
    J Alzheimers Dis. 2020 Oct 2. pii: JAD200507. doi: 10.3233/JAD-200507.
    PubMed     Abstract available


  1072. STONNINGTON CM, Velgos SN, Chen Y, Syed S, et al
    Interaction Between BDNF Val66Met and APOE4 on Biomarkers of Alzheimer's Disease and Cognitive Decline.
    J Alzheimers Dis. 2020 Oct 2. pii: JAD200132. doi: 10.3233/JAD-200132.
    PubMed     Abstract available


  1073. LEE JH, Byun MS, Yi D, Ko K, et al
    Long-Term Exposure to PM10 and in vivo Alzheimer's Disease Pathologies.
    J Alzheimers Dis. 2020 Oct 1. pii: JAD200694. doi: 10.3233/JAD-200694.
    PubMed     Abstract available


  1074. GAVRIEL Y, Rabinovich-Nikitin I, Ezra A, Barbiro B, et al
    Subcutaneous Administration of AMD3100 into Mice Models of Alzheimer's Disease Ameliorated Cognitive Impairment, Reduced Neuroinflammation, and Improved Pathophysiological Markers.
    J Alzheimers Dis. 2020 Oct 1. pii: JAD200506. doi: 10.3233/JAD-200506.
    PubMed     Abstract available


  1075. GAO L, Wang J, Jiang Y, Wei S, et al
    Relationship Between Peripheral Transport Proteins and Plasma Amyloid-beta in Patients with Alzheimer's Disease were Different from Cognitively Normal Controls: A Propensity Score Matching Analysis.
    J Alzheimers Dis. 2020 Oct 1. pii: JAD191320. doi: 10.3233/JAD-191320.
    PubMed     Abstract available


    September 2020
  1076. POSADA-DUQUE RA, Cardona-Gomez GP
    CDK5 Targeting as a Therapy for Recovering Neurovascular Unit Integrity in Alzheimer's Disease.
    J Alzheimers Dis. 2020 Sep 28. pii: JAD200730. doi: 10.3233/JAD-200730.
    PubMed     Abstract available


  1077. SI Z, Wang X
    The Neuroprotective and Neurodegeneration Effects of Heme Oxygenase-1 in Alzheimer's Disease.
    J Alzheimers Dis. 2020 Sep 28. pii: JAD200720. doi: 10.3233/JAD-200720.
    PubMed     Abstract available


  1078. GEERTS H, Spiros A
    Simulating the Effects of Common Comedications and Genotypes on Alzheimer's Cognitive Trajectory Using a Quantitative Systems Pharmacology Approach.
    J Alzheimers Dis. 2020 Sep 28. pii: JAD200688. doi: 10.3233/JAD-200688.
    PubMed     Abstract available


  1079. DUARTE-GUTERMAN P, Albert AY, Inkster AM, Barha CK, et al
    Inflammation in Alzheimer's Disease: Do Sex and APOE Matter?
    J Alzheimers Dis. 2020 Sep 27. pii: JAD200982. doi: 10.3233/JAD-200982.
    PubMed     Abstract available


  1080. TORRES-ACOSTA N, O'Keefe JH, O'Keefe EL, Isaacson R, et al
    Therapeutic Potential of TNF-alpha Inhibition for Alzheimer's Disease Prevention.
    J Alzheimers Dis. 2020 Sep 27. pii: JAD200711. doi: 10.3233/JAD-200711.
    PubMed     Abstract available


  1081. TALAN J
    A Life Committed to Changing the Face of Alzheimer's.
    J Alzheimers Dis. 2020 Sep 25. pii: JAD201108. doi: 10.3233/JAD-201108.
    PubMed    


  1082. LI D, Liu Y, Zeng X, Xiong Z, et al
    Quantitative Study of the Changes in Cerebral Blood Flow and Iron Deposition During Progression of Alzheimer's Disease.
    J Alzheimers Dis. 2020 Sep 25. pii: JAD200843. doi: 10.3233/JAD-200843.
    PubMed     Abstract available


  1083. YUAN X, Wang L, Tendon N, Sun H, et al
    Triheptanoin Mitigates Brain ATP Depletion and Mitochondrial Dysfunction in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2020 Sep 25. pii: JAD200594. doi: 10.3233/JAD-200594.
    PubMed     Abstract available


  1084. CARDOSO R, Lemos C, Oliveiros B, Rosario Almeida M, et al
    APOEvarepsilon4-TOMM40L Haplotype Increases the Risk of Mild Cognitive Impairment Conversion to Alzheimer's Disease.
    J Alzheimers Dis. 2020 Sep 25. pii: JAD200556. doi: 10.3233/JAD-200556.
    PubMed     Abstract available


  1085. ABDELNOUR C, Esteban de Antonio E, Perez-Cordon A, Lafuente A, et al
    Managing Clinical Trials for Alzheimer's Disease During the COVID-19 Crisis: Experience at Fundacio ACE in Barcelona, Spain.
    J Alzheimers Dis. 2020 Sep 23. pii: JAD200750. doi: 10.3233/JAD-200750.
    PubMed     Abstract available


  1086. MOREIRA NCDS, Lima JEBF, Chierrito TPC, Carvalho I, et al
    Novel Hybrid Acetylcholinesterase Inhibitors Induce Differentiation and Neuritogenesis in Neuronal Cells in vitro Through Activation of the AKT Pathway.
    J Alzheimers Dis. 2020 Sep 23. pii: JAD200425. doi: 10.3233/JAD-200425.
    PubMed     Abstract available


  1087. KATHERINE BLUJUS J, Elizabeth Korthauer L, Awe E, Frahmand M, et al
    Single Nucleotide Polymorphisms in Alzheimer's Disease Risk Genes Are Associated with Intrinsic Connectivity in Middle Age.
    J Alzheimers Dis. 2020 Sep 20. pii: JAD200444. doi: 10.3233/JAD-200444.
    PubMed     Abstract available


  1088. XIA Y, Yassi N, Raniga P, Bourgeat P, et al
    Comorbidity of Cerebrovascular and Alzheimer's Disease in Aging.
    J Alzheimers Dis. 2020 Sep 19. pii: JAD200419. doi: 10.3233/JAD-200419.
    PubMed     Abstract available


  1089. LI Y, Li S, Xu S, Yu H, et al
    Association of Androgens and Gonadotropins with Amnestic Mild Cognitive Impairment and Probable Alzheimer's Disease in Chinese Elderly Men.
    J Alzheimers Dis. 2020 Sep 19. pii: JAD200233. doi: 10.3233/JAD-200233.
    PubMed     Abstract available


    February 2020
  1090. ARNALDI D, Donniaquio A, Mattioli P, Massa F, et al
    Epilepsy in Neurodegenerative Dementias: A Clinical, Epidemiological, and EEG Study.
    J Alzheimers Dis. 2020 Feb 25. pii: JAD191315. doi: 10.3233/JAD-191315.
    PubMed     Abstract available


    January 2020
  1091. FALGAS N, Balasa M, Bargallo N, Borrego-Ecija S, et al
    Diagnostic Accuracy of MRI Visual Rating Scales in the Diagnosis of Early Onset Cognitive Impairment.
    J Alzheimers Dis. 2020 Jan 13. pii: JAD191167. doi: 10.3233/JAD-191167.
    PubMed     Abstract available


  1092. HAMILTON RKB, Phelan CH, Chin NA, Wyman MF, et al
    The U-ARE Protocol: A Pragmatic Approach to Decisional Capacity Assessment for Clinical Research.
    J Alzheimers Dis. 2020;73:431-442.
    PubMed     Abstract available


  1093. WANG YL, Chen W, Cai WJ, Hu H, et al
    Associations of White Matter Hyperintensities with Cognitive Decline: A Longitudinal Study.
    J Alzheimers Dis. 2020;73:759-768.
    PubMed     Abstract available


  1094. ECKERSTROM C, Eckerstrom M, Gothlin M, Molinder A, et al
    Characteristic Biomarker and Cognitive Profile in Incipient Mixed Dementia.
    J Alzheimers Dis. 2020;73:597-607.
    PubMed     Abstract available


  1095. REIMAND J, Groot C, Teunissen CE, Windhorst AD, et al
    Why Is Amyloid-beta PET Requested After Performing CSF Biomarkers?
    J Alzheimers Dis. 2020;73:559-569.
    PubMed     Abstract available


  1096. ROBINSON AC, Chew-Graham S, Davidson YS, Horan MA, et al
    A Comparative Study of Pathological Outcomes in The University of Manchester Longitudinal Study of Cognition in Normal Healthy Old Age and Brains for Dementia Research Cohorts.
    J Alzheimers Dis. 2020;73:619-632.
    PubMed     Abstract available


  1097. KLINEDINST BS, Le ST, Larsen B, Pappas C, et al
    Genetic Factors of Alzheimer's Disease Modulate How Diet is Associated with Long-Term Cognitive Trajectories: A UK Biobank Study.
    J Alzheimers Dis. 2020;78:1245-1257.
    PubMed     Abstract available


  1098. ZHANG Y, Hao Y, Li L, Xia K, et al
    A Novel Computational Proxy for Characterizing Cognitive Reserve in Alzheimer's Disease.
    J Alzheimers Dis. 2020;78:1217-1228.
    PubMed     Abstract available


  1099. SRIVASTAVA A, Das B, Yao AY, Yan R, et al
    Metabotropic Glutamate Receptors in Alzheimer's Disease Synaptic Dysfunction: Therapeutic Opportunities and Hope for the Future.
    J Alzheimers Dis. 2020;78:1345-1361.
    PubMed     Abstract available


  1100. LIU N, Sun J, Wang X, Zhao M, et al
    The Impact of Dementia on the Clinical Outcome of COVID-19: A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2020;78:1775-1782.
    PubMed     Abstract available


  1101. KRESGE HA, Liu D, Gupta DK, Moore EE, et al
    Lower Left Ventricular Ejection Fraction Relates to Cerebrospinal Fluid Biomarker Evidence of Neurodegeneration in Older Adults.
    J Alzheimers Dis. 2020;74:965-974.
    PubMed     Abstract available


  1102. WATT G, Shang K, Zieba J, Olaya J, et al
    Chronic Treatment with 50 mg/kg Cannabidiol Improves Cognition and Moderately Reduces Abeta40 Levels in 12-Month-Old Male AbetaPPswe/PS1DeltaE9 Transgenic Mice.
    J Alzheimers Dis. 2020;74:937-950.
    PubMed     Abstract available


  1103. GRONTVEDT GR, Lauridsen C, Berge G, White LR, et al
    The Amyloid, Tau, and Neurodegeneration (A/T/N) Classification Applied to a Clinical Research Cohort with Long-Term Follow-Up.
    J Alzheimers Dis. 2020;74:829-837.
    PubMed     Abstract available


  1104. RICHARDSON K, Wharton SB, Grossi CM, Matthews FE, et al
    Neuropathological Correlates of Cumulative Benzodiazepine and Anticholinergic Drug Use.
    J Alzheimers Dis. 2020;74:999-1009.
    PubMed     Abstract available


  1105. ZHANG J, Hua XF, Gu J, Chen F, et al
    High Mobility Group Box 1 Ameliorates Cognitive Impairment in the 3xTg-AD Mouse Model.
    J Alzheimers Dis. 2020;74:851-864.
    PubMed     Abstract available


  1106. SUNDSTROM A, Sorman DE, Hansson P, Ljungberg JK, et al
    Mental Demands at Work and Risk of Dementia.
    J Alzheimers Dis. 2020;74:735-740.
    PubMed     Abstract available


  1107. BREWER GJ, Herrera RA, Philipp S, Sosna J, et al
    Age-Related Intraneuronal Aggregation of Amyloid-beta in Endosomes, Mitochondria, Autophagosomes, and Lysosomes.
    J Alzheimers Dis. 2020;73:229-246.
    PubMed     Abstract available


  1108. VERGOUW LJM, Bosman B, van de Beek M, Salome M, et al
    Family History is Associated with Phenotype in Dementia with Lewy Bodies.
    J Alzheimers Dis. 2020;73:269-275.
    PubMed     Abstract available


  1109. ARFANAKIS K, Evia AM, Leurgans SE, Cardoso LFC, et al
    Neuropathologic Correlates of White Matter Hyperintensities in a Community-Based Cohort of Older Adults.
    J Alzheimers Dis. 2020;73:333-345.
    PubMed     Abstract available


  1110. TSUNODA K, Yamashita T, Osakada Y, Sasaki R, et al
    Early Emergence of Neuropsychiatric Symptoms in Cognitively Normal Subjects and Mild Cognitive Impairment.
    J Alzheimers Dis. 2020;73:209-215.
    PubMed     Abstract available


  1111. DAVIDOWITZ EJ, Krishnamurthy PK, Lopez P, Jimenez H, et al
    In Vivo Validation of a Small Molecule Inhibitor of Tau Self-Association in htau Mice.
    J Alzheimers Dis. 2020;73:147-161.
    PubMed     Abstract available


  1112. PARVAND M, Rankin CH
    Is There a Shared Etiology of Olfactory Impairments in Normal Aging and Neurodegenerative Disease?
    J Alzheimers Dis. 2020;73:1-21.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: